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Abstract
DYSPNEA: EFFECT OF AURICULAR ACUPRESSURE IN END STAGE LUNG
CANCER PATIENTS, A PILOT FEASIBILITY STUDY
Roger A. Strong, Ph.D., RN
Hahn School of Nursing and Health Sciences
University of San Diego, San Diego, C A
Jane Georges, Ph.D. RN, Advisor
Introduction: Dyspnea is a debilitating symptom, common in advanced lung cancer
patients, and poorly controlled. The National Institutes of Health has promoted the need
for research regarding end of life care symptom control.
Purpose: Conduct a feasibility study evaluating auricular acupressure effects on dyspnea
in hospice lung cancer patients.
Theoretical Framework: The UCSF School of Nursing Symptom Management Faculty
Group's Model for Symptom Management was used for the conceptual framework. The
model includes three dimensions: symptom experience, symptom management strategies,
and symptom outcomes. The Human Energy Field Theory provided context for using
auricular acupressure.
Aim: Conduct a pilot study evaluating feasibility and effects of auricular acupressure on
dyspnea. Hypotheses: auricular-acupressure seed adhesive use on appropriate points plus
standard care (SC) would be more effective than usual care or usual care plus placebo in
(1) reducing dyspnea and (2) increasing oxygen saturation.
Methods: Both quantitative and qualitative methods. Sample -11 hospice patients with
lung cancer and dyspnea. Procedure - 8 times (Day 1 baseline and post intervention,
Days 2 early-late, 3 early-late, 4 early-late follow-ups) dyspnea was measured by the
Cancer Dyspnea Scale and oxygen saturation was measured by pulse-oximeter.

Qualitative questions were asked on Days 1 and 4. A trained professional administered
the acupressure intervention after baseline assessments. Design - The experimental
design included 3 conditions with eight measurement points in time. Patients were
randomly assigned to one of three treatment conditions: (1) Standard Care; (2) Standard
Care with seed adhesive on inappropriate points (placebo); (3) Standard Care with seed
adhesive Auricular acupressure on appropriate points. The results were analyzed using
analysis of variance (ANOVA).
Results: Both quantitative and qualitative analyses supported the presence of acupressure
effects with medium to large effects and a significant effect for dyspnea effort.
Conclusions: Although difficult to recruit patients to a trial of alternative therapy in
advanced disease, it is possible to test such treatments that potentially can improve
symptoms in palliative care. Auricular acupressure may help ameliorate dyspnea. There
is a continued need for symptom control at end of the life. The role of nursing is central
to end of life care.
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Preface
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Chapter 1 Introduction and Significance
Dyspnea & Context
Dyspnea Definition and Prevalence
Dyspnea as a word is derived from ancient Greek; "dys," means disordered or
abnormal and "pnoia" means breath. Hence, dyspnea is literally translated as meaning
disordered breathing. Dyspnea, also often called breathlessness or shortness of breath, is
a common and debilitating symptom of advanced lung cancer patients (Thomas & von
Gunten, 2006; Bruera, Sweeney, Ripamonti, 2002; Ahmedzai, 1993; Cowcher & Hanks,
1990).
In advanced lung cancer patients, reports give a range of dyspnea occurrence of
21% to 79% (Ripamonti, 1999) and Yoder (2006) reports on research showing that 60%
of lung cancer patients develop dyspnea early and that about 65% experience dyspnea
sometime during their illness. These prevalence estimates are also in line with Bruera,
Schmitz, Pither, Neumann, and Hanson's (2000) report of a 55% incidence of dyspnea in
ambulatory terminally ill cancer patients (not all of whom had lung cancer). Additional
reports on dyspnea incidence rates are presented below in the section, 'Research Needed
Regarding End-of-Life Symptom Management.'

Nursing Mandate to Study Dyspnea
A symptom of cardiopulmonary disorder, dyspnea is assessed and managed by
nurses in both as an acute and a chronic problem. In a classic review of the sensation of
dyspnea, Carrieri-Kohlman, Janson-Bjerklie, and Jacobs (1984) wrote: "In the recent
social policy statement by American Nurses' Association [ANS, 1980], nursing was
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defined as the diagnosis and treatment of human responses to health problems.
Subsequently, the symptom of ineffective breathing patterns has been listed as an
accepted nursing diagnosis at the Fifth National Conference on Nursing Diagnosis, April
1982, St. Louis. [Kim & Moritz DA, 1982]. These documents provide a mandate for
nurses to study the measurement and management of symptoms and responses to illness,
dyspnea being an example."
In her overview article on terminal dyspnea, LaDuke (2001) maintains, even in
her title, "Patient deaths are inevitable. 'Bad deaths' - those accompanied by severe
suffering ~ are not." She notes that dyspnea is characterized by subjective awareness of
uncomfortable and difficult breathing. Many patients describe the experience as
agonizing and even worse than pain. Terminal dyspnea, sometimes described as "air
hunger" (Tarzian, 2000), is present in as many as 75% of those who are dying (Rousseau,
1997). In fact, dyspnea should probably be expected in most dying patients (Berry,
2002). Even though dyspnea is often thought of as characteristic of chronic obstructive
pulmonary disease (COPD), pneumonia, heart failure, and pulmonary system
malignances, it can and does appear in the absence of any cardiopulmonary pathology
(Rousseau, 1999). Nursing professionals are those who most often respond to dyspnea's
appearance. Inzeo and Tyson (2003) specifically identify the key role of nursing in the
assessment and management of dyspneic patients with lung cancer and Indelicato (2007)
provides both an overview of and 72 references for "The advanced practice nurse's role
in palliative are and the management of dyspnea."
Dyspnea is not always well assessed or well managed. Three nurses, Webb,
Moody, and Mason (2000) note this and describe dyspnea assessment and management in
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72 hospice patients using a retrospective, descriptive design with chart audits as the
source of data. They conclude that dyspnea assessment needs to be frequently done
employing standardized instruments to evaluate intensity of dyspnea and accompanying
distress. Additionally, they recommend that these types of instruments be used in clinical
trials to determine treatment effectiveness.

Theoretical Models
How does one begin to understand the phenomenon that is labeled dyspnea?
Beyond attempting to develop some way to organize the information about dyspnea,
Lenz, Suppe, Gift, Pugh, and Milligan (1995) make the case that use of middle-range
theories as oppose to grand theories or broad-scope conceptual frameworks will enhance
the generation of new knowledge. They argue that placing greater emphasis on such
middle-range theories will more efficiently and quickly advance theory-research and
theory-practice linkages. These authors cite Merton (1968) as describing middle-range
theories as those falling between working hypotheses, an essential part of carrying out
research and "the all-inclusive systematic efforts to develop a unified theory [of the
discipline]." (p 39)
Lenz et al. (1995) list some middle-range theories that have been developed by
nurses and point out that these middle-range theories are now being used in an increasing
number of clinical and research settings. These include such middle-range theories as
Mishel's (1988, 1990) theory of uncertainty in illness, Cox's (1982) interaction model of
client health behavior, Morse and Johnson's (1991) illness constellation model, and
Pender's (1987) model of health promotion and illness prevention.

Prominent among those in nursing scholarship that support the importance of
middle-range theories is the UCSF School of Nursing Symptom Management Faculty
Group (Dodd, Janson, Facioine, Faucett, Froelicher, Humphreys, Lee, Miaskowski,
Puntillo, Rankin, & Taylor, 2001). They state, "The UCSF faculty members are
committed to developing symptom management knowledge and middle range theories
are useful for this purpose" (p 675). This UCSF group themselves have proposed a
Symptom Management Conceptual Model (SMCM, Dodd, et al. 2001) updated and
revised from their earlier model (Larson, Carrieri-Kohlman, Dodd, Douglas, Faucett,
Froelicher, Gortner, Halliburton, Janson, Lee, Miaskowski, Savedra, Stotts, Taylor,
Underwood, 1994a, 1994b). See figure 1 for a schematic presentation of the Revised
Symptom Management Conceptual Model (RSMC Model).
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Figure 1. Revised Symptom Management Conceptual Model (RSMC Model).
This is an evidence-based conceptual model for symptom management that has
three basic dimensions: symptom experience, symptom management strategies, and
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outcomes. Within the model, "a symptom is defined as a subjective experience reflecting
changes in the biopsychosocial functioning, sensations, or cognition of an individual"
(Dodd et al. 2001, p. 669). The model describes the interrelatedness of the three
dimensions within three domains of nursing science (person domain, health & illness
domain, and environmental domain). Within the symptom experience dimension, there
are three sub-dimensions of perception of symptoms, evaluation of symptoms, and
response to symptoms. It is based on five assumptions: (1) the gold standard for
understanding and studying symptoms is the perception of the individual experiencing
the symptom and the individual's report of the experience; (2) the symptom need not be
experienced by an individual in order for the symptom management model to be applied
since the individual can be at risk for symptom development from the impact of a context
variable such as a work hazard and intervention strategies can be initiated before the
symptom is experienced by the individual; (3) nonverbal patients such as infants or poststroke aphasic individuals may experience symptoms where the interpretation by a parent
or caregiver is accepted as accurate for intervention purposes since all troublesome
symptoms need to be managed; (4) the target of management strategy can be the level of
the individual, group, family, or work environment; (5) symptom management is a
dynamic process in that it is modified by individual outcomes and the influences of the
three nursing domains of person, health/illness, and environment. Note should be made
that the authors' statement of six assumptions in their 2000 article is incorrect. There are
only five listed in that article and, indeed, Elfreida O'Neil reported to this researcher that
the assumptions do number only five (O'Neil, personal communication, 2004).
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Research Needed Regarding End-of-Life Symptom Management
The National Institutes of Health has identified a need for research regarding
symptom management and end of life care (Grady, 2005; National Institutes of Health,
2005). In setting research priorities specifically in respiratory nursing, the American
Thoracic Society (1998) included the need for research on specific interventions for
ameliorating dyspnea. A common end of life diagnosis that comes with panoply of
difficult to manage symptoms is lung cancer. More people die of lung cancer than of
colon, breast, and prostate cancers combined. The American Cancer Society estimates
that there were 170,000 people in 2006 that had lung cancer with an estimated 162,000
deaths. For 2008, there are an estimated 215,020 cases of lung cancer in the United
States (American Cancer Society, 2008). The numbers simply keep climbing.
There are two major types of lung cancer: non-small cell and small cell. Nonsmall cell lung cancer (NSCLC) is the most common type (Shepherd, 1994). Cooley
(1998) reported that for both men and women in North American, lung cancer is the
number one cause of cancer mortality (Parker, Tong, Bolden, & Wingo, 1997). In 2007
this is apparently still the case and Arenberg (2007) points out that though lung cancer
leads in cancer causing deaths, it does not lead in the amount of research funds.
Many advanced cancer patients avail themselves of the services of hospices.
Weitzner, Moody, and McMillan (1997) report that a retrospective review of charts from
a large hospice in west-central Florida identified the most common physical problem
among cancer patients was pain (87%), with dyspnea being the second most common
physical problem (56%). These percentages are higher than those reported by Vainio and
Auvinen (1996), although it should be noted that Vainio and Auvinen collected data on
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admission to hospice care, while Witzner et al. collected data from patients closer to
death. In a sample of ambulatory patients with advanced lung cancer, Tanaka, Akechi,
Okuyama, Nishiwaki, & Uchitomi (2002) found that over half (55%) the sample
experienced clinical dyspnea as measured by the Cancer Dyspnea Scale (CDS) and the
Dyspnea Numeric Scale (DNS). Also, Dudgeon, Kristjanson, Sloan, Lertzman, and
Clement (2001) found a similar prevalence (46%) in a very large (over 900) sample of
ambulatory lung cancer patients. More agreement on this general prevalence rate finding
is found in the Skaug, Eide, and Gulsvik (2007) Norwegian community study looking at
lung cancer diagnosed cases within a defined hospital area from 1990 to 1996. Here,
dyspnea was found in 54% of the cases. Finally, Doorenbos, Given, Given, and
Verbitsky (2006) reported that, in their study of symptom experience in the last year of
life for individuals with cancer, dyspnea was in the top five most prevalent symptoms.
They also note that in their last year of life, patients with lung cancer experienced more
symptoms than those with other solid tumor cancers.
The World Health Organization (1990) defines palliative care as the provision of
relief from pain and other distressing symptoms. Management of symptoms is a crucial
part of the role of nursing in the hospice setting. Besides pain, a critically important
symptom for those with impaired breathing is dyspnea. Yet research reveals that dyspnea
is frequently inadequately assessed and reported (Moody, McCormick, & Williams,
1990). Good symptom control is important generally, especially for common symptoms
such as dyspnea (Vignaroli and Bruera, 2006), and is achieved for dyspnea less
frequently than for other symptoms including pain and nausea (Higginson & McCarthy,
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1989; Kazanowski, 2001). This may be due to dyspnea not being adequately assessed
near end of life (Escalante, Martin, Eltin, Cantor, Harle, Price, and Kish, 1996).
Manzullo, E.F. & Rubenstein, E.B. (1996).). Witzner et al. (1997) note: "Few
intervention studies exist that have demonstrated which methods of treating dyspnea
work best. Clinical guidelines for dyspnea are needed such as those developed for pain.
Interestingly, the historical model of assessment of the experience of dyspnea is the
assessment of pain (Matzo et al. 2001).
This research addressed the symptom of dyspnea within advanced lung cancer
patients in a hospice setting. For hospice care patients, symptom management is a central
goal of treatment. Sadly, as noted above dyspnea is inadequately assessed at end of life
and is less frequently controlled well than other symptoms including the symptom of pain
(Higginson & McCarthy, 1989; Kazanowski, 2001). One option for ameliorating the
experience of dyspnea in this patient population would be auricular acupressure, a
complementary alternative intervention.

Dyspnea Assessment
In nursing science, theoretical models are utilized as a basis for the development
of new instruments. Conversely, it is also the case that the new instruments of
measurement lead to revised or new theoretical models. The following, then, is a brief
description of the development of current dyspnea measures.
Earlier definitions of dyspnea were based on objective symptoms, sometimes
referred to as signs, such as "difficult or disordered breathing" (Williams, 1845). A
hundred years later, there were still some confusing of symptoms and signs, e.g., Wright
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and Branscomb's (1954) "difficult, labored, uncomfortable breathing." Today, the
general consensus is that the dyspnea is a subjective symptom, experienced by the patient
only, and reported by the patient (American Thoracic Society, 1999). Even in the 1950s
and 60s when the research on dyspnea primarily dealt with the impact of mechanical
loads on respiratory symptoms (Howell & Campbell, 1966), there was an awareness that
dyspnea may come with several different qualities (hence, as experienced by the patient),
and that the sense of effort (again, something experienced by the patient) was the primary
component of breathing discomfort (American Thoracic Society, 1999). In their article
on symptom control in palliative care, Fabbro, Dalai, and Bruera (2006) were careful to
point out both that dyspnea is a subjective symptom and that objective assessments (e.g.,
tachypnea and oxygenation saturation levels) "may not adequately reflect the distress
experience by patients with dyspnea." (p 423).
There is an astonishing array of instruments for measuring dyspnea. Table 1
provides an alphabetical listing of most of them. Researchers aiming at the development
of dyspnea assessment tools have addressed the many different aspects of the
phenomenon. These range from in-depth interviews to simple visual analogue scales, and
include retrospective reports of impact of breathlessness, current descriptions of a
symptom being immediately experienced, descriptors of breathlessness,
psychophysiological magnitude estimation, and single factor and multi-factor scales. The
range of attempts to describe dyspnea is immense. As with dyspnea itself, some
approach to organizing the assessments of dyspnea is needed. In Chapter Two, four
general schemes for accomplishing this are presented. McCord and Cronin-Stubb (1992)
use four domains within a model of dyspnea: culture, environment, perception, and
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psychological status. Carrieri-Kohlman and Janson (1999) use four descriptive
categories for classification of degrees of dyspnea (qualitative descriptions, intensity,
affective components, and activities of daily living). Sorenson (2000) presents three
content groupings of dyspnea (activities of daily living, exercise, and health-related
quality of life), while Cullen and Rodak (2002) use six clinical utility categories for
grouping (exercise, activities of daily living, benchmark, outcome, responsiveness, and
clinical trials) and two dimensions of assessment in evaluating the clinical utility of
interventions (the discriminative versus the evaluative instruments). The choice of
dyspnea measurement should be made keeping in mind the purpose of the study and
populations of the studies within which a measurement was developed.

Hospice and Palliative Care
The unique population that seeks hospice and palliative care and the nature of the
services in this area being prevention and relief of suffering are the sources of concerns
and issues regarding research in this area (Ferrell and Grant, 2001; Addington-Hall,
2007). Terminally ill patients are a vulnerable group, research participation can be
burdensome, and the methods that best address the questions need to be carefully
evaluated. Hence, there are both ethical and research methodological issues involved. A
number of research approaches to the challenges involved have been proposed. In the
current study, efforts were made to lessen the participation burden as much as possible,
clear consent procedures were developed, and both quantitative and qualitative methods
were used as part of the research design. Indeed, in spite of challenges in hospice and
palliative care, research must be conducted in order to build an evolving knowledge base
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that allows for the delivery of quality hospice and palliative care. As Ferrell (2004)
asserts, "Improved care will not happen without inquiry." (p. 408)

Traditional Chinese Medicine, Acupuncture, and Acupressure
Acupuncture is an ancient Chinese procedure for alleviating many different types
of medical complaints. It involves the use of needles that are inserted in specified points
of the body. Such insertion is assumed to change the flow of energy along meridians in
the human body. Acupressure is assumed to produce similar effects, but by applying
pressure to specified points of the body.
Some reviews of treatment for dyspnea already include sections on acupuncture
and acupressure. Manning (2000), writing in the journal Respiratory Care, included
these two procedures in his section on alternative medicine. His review concluded that
traditional acupuncture produced greater improvement in breathlessness ratings and the
6-min walk distance than did a placebo acupuncture procedure. Also, in a study that did
not use a control condition, acupuncture generated "prompt and significant improvements
in dyspnea, relaxation, and anxiety." (p 1348) Manning also reported that patients using
auricular acupressure, a procedure related to Auricular acupressure, demonstrated
significantly lower visual analog scale (VAS) ratings of breathlessness for real versus
sham acupoints. See Chapter Two for details of these and other studies.

Research Purpose and Hypotheses
The focus of this research was on those individuals in a hospice program who
have the diagnosis of lung cancer, a prognosis of less than six months, and the specific
symptom of dyspnea.
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The overall purpose of this research was to function as a pilot feasibility study on
evaluating the effects of Auricular acupressure on dyspnea (shortness of breath) in
terminal lung cancer patients. The general research question was to determine whether
the dependent variable, dyspnea, would be differentially decreased in hospice lung cancer
patients across three levels of the independent variable, treatment condition. The three
levels of the independent variable consisted of Auricular acupressure plus standard of
care, sham Auricular acupressure plus standard of care, and standard of care.
Additionally, a simple thematic analysis qualitative method was used to place the
quantitative results in a broader and richer context [Braun and Clarke, 2008].
It is important to collect qualitative data in symptom and palliative care research.
Such data provide a source of richness regarding the experience of those individuals with
the symptoms of interest and this information may not be captured by quantitative
methods only. Additionally, qualitative data can compliment and reinforce the
quantitative results.
To address this specific aim and the general question, there were three basic
hypotheses:
Hypothesis 1. Over four days there would be a decrease in dyspnea for the
standard care plus seed adhesive Auricular acupressure group compared to a standard
care group and a standard care non-appropriate seed point adhesive placebo group.
Hypothesis 2. Over four days there would be an increase in the levels of oxygen
saturation for standard care plus seed adhesive Auricular acupressure group compared to
a standard care group and a standard care non-appropriate seed point adhesive placebo
group.
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Chapter Two, the background and literature, presents detail regarding the
theoretical framework, models of dyspnea, issues of dyspnea assessment, and a brief
background on traditional Chinese medicine, acupuncture, and acupressure. Chapter
Three, the methods section, presents the research design, the sample, data collection
procedures, measurement, the experimental procedure, and data analysis.
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Chapter 2 Background and Literature Review
The purpose of this research was to conduct a pilot feasibility study regarding
evaluating the effects of Auricular acupressure on dyspnea in hospice lung cancer
patients. This literature review will provide a critique and synthesis of the current
knowledge regarding dyspnea. The theoretical framework guiding this study will be
described and critiqued along with a presentation of efforts to describe and understand
dyspnea, followed by an analysis of alternative models of dyspnea. The instrument that
was used to assess dyspnea in this study will be presented and placed within the context
of a description of critiques of alternative instruments for measuring dyspnea. Finally, a
description of the basis for Chinese medicine will be presented along with acupuncture
and acupressure as medical treatments.

Theoretical Framework
Symptom Management Model (RSMC)
The UCSF School of Nursing Symptom Management Faculty Group's Model for
Symptom Management was used as the conceptual framework for this study (Larson, et
al.l994a, 1994b; Dodd et al, 2001). Interestingly, after this model was proposed in 2005
for this research, the researcher found that later another doctoral student adopted this
same model for her study of dyspnea in patients with lung cancer under palliative care (I.
Henoch, personal communication, February 11,2008; Henoch, 2007). The model's
broad perspective of symptom management includes three dimensions: symptom
experience, symptom management strategies, and symptom outcomes. See Figure 1 for a
schematic diagram of the RSCM Model (Dodd et al, 2001). As Dodd et. al. (2001) state,

15
"Healthcare providers have difficulty developing symptom management strategies that
can be applied across acute and home-care settings because few models of symptom
management have been tested empirically" (p 669). The RSCM model is a generic
symptom management model that can provide direction for "selecting clinical
interventions, informing research, and bridging an array of symptoms associated with a
variety of disease and conditions" (p. 669). The model also has as its base, the nature of
the individual's experience of the symptom.
Dyspnea as Symptom
Many advanced cancer patients avail themselves of hospice services. For hospice
care patients, symptom management is one of the central goals of treatment. Dyspnea is
one of the most important symptoms. Dyspnea is also less frequently controlled well
than other symptoms including the symptom of pain (Higginson & McCarthy, 1989).
Interestingly the model of assessment of dyspnea is the assessment of pain (Matzo et al.
2001).
When asked what his experience of breathlessness was like, one patient reported
that the dyspnea sensation was like "being at the bottom of a swimming pool, struggling
but unable to reach the top to breathe" (Dudgeon & Rosenthal, 1996). Asking the patient
what he or she experiences is crucial in evaluating dyspnea, since dyspnea is a sensory
experience perceived and interpreted by the patient (Widimsky, 1979; Carriere-Kohlman,
Janson-Bjerklie, & Jacobs, 1984; American Thoracic Society, 1999; Dodd et al., 2001).
Indeed, symptom experience is one of the three dimensions in the RSMC Model (Dodd et
al. 2001). Within the model, the person is viewed as central, with the person's symptom
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experience itself having three components: (1) perception of the symptom (a change in
sensation); (2) evaluation of the symptom (interpretation); (3) response to symptom.
Researchers and clinicians have attempted to define dyspnea through various
metaphors (American Thoracic Society, 1999). These include such descriptions as "an
uncomfortable sensation of breathing" (Mahler & Schwartzstein, 1995); "the sensation of
feeling breathless or experiencing air hunger" (Simon, Schwartzstein, Weiss, LaHive,
Fencl, Teghtsoonian, & Weinberger, 1989); "difficult, labored, uncomfortable breathing"
(Wright & Branscomb, 1954); and "awareness of respiratory distress" (Wasserman &
Cassaburi, 1988). These attempts at descriptive definition mix symptoms (what patients
report they are feeling) and physical signs (what a physician or nurse observes about the
patient such as the patient exhibiting labored breathing). It is important to remember that
only the person who is experiencing a symptom can describe it.
Even though it is the patient who describes a symptom that is experienced, it is
possible to generate a more general definition of dyspnea while preserving the necessary
attribute of it being a subjective experience. The American Thoracic Society offered this
broad definition (1999): "[W]e suggest that dyspnea is a term used to characterize a
subjective experience of breathing discomfort that consists of qualitatively distinct
sensations that vary in intensity. The experience derives from interactions among
multiple physiological, psychological, social, and environmental factors, and may induce
secondary physiological and behavioral responses." An examination of the Figure 1
RSMC Model reveals how well the general model of symptom management and this
broad definition of the specific symptom dyspnea agree regarding the symptom
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experience. Both identify three components of the symptom experience: perception of,
evaluation of, and response to symptoms.
Given that the literature consistently presents dyspnea as a subjective symptom
(Carrieri-Kohlman, Janson-Bjerklie, & Jacobs, 1984; Gift, 1987; Cockcroft, Adams, &
Guz, 1989; Lenz et al, 1995; American Thoracic Society, 1999; Wilcock, Crosby, Hughs,
Fielding, Corcoran, Tattersfield, 2002) and that it is detected only by the patient who
reports the sensation of difficult or labored breathing, it may be helpful to examine the
language of breathlessness. That is, how do patients describe breathlessness; what
descriptors do they use? Importantly, in the development phase of their instrument, the
Cancer Dyspnea Scale, Tanaka, Akechi, Okuyama, Nishiwaki, & Uchitomi (2000)
interviewed dyspneic patients in a thoracic oncology division and palliative care unit.
Additionally, they brainstormed with the staff of the same unit and reviewed papers on
dyspnea. Eventually, the developmental and validation processes reduced an initial set of
179 terms to 24 (see Appendix for these CDS items).
There were earlier attempts to examine the language of breathlessness often using
qualitative methods. Simon, Schwartzstein, Weiss, LaHive, Fencl, Teghtsoonian, &
Weinberger (1989) interviewed patients with a variety of cardiac and pulmonary diseases,
compiling a list of 19 descriptors of breathlessness. Interestingly, when the researchers
used eight different stimuli to induce breathlessness in 30 subjects who then chose
descriptors from the list best capturing how they felt, separate groups of descriptors
emerged for varying stimuli. The authors surmised that the label breathlessness might
actually apply to many different sensations. Indeed, in a follow-up study, Simon,
Schwartzstein, Weiss, LaHive, Fencl, Teghtsoonian, & Weinberger (1990) found patients
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were able to distinguish different sensations of breathlessness. Additionally, there was
some association between the underlying disease and the qualitative descriptors selected.
Elliot, Adams, Cockcroft, Macrae, Murphy, & Guz (1991) conducted a study of
hospital staff, beginning with 18 qualitative descriptors of breathlessness discomfort from
the Simon et al. (1989) study. They circulated the 18 descriptors among hospital staff,
and asked for additional descriptors of the staffs respiratory sensations during exercise.
Twelve respiratory physicians on the staff were asked to contribute descriptors used by
patients. This generated 45 descriptors. These were then given to five senior nurses who
recommended changes of the descriptors for greater ease of understanding by patients.
Patients (N= 208) who described breathing troubles during walking, running, or climbing
stairs were then given the list of descriptors and asked to rate them for agreement with
their own sensations on two separate occasions, using response options of yes, no, or
don't know. Some items were more consistent over time than others, but the descriptors
did group into 12 clusters and 169 of the 208 patients were considered reliable in their
responses over the two administrations. Again, there was an association between
descriptors endorsed and underlying disorders. For example, chronic obstruction airway
disease (COAD) patients were more likely to endorse distress, asthma patients to endorse
wheeziness, restrictive airway disease patients to endorse rapid breathing, and cardiac
patients to choose a need to sigh. A more recent study (Wilcock, Crosby, Hughs,
Fielding, Corcoran, Tattersfield, 2002) using only 15 descriptors of breathlessness also
found that patients with different diagnoses (six sub-groups of lung cancer diagnosis four
sub-groups of nonmalignant cardiorespiratory disease diagnosis) were differentially
likely to endorse the descriptors. Such relationships would support the RSMC Model in

19
that the Health and Illness domain (e.g., disease) would impact the perception of a
symptom within the symptom experience dimension.
It would appear that Sorenson (2001) was correct in stating, "Since this symptom
manifests differently in each patient, it would be impossible to design a one-size-fits all
instrument to assess dyspnea or serve as an outcome measure in dyspnea control"
(pl331). This is echoed by Cullen & Rodak (2002) in their article assessing the clinical
utility of breathlessness measures, which they state may have different clinical utility for
different diagnoses. Additionally, the American Thoracic Society Consensus Guideline
on Dyspnea (1999) directs that dyspnea assessments should be applied as related to the
purpose for which they were designed: "Any assessment of dyspnea must take into
consideration the question being asked. Are we trying to measure the intensity or quality
of the sensation of respiratory discomfort or the emotional or behavioral response to the
discomfort?" (p 322)
An interesting qualitative methods study by Bailey (2004) was designed to
understand the affective component of dyspnea. Their focus was on the dyspnea-anxietydyspnea cycle in COPD patients' stories of breathlessness. Using 10 patient-family-nurse
units and an ethnographic research design with in-depth interviews and narrative analysis,
Bailey found that anxiety as manifested in a dyspnea-anxiety-dyspnea cycle for acute
episodes was an important component of the dyspnea experience. She maintains that this
component needs to be recognized by healthcare providers and she states that it is
potentially measurable. Presence of anxiety related to dyspnea was also found by Bruera
et al. (2000) who reported a correlation of .31 between dyspnea intensity and the level of
anxiety in 135 ambulatory terminally ill patients with cancer, of whom 55% manifested
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dyspnea. As noted below, Tanaka et al.'s (2000) Cancer Dyspnea Scale has three
dimensions, one of which is anxiety. Also, Chiu, Hu, Lue, Yao, Chen, and Wakai (2004)
found in their quantitative study of correlates of dyspnea in Taiwanese patients that
anxiety again makes an appearance. This appears to be a type of convergence of findings
between qualitative and quantitative research methods.
Joyce (M. Joyce, personal communication, February 19, 2008; Joyce, 2006), at
the 2006 UICC World Cancer Congress, reported her work reviewing qualitative research
on dyspnea in search for themes regarding the experience of dyspnea beyond the simple
description of the experience itself. She conducted a search using bibliographic
computerized databases between 1990 and 2005. This identified nine English language
citations for patients' experience of dyspnea being evaluated using qualitative methods.
Joyce has not yet published this work, but she did respond to an inquiry and send
the power point presentation that she used (M. Joyce, personal communication, February
19,2008) wherein she stated, "Qualitative research method is primary source of
exploring symptom experience." (2nd slide) The power point presentation also included
the references for the nine articles (Brown, Carrieri, Janson-Bjerklie, and Dodd, 1986;
DeVito, 1990; Roberts, Thome, and Pearson, 1993; O'Driscoll, Corner, and Bailey, 1999;
Shih and Chu, 1999; Bailey, 2001; Bailey and Tilley, 2002; Hately, Laurence, Scott,
Baker, and Thomas, 2003; Heinzer, Bish, and Detwiler, 2003). Using Forchuk and
Roberts' guidelines (1993) for critiquing qualitative research, Joyce found among these
nine articles the three qualitative methods of phenomenology, triangulation, and narrative
ethnography. Common across these nine studies were the three themes of profound fear,
loss of vitality, and the need to legitimize dyspnea distress.
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RSMC Model and Dyspnea
The use of the RSMC Model as the conceptual framework for this research is
supported by the conceptualization of dyspnea in the research literature. The consensus
now is that manifestations of subjective symptoms such as dyspnea are not simple
reflections of the intensity of the mechano- and chemo-receptor level (Tanaka et al
2002b; Ripamonti & Bruera, 1997; Bruera & Ripamonti, 1999). Moderators are thought
to amplify or decrease perceived dyspnea intensity at the cortical level and include such
as psychological state, cultural background, environment, and life experiences
(Ripamonti & Bruera, 1997; Bruera & Ripamonti, 1998). These assertions are supported
by studies that demonstrated significant relationships of dyspnea with such psychological
states as anxiety and depression in non-cancer samples (Dales, Spitzer, Schechter, et al.,
1989; O'Connor, Rablin, & Morgan, 1996) and anxiety in cancer patients (Bruera &
Ripamonti, 1998; Dudgeon & Lertzman, 1998). Dyspnea has also correlated with such
demographic factors as sex and age in non-cancer patients (O'Connor, Rablin, &
Morgan, 1996; Gijsbers Van Wijk & Kolk, 1997; Metlay, Schulz, Li YH, et al., 1997).
Environmental factors such as exposure to asbestos, coal dust, cotton dust or grain dust
were also related to presence of dyspnea (Dudgeon et al. 2001).
Dyspnea is a complex symptom, from its lack of systematic reflection of
underlying causes, to its multi-dimensionality, to its manifestation being related to the
individual, the environment, and the health or illness status of the person. One way to
organize this complexity and to generate strategies or guidelines for research and clinical
practice would be to conceptualize dyspnea within the RSMC Model.
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This RSMC model for symptom management is an evidence-based conceptual
model that has the three basic dimensions of (1) symptom experience, (2) symptom
management strategies, and (3) outcomes. Within the model, consistent with the
literature on dyspnea, "a symptom is defined as a subjective experience reflecting
changes in the biopsychosocial functioning, sensations, or cognition of an individual"
(Dodd et al. 2001, p. 669). The model describes the interrelatedness of the three basic
dimensions within the three domains of nursing science (1) person domain, (2) health &
illness domain, and (3) environmental domain. Again, consistent with dyspnea literature,
within the symptom experience dimension, there are three sub-dimensions of (1)
perception of symptoms, (2) evaluation of symptoms, and (3) response to symptoms. See
Figure 1 above or Appendix A for a graphic schematic of this model.
The RSMC Model is based on five assumptions: (1) the gold standard for
understanding and studying symptoms is the perception of the individual experiencing
the symptom and the individual's report of the experience; (2) the symptom need not be
experienced by an individual in order for the symptom management model to be applied,
since the individual can be at risk for symptom development from the impact of a context
variable such as a work hazard, and intervention strategies can be initiated before the
symptom is experienced by the individual; (3) nonverbal patients such as infants or poststroke aphasic individuals may experience symptoms where the interpretation by a parent
or caregiver is accepted as accurate for intervention purposes; (4) the target of
management strategy can be the level of the individual, group, family, or work
environment; (5) symptom management is a dynamic process in that it is modified by
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individual outcomes and the influences of the three nursing domains of person,
health/illness, and environment.
Congruent with the RSMC Model and the dyspnea literature, Bruera and
Ripamonti (1998) and Ripamonti (1998) recommended that a scale to measure dyspnea
for investigating etiology and establishing therapeutic strategies should have six
characteristics: (1) be multidimensional; (2) be self-rating since dyspnea is subjective;
(3) be easy and simple enough to be completed by patients with dyspnea; (4) be evaluated
not by physical effort evoking dyspnea, but by perceived dyspnea itself so that even
bedridden patients can complete it; (5) have its reliability and validity in cancer patients
confirmed; (6) be sensitive to clinical changes due to treatment or progression of the
disease over time.

Early Organizational Models of Dyspnea
Review of dyspnea models other than the RSMC Model not only provides an
historical perspective of the field, but also identifies the common components of a set of
models. In addition, this review will assist the reader in understanding the RMSC Model
itself, since it is the inheritor and improver of models developed over the last two
decades.
Interestingly, the first and second researcher names attached to models of dyspnea
are names that reappear and are associated with more than one model. The first name is
Virginia Carrieri-Kohlman, D.N.Sc, R.N. The second name is Audrey G. Gift, Ph.D.,
R.N. The field of nursing can thus lay-claim to the first models of dyspnea.
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Carrieri-Kohlman Dyspnea Variables Model
The model by Carrieri-Kohlman and colleagues (Carrieri-Kohlman, JansonBjerklie, & Jacobs, 1984) was intended as a means to begin organizing the broad range of
phenomena related to the complex construct of dyspnea. It was thus more a listing of
categories of dyspnea phenomena than the more dynamic models that would emerge over
time. Still, anyone who has attempted to grasp the literature surrounding any concept,
including those of different clinical symptoms, can appreciate the immense step it is to
present a way of organizing that material. The only name these researchers gave to their
model was "Variables Related To Dyspnea" (Carrieri-Kohlman et al. 1984, p 443).
Importantly, dimensions and components of later models can already be seen in
this heuristic organizing of variables related to dyspnea. The three general domains of
variable listing echo through later models: personal, health status, and situational. These
domains were conceptualized as being related to two groupings of amelioration
strategies: patient coping strategies and self-care behaviors, and therapeutic management
strategies. Finally, these two strategies were organized as related to dyspnea itself with
three areas: description, mechanisms, and measurement. The model, as do all other
models, assumes dyspnea, like pain, to be a sensory experience of the individual.
Although providing direction for studying dyspnea risk factors, the model is
limited to the description and measurement of dyspnea. The grouping of some of the
factors could be differently conceptualized. For example, some of the variables such as
health status could be considered outcomes or consequences of dyspnea, and a bidirectional causal path between dyspnea and such variables would better capture what
probably does take place. Still, although dynamics were not presented in this listing of
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phenomena, the authors were cognizant of the complex relationships among these
variables. They ended their paper with this statement: "The obviously complex,
multivariate relationships of all these factors and dyspnea need to be acknowledged in
systematic study of this significant clinical symptom" (p. 443.)

Gift Five Elements Model
The next major model of dyspnea was that of Gift (1987, 1990a). This model,
like that of Carrieri-Kohlman's was still a template for organizing dyspnea related
phenomena. It was a framework with five components (Gift, 1990a), that McCarley
(1999) has described as a kind of pie chart of elements. The five components were: (1)
the sensation of dyspnea (physiological component), mediated or activated by sensory
receptors and the central nervous system; (2) the perception of dyspnea (cognitive
component) with interpretation of the sensation and affected by past experience and
present expectation; (3) the distress of dyspnea (psychological component) characterized
in psychoemotional terms and include the psychological correlates of dyspnea; (4) the
response to dyspnea encompassing coping style and strategies used by the individual; (5)
the reporting of dyspnea (social component), including the descriptors used and the
decision to report the experience or not.
The Gift model incorporated dimensions or domains that will be reflected later in
more complex, dynamic models. These included such dimensions as the physiological,
the psychological, the person (cognitive), behavioral, and social. Gift's model presented
a holistic representation of the dyspnea experience. The model is limited in that it does
not address risk factors for dyspnea, precipitating factors, or consequences for the

individual. Nonetheless, as with the organizing model of Carrien-Kohlman, one can see
the precursors of important elements of the later, more complex, dynamic models.

Later Dynamic Models of Dyspnea
Following Carrieri-Kohlman and Gift, there were a series of models focused on
different aspects of dyspnea, although the aspects are usually placed within a larger
conceptual framework. These larger frameworks were all quite similar in being multidimensional, having psychological and physiological components, placing the person in
some setting (environment, social, life context), and delineating some relationships
among model components.

Steele and Shaver Person-Environment Model
For example, Steele and Shaver (1992) offered a person-environment ecological
framework wherein they conceptualized dyspnea as a nociceptive (body part damage)
phenomenon, and took into account biopsychosocial factors that affect dyspnea. This has
also be labeled an ecologic model of dyspnea because the authors presented dyspnea as a
biopsychosocial phenomenon. Although these researchers had a multi-domain model
and they did have dynamic relationships among elements of the model (i.e., feedback
loops), the schema and the relationships among model elements are often difficult to
track or interpret. Also, their focus was on perceptual sensitivity, defined using
magnitude estimation procedures. They did provide a quantifiable estimate of sensitivity
to dyspnea generating stimluli [Mathler, Rosiello, Harver, Lentine, McGovern, &
Daubenspeck, 1987).

Breslin, Roy, and Robinson's Physiological Model
Breslin, Roy, and Robinson (1992) also presented a large framework, but their
focus was on the role of the respiratory pump and respiratory muscle function as the basic
process contributing to dyspnea. Still, their integrated metaparadigm conceptualized
basic nursing science as the understanding of the life processes and clinical science as
diagnosis and treatment. This Breslin et al. metaparadigm is similar to the CarrieriKohlman, Lindsey, and West (1993) general framework of selected biological and
psychosocial life processes along with use of pathophysiological concepts. In both of
these models, dyspnea is understood as an alteration in the normal life process of
sensation. Indeed, Carrieri-Kohlman, Lindsey, & West (1993) used these general
frameworks to propose a treatment of dyspnea distress based on the idea of
desensitization, a concept also found in the model of Steele and Shaver (1992) discussed
above. Hence, such models can lead to development of treatment possibilities.

McCord and Cronin-Stubbs Mediation Model
McCord and Cronin-Stubbs (1992) also presented a larger model of dyspnea with
domains of antecedents, mediators, reactions, and consequences or outcomes. Dyspnea
was seen as a multi-dimensional disorder where physiologic and psychogenic antecedents
were mediated by culture, environment, perception, and psychological status to yield the
reaction of dyspnea sensation. This model presented three areas of consequences:
resolution (patient takes action that resolves the dyspnea sensation); adaptation (patient
takes action that mediates dyspnea but does not completely resolve it); and no response
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(where the action has no effect on dyspnea, either the intensity or duration). Hence,
within this framework, coping strategies and management were seen as changing the
degree of dyspnea instead of affecting the consequences of dyspnea on quality of life of
the person. Most of the models developed up to when this model was presented did not
address the impact on quality of life.
The particular focus of the McCord and Cronin-Stubbs (1992) model was actually
on measurement. Indeed, the authors grouped a variety of assessments of dyspnea and
dyspnea related phenomena under the four domains of their model: antecedents,
mediators, reactions, and consequences of dyspnea. Hence, McCord and Cronin-Stubbs
(1992) and their model will be re-visited below in the sub-section on dyspnea assessment.

West and Popkess-Vawter ModifiedZelechowski Action Model
The next model of interest is that of West and Popkess-Vawter (1994), which was
an adaptation of an earlier Zelechowski (1977) model of breathlessness that had
physiological and psychological dimensions. The focus of the Zelechowski model was
on the response or reaction to dyspnea, the actions taken in the presence of dyspnea.
Individuals were conceptualized as having different actions such as anxiety, anger, and
exercise, or having or non-action such as sleep, depression, or apathy. These actions in
the presence of dyspnea were hypothesized to, in turn, influence dyspnea. Hence, there is
a dynamic aspect to the Zelechowksi model, the presence of feedback loops. Although
the focus of the model was on reactions to dyspnea, the model did also include dyspnea
antecedent conditions such as degree of perceived threat and/or physiological changes.

In their modification of the Zelechowski model, West and Popkess-Vawter (1994)
expanded the list of antecedent conditions. They also added positive and negative
adaptive responses as outcomes. The focus of the adapted model was still on the type of
actions taken in the presence of dyspnea.

Campbell Antecedent-Response Model for Terminal Diseases
Campbell (1996) developed a model focused on dyspnea in patients with terminal
diseases and offered schema for describing the relationships between antecedents of and
response to dyspnea. Even more specifically, the focus was on those patients who
refused intubation or ventilation. Still, even with such specific focus for a model, it had
some of the same general features found in nearly all models developed to describe
dyspnea. These included the elements of antecedents and reactions to dyspnea. There
were also physiologic versus psychogenic categories for grouping dyspnea both
antecedents and reactions. Physiologic antecedents were those conditions likely to
increase the work or breathing (including cardiac, pulmonary, and neuromuscular
disease) and physiologic reactions included tachypnea, tachycardia, use of accessory
muscles, and tidal volume changes. Psychogenic antecedents included those that
Campbell identified as having no physiologic source (including anxiety, anger, and
depression) and psychogenic reactions included panic, fear, frustration, anger, and
anxiety. Hence, some possible emotional states were also among possible antecedents.
Interestingly, research has not supported the relationship between the either the
physiologic antecedents or some of the-physiologic reactions identified in the model and

dyspnea in patients with COPD (McCarley, 1999). Also depression is not likely to be an
antecedent for dyspnea and is more likely a consequence.

McCarley Chronic Dyspnea Model
Although temporally McCarley's (1999) model of chronic dyspnea came after
that of either the model of unpleasant symptoms described below or the initial version of
the symptom management model (Larson et al, 1994a, 1994b) described above in its
revised form (Dodd et al, 2001), it is basically an add on for these more general models.
In her review of what had come before her own model, McCarley did cite and describe
the unpleasant symptom theory, but she did not present a description of the initial version
of the symptom management.
As the title clearly states, McCarley's (1999) model focused on chronic dyspnea
as opposed to acute dyspnea, and given the nature of chronic versus acute dyspnea, the
primary focus of her model was on the consequences of chronic dyspnea.. Her primary
criticism of other models was that they did not differentiate between acute and chronic
dyspnea. Gift (1987), who has been involved in the development of models, did at least
differentiate between acute dyspnea as having rapid onset, and chronic dyspnea as being
persistent over time but with the intensity changing. McCarley did point out that within a
model, one would want to identify differences for acute versus chronic dyspnea. For
example, the emotional responses to chronic as opposed to chronic dyspnea might be
expected to be quite different.
Although McCarley states that'her purpose was to propose a new model of
chronic dyspnea to guide care and evaluation of chronic dyspnea in patients living with
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COPD, she did place her own model within the then developing concept of dyspnea as
multi-factorial. She also delineated three components of a model of chronic dyspnea
(physiologic, the symptom dyspnea, and consequences). Although her model did have
three components, her interest here in chronic dyspnea led to an emphasis of the
consequences of dyspnea rather than its antecedents. The structure of her model was is
similar to that of Campbell's (1996), but she noted that there was only a minor focus on
dyspnea antecedents. Also she did not use psychogenic stimuli as antecedents in her
model but rather as sequelae of living with the persistent distress of chronic dyspnea.
Finally, McCarley described consequences as also multi-factorial and having dimensions
of the physical, psychological, and socio-cultural. She noted that, unlike other models of
dyspnea McCarley did not place the sensations of fear and panic as consequences of
acute dyspnea. Here, one can see how particular models will lead to different emphasis
and, hence, guidelines for research and clinical practice.

Theory of Unpleasant Symptoms Model
Lenz, Suppe, Gift, Pugh, and Milligan (1997) offered a model that attempted to
describe unpleasant symptoms generally. This model was briefly presented above as an
exemplar of a middle-range theory. Labeled the "Theory of Unpleasant Symptoms," this
model was developed from research on dyspnea in populations of COPD and asthma
patients, and research of fatigue during intrapartum and postpartum periods. As many
researchers of dyspnea have done, pain was used as a general analogue. Dyspnea was
presented as having both physiological or sensory and psychological or cognitive
dimensions. The psychological or cognitive attributes of dyspnea were seen as similar to
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the distress components of pain. Importantly, as part of the process of identifying
fundamental features of dyspnea, the same individuals were evaluated at times when they
and did not have dyspnea. In a series of studies (Gift, 1990b, 1991; Gift, Plaut, & Jacox,
1986), psychological (cognitive) or distress attributes of dyspnea were demonstrated to be
similar to pain. These attributes of dyspnea were also found in these studies to be related
to anxiety, somatization, and depression).
Consistent with the emerging basic understanding of dyspnea and unpleasant
symptoms, the Theory of Unpleasant Symptoms included three dimensions of
antecedents of unpleasant symptoms affecting an individual's predisposition to or
manifestation of the symptom. These three familiar dimensions were physiological,
psychological, and situational. They were also understood to affect the characteristics of
the symptom as well as performance variables (physical performance, functional status,
and cognitive functioning) affected by the symptom.
Specific to dyspnea and consistent with all other theorists, researchers and the
general literature, Lenz et al (1996) conceived of dyspnea as a subjective symptom rather
than an object sign. They pointed out that dyspnea could be detected only in the patient
who reported the sensation of labored or difficult breathing. Through observation others
could identify labored breathing, but only the patient experienced the sensation of labored
breathing. Hence, these authors clearly stated that dyspnea must not be confused with
rapid respiratory rate, deep breathing, or other signs of respiratory distress. Supporting
the conceptualization of dyspnea as a sensation, Wolcove, Dajcxman, Colocone, and
Kriesman (1989) demonstrated the lack of a consistent relationship between pulmonary
function and dyspnea.
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In summarizing their own synthesis of the literature and their basic concept of
dyspnea, Lenz et al (1995) presented dyspnea as an unpleasant symptom having five
components. These were the same five components of dyspnea explicated in Gift's
(1990a) pie chart model for organizing dyspnea phenomena presented in more extended
description above. In brief, these five components are: (1) the sensation of dyspnea; (2)
the perception of dyspnea; (3) the distress of dyspnea; (4) the response to dyspnea; (5) the
reporting of dyspnea. Lenz et al (1995) noted that one could consider these components
as the domains of the concept of dyspnea. They also concluded that dimensions of the
dyspnea variable would include duration, strength or intensity, degree of distress, and
quality.
Here, then, is a middle range theory or model of dyspnea, and unpleasant
symptoms generally, that is based on research and a synthesis of the literature, uses
dyspnea as one of the two unpleasant symptoms evaluated in leading to the model,
incorporates the basic domains and dimensions identified in the literature as part of the
concept of dyspnea, and can be heuristic in providing guidelines for research and clinical
practice.
It is interesting that this middle-range theory of unpleasant symptoms with its
summary of the field, use of dyspnea as an primary example of an unpleasant symptom,
capturing of the multi-factorial nature of symptoms including dyspnea, and ability to
guide research and practice emerged at about the same time as the RSMC Model that also
used literature on dyspnea as a source of information for model development. There are
different foci within these two models that are captured by their titles. The unpleasant
symptoms model is focused on describing unpleasant symptoms while the RSMC Model

is focused on general symptom management. Still, although the two models also use
some different labels for elements of the models and use some element labels differently,
both are evidence based, both see dyspnea as a symptom as subjective and multidimensional, with antecedents and outcomes that are also multi-dimensional, and both
identify the issue of the operationalization or assessment of a symptom as being of
primary importance.

Conceptual Models and Measurement
Conceptual models are touted as guiding researchers to, among other things,
develop better assessments. It is also true that the development of measurements led to
modification of models or the development of new models (Scott, 2004). This happens in
all areas of science. If you can now measure something that you could not earlier, then
you will learn new things about that which is measured. An example in the field of
dyspnea would be the use of visual analogue scales to capture a subjective experience
(Hayes & Patterson, 1921) and later measure "feelings" (Aitken, 1969) and pain
(McDowell & Newell, 1996), and later still to measure dyspnea (Adams, Chronos, Lane,
& Gjuz, 1985; Gift, 1989; Wilson & Jones, 1989; Muza, Silverman, Gilmore, Hellerstein,
& Kelsen, 1990). Eventually, such scales were used to demonstrate that patients could
differentiate between their experience of shortness of breath and their anxiety regarding
that shortness of breath (Carrieri-Kohlman, Gormley, Douglas, Paul, Stulbarg, 1996).
One could, as does Scott (2004), consider this effort of Carrieri-Kohlman et al.
(1996) as presenting a model for management of dyspnea that considers the fear and
panic involved and suggesting that desensitization would be an appropriate intervention.
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Indeed, exactly this is recommended in a later Carrieri-Kohlman article (CarrieriKohlman, Gormley, Eiser, Demir-Deviren, Nguyen, Paul, and Stulbarg, 2001). The
development of tools affects the development of our perception of the phenomena that we
find of interest. Partially because there were instruments that allowed the differential and
independent measurement of patients' experiences of the sensation of dyspnea as
opposed to their experiences of the affective components of dyspnea, these authors could
hypothesize that and test whether patients could differentiate between the experience of
the sensation versus that of the affect. This work then led to a recommended intervention
for dyspnea, desensitization.
It seems appropriate that this general review of models of dyspnea ends where it
began, with the researcher and nurse, Virginia Carrieri-Kohlman.

Assessment Instruments
There are many instruments for measuring dyspnea. However and importantly,
Spector and Klein (2001) state the necessity of more sensitive instruments for assessing
dyspnea in critically and terminally ill patients. Also Bruera and Ripamonti (1998) and
Ripamonti (1998) provided recommendations for any scale measuring dyspnea for
investigating etiology and establishing therapeutic strategies: (1) be multidimensional;
(2) be self-rating since dyspnea is subjective; (3) be easy and simple enough to be
completed by patients with dyspnea; (4) be evaluated not by physical effort evoking
dyspnea, but by perceived dyspnea itself so that even bedridden patients can complete it;
(5) have its reliability and validity in cancer patients confirmed; (6) be sensitive to
clinical changes due to treatment or progression of the disease over time.
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The Cancer Dyspnea Scale
In this research, the scale for assessing dyspnea was the Cancer Dyspnea Scale
(CDS). It was developed using patients with cancer, has been used in studies with
advanced lung cancer patients (Tanaka et al. 2002b), and, because of its simplicity, is
feasible for use with hospice lung cancer patients. The CDS also meets the six criteria of
Bruera and Ripamonti (1998) and Ripamonti (1998) stated above. In the text above, it
was mentioned that I. Henoch (personal communication, February 11,2008) had adopted
the same theoretical framework for her doctoral work as was here. Additionally, she also
chose to use the CDS in her research.
The CDS (Tanaka et al. 2000) is a brief, self-reporting scale designed to measure
dyspnea's multidimensional nature. It assesses three dimensions: sense of effort
(Dyspnea Effort), sense of anxiety (Dyspnea Anxiety), and sense of discomfort (Dyspnea
Discomfort). Although the authors note that the CDS can also yield a total score
(Dyspnea Total), the three factors are correlated with each other at only moderate levels
(.27, .30, and .55). Hence, the factors can be interpreted as reflecting the
multidimensional nature of dyspnea. There is no evaluation of physical function evoking
dyspnea since the authors did not want to limit the sensitivity of the instrument when it is
used with bedridden patients. The items can be read aloud and the patient can respond
with a number from the 5-point scale, if the terminally ill patient cannot read the items or
use a pencil to respond to them.
The CDS reflects well the RSMC Model in that it is a multi-dimensional
assessment of symptom experience. The three factors of the CDS can be conceptualized

as capturing the RSMC Model's three dimensions of symptom experience. Sense of
effort is recognition or perception of the presence of the symptom of dyspnea. Sense of
discomfort is the evaluation of the symptom, including an evaluation of threat. Sense of
anxiety is a response to the symptom. Additionally, Tanaka, Akechi, Okuyama,
Nishiwaki, & Uchitomi (2002b) state, "The manifestations of subjective symptoms have
recently come to be interpreted as resulting from the interaction of production,
perception, and expression, not as a direct representative of the intensity of the
production of the dyspnea at the mechano- and chemo-receptor level" (p 491). This is
certainly consistent with the RMSC Model, as the study of these researchers described
below.
Tanaka et al. (2002b), a study looking at the correlates of dyspnea in advanced
lung cancer patients, used the CDS to measure dyspnea. Congruent with the RMSC
model, they not only conceptualized and measured dyspnea as a multi-dimensional
construct, but they evaluated how dyspnea was related to a broad range of medicopsycho-social factors. The medical factors included clinical stage, performance status,
oxygen saturation levels, organic causes of dyspnea, and other symptoms such as cough
and pain. The psychological factors included anxiety and depression, while the social
factors included education, marital status, and existence of confidents. Multiple
regression analysis demonstrated that psychological distress, presence of organic causes,
cough, and pain were significantly related to dyspnea (R2 = .30, p < .05). The study
confirmed that dyspnea is multi-dimensional and that the intervention for psychological
distress and pain could be a beneficial therapeutic strategy.
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Other researchers are now also using the CDS, including versions that are being
translated into other languages. For example, Henoch, Bergman, and Gaston-Johansson
(2006) translated the CDS into Swedish and evaluated its psychometric properties on a
Swedish sample of 99 patients with advanced lung cancer. Using Cronbach's alpha, they
reported that the CDS internal consistency was excellent with a coefficient range of .81 to
.90. Convergent validity was evaluated through correlations of the CDS with measures
of discomfort and both physical and emotional function (r = .34 to .57) as well as with
other measures of dyspnea (r = .63 to .68). Interestingly, the researchers reported that the
CDS was better at assessing dyspnea's psychological dimension than was the VAS-D
(Visual Analog Scale for Dyspnea). Finally, the researchers report that factor analysis of
the CDS items yielded the expected three dimensions of effort, anxiety and discomfort.
Further they report that these CDS factors correlated as expected with specific other
instruments as well as related-factors from other instruments.
For evaluating effects of therapeutic interventions, an important attribute of an
assessment of dyspnea would be responsiveness. That is, is the instrument capable of
detecting expected changes? The CDS was used as part of a study of the effect of
nebulized furosemide on dyspnea in end of life cancer patients. The CDS was given
before and 60 minutes after inhalation. The researchers found that the CDS demonstrated
a significant change in the total dyspnea score from before to after inhalation as well as
significant changes in both sense of effort and sense of anxiety (Kohara, Ueoka, Aoe,
Maeda, Takeyama, Saito, Shima, and Uchitomi, 2003).
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Other Dyspnea Measuring Instruments
At the end of the section on dyspnea models above, the relationship between
theory and measurement was briefly discussed. This relationship is also illustrated by the
area of work that could be labeled the language of breathlessness. This area of thought
and research was described above in the section on models of dyspnea. It could as easily
have been placed here under assessment. It will again be described more briefly below.
There are four categories of mechanisms of dyspnea (Carrieri-Kohlman, JansonBjerklie, & Jacobs, 1984): (1) stimulation of afferent intrapulmonary receptors; (2)
increased sensitivity to changes in ventilation perceived via central nervous system
mechanisms; (3) reduced ventilatory capacity or breathing reserved; (4) stimulation of
neural receptors in the musculature of the intercostals and diaphragm and of receptors in
skeletal joints. However, the mechanisms are not well understood and there is no general
theory explaining dyspnea's physiologic basis completely (Carrieri-Kohlman, JansonBjerklie, & Jacobs, 1984; Sassi-Dambron, Eakin, Ries, & Kaplan, 1995).
There is also no general agreement about the appropriate method for measuring
dyspnea (Sassi-Dambron, Eakin, Ries, & Kaplan, 1995; Eakin, Kaplan, & Ries, 1993).
The lack of a complete understanding of the underlying causes of dyspnea and the lack of
a consistent and systematic relationship between the assumed physiological substratum of
dyspnea and patient reporting of dyspnea as well as the lack of consistent, observable
signs and the subjective experience of dyspnea do raise the question of how one would go
about measuring dyspnea. As with everything else connected to dyspnea, the attempts to
measure it have been multi-factorial. This is not to maintain that all measurements
assumed a multi-dimensional nature of dyspnea, but that the efforts at measurement have
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addressed many different aspects of the phenomenon. Additionally, the aspect chosen for
assessment depended upon the research question at the time ranging from assessing the
breath effects of exercise in normal subjects to evaluating the multi-dimensional nature of
dyspnea in cancer patients.
Efforts to develop measurements for dyspnea and its different aspects have
employed different techniques of assessment. These ranged from in-depth interviews to
simple visual analogue scales, from retrospective reports of impact of breathlessness to
current descriptions of a symptom being immediately experience, from listing or
checking off descriptors of breathlessness to the use of psychophysiological magnitude
estimation, from signal factor to multi-dimensional scales, the history of the assessment
of dyspnea is a complex one, the number and range of attempts is enough to take one's
breath away. Table 1 presents an alphabetic listing of instruments for measuring
dyspnea. Such simple listings are helpful but not a complete answer. As models for
dyspnea itself, some approach to organizing the assessments of dyspnea is needed.
Table 1. Alphabetical listing of dyspnea measurement instruments
Tool&
Brief Description
Psychometrics & Appraisal
Reference
ATS-DLD-78 Extensive information on antecedents
Lacking documented
and mediators, including respiratory
Comstock et
psychometric rigor; does not
symptoms
assess changes over short
al. 1979
time periods
0-4 scale ADL, also called 5-level SOB Psychometric properties not
ATS/SOB
Moody et al. or GBS [see below]; similar to the
well established; reliability
MRC
1990
not documentedATT
Lareau 1986
BDI/TDI
Mahler et al.
1984; Mahler
etal. 1987

8 5-item self-report on 1 to 7 point scale
from as active as ever to have omitted
entirely with 4 sub-scales
Interviewer scored 0-12 for BDI related
to magnitude of work, activities, effort
related to breathlessness. TDI assesses
change scored -9 to +9 ADL

No published data on
reliability or validity
Good reliability and validity
with psychometrics well
established for range of
pulmonary and cardiac
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BESC
Kinsman et
al. 1983

89 item self-report checklist with
dyspnea one of 11 categories

Borg
Borg 1970;
Burdon et al
1982;
Silverman et
al. 1988

0-10 scale [no dyspnea to maximal
dyspnea]; was modified from earlier
15-point rating version. Used to assess
reactions during exercise.

BPQ
Hyland et al.
1994
CDAT
Moody et al.
1990

33 items & 13 domains such as waking,
bending, bathing. 27 items for
'problem score.'
A general assessment tool that includes
evaluation of dyspnea

CDS
Tanaka et al.
2000; Tanaka
et al 2002a,
2002b

Self-report 12-item, 3 factor (effort,
discomfort, anxiety), scale using 5point scale from not at all to very much

CRQ
Guyatt et al.
1987

20 items, 4 domains of dyspnea,
fatigue, mastery, emotion with each
scored 1-7 for severity of dyspnea

DIS
Carrieri &
JansonBjerklie 1986

Comprehensive & qualitative
information on experience with living
with dyspnea, 48 items & 2 sections:
Shortness of breath (SOB) & impact of
SOB on ADL
0 ["no dyspnea"] to 10 ["as bad as can
be imagined"] numeric scale of global
dyspnea; the DNS is very similar to the
NRS, but Tanaka et al 2002a do not
reference the NRS
19-item self-report questionnaire
developed on pulmonary and cardiac
patients with breathlessness and
healthy college students with induced
breathlessness

DNS
Tanaka et al
2002a
DOB
Simon et al.
1989

patients
Acceptable to high internal
consistency reliability for 10
categories, but not for
dyspnea.
Reasonable test-retest
reliability and concurrent
validity, but needs to be
tested with larger samples;
can discriminate between
patients' perceived shortness
of breath
Good test-retest reliability
and construct validity;
developed for clinical trials
Good content & concurrent
validity; good internal
consistency; needs testing
applicability for clinical
practice & research
Good reliability, concurrent
validity, and construct
validity; good for clinical
trials and sensitive to
change; can discriminate
between patients' perceived
shortness of breath
Good test-retest & internal
consistency reliability and
concurrent validity; needs be
evaluated on larger samples
No documentation of
psychometric properties;
long & not practical for large
samples or for routine use
Good test-retest reliability
and convergent validity with
the CDS

Good test-retest reliability
and construct validity; needs
testing to determine if list of
symptoms represents larger
samples
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GBS
MDI
Stoller et al.
1986
ME
Mahler et al.
1987;Nield
etal. 1989;
McCord &
CroninStubbs 1992
MRC
Mahler et al.
1987

Same as ATS/SOB [see above]
Interview guide with 5-point raring
scale and 3 subscales (based on &
similar to BDI)
Psychophysiologic technique based on
Steven's power law measuring subject
magnitude of a sensation produced by
range of physical stimulus intensities

NRS
Gift&
Narsavage
1998

11 numbers from 0 to 10 with end
anchors of "no shortness of breath" and
"as bad as it can be"

OCD
McGavin et
al. 1978;
Mahler et al.
1987
PFSDQ
Lareau et al.
1994
PFSS
Weaver &
Narsavage
1989,1992

VAS 10 cm line with activities such as
sleeping to brisk uphill walking along
the line ADL

PRUS
Fletcher
1952; Stoller
etal. 1986
RDOS
Campbell
2008
SBAT
Lareau et al.

5-point scale grading breathlessness
from activities that induce dyspnea to
severe impairment ADL

Reasonable validity but
reliability is not documented
Like the VAS this is more a
technique for assessment
rather than a particular
content assessment; reliable
and valid but some
questions; construct validity
established
Interrater reliability &
concurrent/construct
validity acceptable; can
discriminate between
patients' perceived shortness
of breath
Good concurrent (with VAS)
and construct validity; in
studies of pain NRS easier
for patients than VAS;
however, no reliability data
presented in primary NRS
article
Reliability and validity
acceptable; can discriminate
between patients' perceived
shortness of breath

164-item, intensity-related for ADLs

Good internal reliability and
construct validity

33 items, self-report with 11 sections
regarding impact on ADL [also
reported as being a 64 items with 11
sections (McCord & Cronin-Stubbs,
1992).
Interview or self-report 5-point rating
scale from patient breath good as
similar others to breathless on talking
or undressing
7-variable observation scale assessing
respiratory distress *

Good internal consistency,
test-retest, and concurrent
validity; sensitive to change

Self-report 2 section tool: [1] 6 general
questions & a number of VAS

Very little psychometric
properties information
available
Good internal consistency
and good convergent and
discriminant validity
Good concurrent validity,
but no published reliability
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SGRQ
Jones et al.
1992;
Ketelaars et
al. 1996
SOBQ
SOLQ
Jones 1998
UCSD/SOBQ
Eakin et al
1998
VAS
Scott &
Huskisson
1979; Gift et
al. 1986; Gift
1989

measuring shortness of breath at
different times and for different
activities; [2] 85 activities in 4 areas
Activities are related to dyspnea for 76
items. Measures HRQL in 3 domains:
symptoms, activity, impact

Same as UCSD/SOBQ [see below]
29 items, 4 dimensions

Self-reported 24-item ADL related to
breathlessness
Horizontal or vertical 100 mm line with
descriptive anchors at the ends [no
breathlessness to greatest
breathlessness]. NOTE: VAS can be
used to assess different dimensions of
dyspnea, e.g., intensity or affect

information.

Good test-retest reliability
and criterion validity;
developed to compare
interventions

Reasonable psychometrics;
developed to compare
interventions
Good internal consistency
and construct validity
The VAS is really more an
assessment technique than a
content specific
measurement; good
reliability & validity and
demonstrated in diverse
samples of pulmonary
patients; can discriminate
between patients' perceived
shortness of breath

*Description of Acronyms
ATS-DLD-78 = American Thoracic Society Standardized Questionnaire
ATS/SOB = American Thoracic Society Shortness of Breath Scale
ATT = Activity Assessment Tool
BDI/TDI = Baseline Dyspnea Index/Transition Dyspnea Index
BESC = Bronchitis-Emphysema Symptom Checklist
BPQ = Breathing Problems Questionnaire
BORG = Borg scale
CDAT = Chronic Disease Assessment Tool
CDS = Cancer Dyspnea (Dyspnoea) Scale
CRQ = Chronic Respiratory Questionnaire
DIS = Dyspnea Interview Schedule
DNS = Dyspnea Numeric Scale
DOB = Descriptors of Breathlessness
GBS = Grades of Breathlessness Scale from American Thoracic Society
MDI = Modified Baseline Dyspnea Index
ME = Magnitude Estimation
MRC = Medical Research Council Breathlessness Scale
NRS = Numeric Rating Scale
OCD = Oxygen Cost Diagram
PFSDQ = Pulmonary Function Status and Dyspnea Questionnaire
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PFSS = Pulmonary Function Status Scale
PRUS = Pnemoconiosis Research Unit Score
RDOS = Respiratory Distress Observation Scale
SB AT = Shortness of Breath Assessment Tool
SGRQ = St George's Respiratory Questionnaire
SOBQ = same as UCSD/SOBQ
SOLQ = Seattle Obstructive Lung Disease Questionnaire
UCSD/SOBQ =UCSD Shortness of Breath Questionnaire
VAS = Visual Analog Scale

One impressive attempt to organize dyspnea assessment is found in the previously
described model offered by McCord and Cronin-Stubbs (1992). They presented an
overview of dyspnea assessment and used a model with the four domains of antecedents,
mediators, reactions, and consequences or outcomes for grouping measurements.
Nonetheless, some of the classifying was difficult to follow, although this is more due to
the nature of the dyspnea and the instruments than any fault of the authors. For example,
the antecedent assessments included the American Thoracic Society Standardized
Questionnaire (ATS-DLD-78). But the ATS-DLD is an extensive questionnaire
providing information regarding both antecedents and mediators of dyspnea. It could be
included within both categories, and the authors so included it in both their diagram and
text. Similarly, the Chronic Disease Assessment Test (CDAT) is an instrument based on
a number of other tools including the Chronic Respiratory Disease Questionnaire,
Arthritis Impact Measurement Survey, the Dyspnea Visual Analog Scale, and the ATS
Grade of Breathlessness Scale. Hence, it winds up in all four categories of antecedents,
mediators, reactions, and consequences. This is not to say that the McCord and CroninStubbs (1992) attempt at organizing dyspnea measures is without value. Indeed, it is an

45
excellent catalogue of measures and it helps the reader to understand what aspect or
aspects of dyspnea each instrument assesses.
Another approach at organizing information about dyspnea instruments is that of
our now familiar researcher, Virginia Carrieri-Kohlman, and a colleague (CarrieriKohlman & Janson, 1999). These authors did not use a model of dyspnea, and did not
attempt to relate the many instruments to components of a model as McCord and Stubbs
(1992) did. Instead, they simply provided four descriptive, non-dynamic categories of
measurements of dyspnea: qualitative descriptions, intensity, affective components, and
activities of daily living. Under qualitative descriptions, they placed much of the
research described earlier about the language of breathlessness. This included verbal
descriptors that may indicate types of sensations of respiration across disease states, but
that probably reflected the pathophysiological mechanism involved (Schwartzstein &
Cristiano, 1996). As noted earlier, different descriptors seemed to be reliably used by
patients (Elliott et al, 1991) and used with different frequencies by patients with different
disorders (Wilcock et al, 2002).
Under measurement of dyspnea intensity, Carrieri-Kohlman and Janson noted the
development of instruments that allow for the evaluation of interventions for dyspnea.
They singled out the Visual Analogue Scale (VAS) for special consideration here.
Originally developed for assessing subjective experiences generally (Hayes & Patterson,
1921) and for measuring feelings (Aitken, 1969) and pain (McDowell & Newell, 1996),
nurse researchers have validated the VAS for measuring dyspnea in chronic COPD and
asthma patients (Gift, 1989) as well as in critically ill ventilated patients (Bouley,

Froman, & Shah, 1999; Knebel, Janson-Bjerklie, Malley, Wilson, & Manni, 1994; Lush,
Janson-Bjerklie, Carrieri, & Lovejoy, 1988).
The VAS is presented as a line that varies in length with the study from 100 to
300 mm (Carrieri-Kohlman et al, 1996; Reardon, Awad, Normandi, Vale, Clark,
ZuWalack, 1994). The scale can be horizontal or vertical and is anchored on each end by
descriptors. The VAS is described has having good validity and reliability (CarrieriKohlman & Janson, 1999; Cullen & Rodak, 2001). It can be used to assess different
dimensions of the same construct.
In this grouping of intensity measures, the authors also could have included the
modified Borg scale (1970) that was initially used to measure effects of perceived
exertion rather than dyspnea itself. Nonetheless, the Borg scale is used to measure
breathlessness clinically (McCord & Cronin-Stubbs, 1992). Instead of a line like the
VAS, the modified Borg scale uses a 0 to 10 ordinal scale. Also, rather than anchor only
the ends of the scale like the VAS does, the modified Borg scale uses verbal expressions
of severity anchored to the numbers. The modified Borg was considered
psychometrically superior to the original Borg since it had ratio properties and non-linear
spacing of the descriptors (Borg, 1982). This instrument was also based on
psychophysical principles and so was considered applicable to other areas. Hence, it is
also used to evaluate breathlessness as well as exertion (Cullen & Rodak, 2002). Another
scale that could be place in this same intensity category would be the Numeric Rating
Scale (NRS) of Gift and Narsavage (1998). As reflected in its name, this scale has
numbers (eleven of them, 0 to 10). But like the VAS, it has anchors only at the ends of
the scale (0 = not shortness of breath and 10 = shortness of breath as bad as can be).

Under their category of measuring affective components of dyspnea, CarrieriKohlman and Janson (1999), reported the work of Steele and colleagues (Steele, Shaver,
Hildebrandt, Schoene, Tyler, Betrus, 1991). Steele et al (1991) used the VAS for
assessing two dimensions of dyspnea: a sensory dimension or the perceptual sensitivity to
breathing effort and an affective dimension or the perceptual sensitivity to breathing
discomfort. Note that these two dyspnea dimensions are among the three assessed by the
CDS. Another study (Carrieri-Kohlman, et all, 1996) also evaluated whether patients can
differentiate distress and anxiety associated with dyspnea. Both studies demonstrated
that dyspnea has more than one dimension and that patients can indeed distinguish
between them.
The earliest clinical scale for measuring dyspnea is that Fletcher (1952) and it
involved assessing dyspnea on a 5-point scale of grades as a function of its impact
activities for patients with lung disease compared to age-comparable individuals without
lung disease. A revised version of this assessment (Schilling, Hughes, & DingwallFordyce, 1955) called the Medical Research Council (MRC) scale (Fletcher CM, Elmes
PC, & Wook CH, 1959) measured reports of dyspnea when patients were walking
distances or climbing stairs. Although Carrieri-Kohlman and Janson (1999) do not report
these earlier attempts, they would fall into these authors last category of dyspnea
assessment, measuring dyspnea with activities of daily living. They do explicitly include
in this category early work by Janson-Bjerklie, Ruma, Stolberg, and Carrieri-Kohlman
(1987). These researchers developed the Dyspnea Interview, an open-ended
questionnaire that included seven dimensions of dyspnea, the symptom pattern,
management strategies used with dyspnea, family support, and education received about

breathlessness. The focus was on activities of daily living. Other instruments that
measure dyspnea as a function of daily activities include the University of California San
Diego (UCSD), Shortness of Breath Scale (SOB) (Sassi_Dambron, Eakin, Ries, &
Kaplan, 1995), the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ)
(Lareau, Carrieri-Kohlman, Janons-Bjerklie, & Roos, 1994), and the Pulmonary
Functional Status Scale (PFSS) (Weaver & Narsavage, 1992).
Another attempt at organizing assessments of dyspnea is that of Sorenson (2000).
She ordered dyspnea instruments into three groupings: (1) activities of daily living, (2)
exercise, and (3) health-related quality of life. She placed the MRC, UCSD/SOBQ, and
ATS/SOB in the activities of daily living group, the Borg and VAS for the exercise
group, and the PFSDQ for health related quality of life. Of course, including the VAS
only under exercise, probably because that area of research was where it was initially
developed, can be misleading. The VAS can be and is used in research that does not
involve induction of dyspnea via exercise.
A review of dyspnea instruments specifically regarding this use for patients with
advanced cancer was undertaken by van der Molen (1995) and included only dyspnea
assessment instruments covered here. She concludes that the instrument one chooses to
use would depend on what the question is. Also, van der Molen notes that dyspnea has
many components and is a multi-dimensional sensation, suggesting that indeed more than
one instrument might be needed. It would also seem that the development and use of
multi-dimensional assessments might be required.
The last attempt to organize dyspnea assessments that will be briefly looked at
here is that of Cullen & Rodak (2002). These authors were interested specifically in the

clinical utility of breathlessness measures. Cullen and Rodak pointed out that dyspnea
assessments were developed to measure breathlessness under different conditions and
various circumstances. The choice of which instrument to use should, in part, be a
function of the conditions and circumstances being studied. These authors grouped
instruments under six clinical utility groupings of exercise, activities of daily living,
benchmark, outcome, responsiveness, and clinical trials. They presented two broad
classification dimensions of dyspnea assessments that cut across the clinical utility
groupings, the discriminative versus the evaluative instruments. A discriminative
instrument is one whose measures differentiate between patients, assessing individual
differences between those who have some characteristic and those who do not. An
evaluative instrument is one that measures change within an individual, perhaps for
assessing change in an individual's health status or circumstances. Such instruments as
the Borg scale and VAS are identified as discriminative while the UCSD/SOBQ and the
PFSDQ are identified as evaluative.
Cullen & Rodak (2002) offer an excellent overview of the issues of measurement,
and their listing of 11 instruments is also a good resource. Additionally, the use of
clinical utility groupings would be helpful to a researcher deciding which instrument to
use to measure dyspnea. However, although the authors classify the VAS as a
discriminative instrument, there is no inherent reason that the VAS could not be used for
evaluative research purposes. Importantly, the authors report that all 11 scales have good
validity and reliability.
The presence of a symptom reminds us of the presence of a person. If we keep in
mind that every time we hear of a symptom, someone, some person is telling us about

their experience of illness. As Tenner (1996) pointed out in his book,' Whereas drugs
and procedures target specific local problems, individual symptoms are often vague:
headaches, fatigue, pain, digestive problems. And while X-ray and magnetic resonance
devices at first seemed to have revealed the body's innermost secrets, now scans and tests
all too often reveal nothing unusual. [The health care professionals] must come to grips
with the very conception it thought it could do without: the patient as a whole system"
(pp 47-48).

Issues of Hospice and Palliative Care Research
Hospice and palliative care research begins with a consideration of the unique
patient population (Ferrell and Grant, 2001) and that, as noted by Addington-Hall (2007),
"Palliative care is concerned with the prevention and relief of suffering . . . [and] is
therefore by definition concerned with a sick patient group who are going to be sicker...
[raising] concerns about whether palliative care research can ever be ethical and, if it can,
how to conduct ethically sensitive studies." (p. 3) Terminally ill patients constitute a
vulnerable group and research participation may be more difficult for them due to the
presence of multi-symptoms and severe problems.
Bruera (1994) wrote that initially palliative care programs were designed with
only service and some teaching in mind. With the emergence of palliative care research
has come issues of the above mentioned patient vulnerability as well as concerns about
unstable mental status, ability to consent, response burden, measurement intrusiveness,
dependence on health care providers, patients' limited time, use of placebos, nature of
research design, nature of the data, subject recruitment and retention, heterogeneity of the
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palliative care population, and involving others (hospice personnel, patients themselves,
family caregivers) in the development of research proposals (Ferrell and Grant, 2001;
Buss and Arnold, 2004; Ferrell, 2004; Penrod and Morrison, 2004; Storey, 2004; Wallen
and Berger, 2004; Aoun and Kristjanson, 2005; Kaasa, Hjermstad, and Loge, 2006;
Addington-Hall, Bruera, Higginson, and Payne, 2007). In fact, it is just such difficulties,
particularly regarding subject recruitment (Storey, 2004) and general logistics (Buss and
Arnold, 2004) that led, in part, to the development of this current pilot feasibility study.
Even in the face of such concerns and challenges, both ethical and practical,
palliative care research must be done. Indeed, given the goals of palliative care, not
conducting research would itself be unethical. Ferrell (2004) writes, "There is no option
to avoid research within the field of palliative care, as like all disease areas, there is a
critical need to conduct research to advance the field. Improved care will not happen
without inquiry." (p. 408)
In 2007, Twaddle, Maxwell, Cassel, Liao, Coyne, Usher, Amin, and Cuny,
reported their study on palliative care benchmarks from academic medical centers and
noted that in the U.S., although palliative care is growing, little is still known about the
quality of care in this area. In 1994, Bruera framed this issue as follows: " . . . one of the
major ethical issues we must confront during the coming decade is whether we can afford
not to make a major commitment to research in palliative care." (p 7) The coming
decade to which Bruera referred ended in 2004, three years before the Twaddle et al.
(2007) article. The issue of research in palliative care medicine and what forms it should
take are still with us.
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Although the issues in this area are still with us, there have been many calls for
more research and a number of research approaches and responses to the challenges of
palliative care research have been proposed and conducted. These range from the need
for a multidisciplinary approach (Kaasa and Hjermstad, and Loge, 2006; Addington-Hall,
2007) and the necessity of using mixed methods (Ferrell and Grant, 2001; Penrod and
Morrison, 2004; Wallen and Berger, 2004; Aoun and Kristjanson, 2005) to designing
studies in ways that address palliative care specific issues (e.g., use of placebos: Ferrell,
2004; Aoun and Kristjanson, 2005; and use of skilled nurses instead of general research
assistants: Ferrell, 2004) and close scrutiny of proposed instruments (Penrod and
Morrison, 2004; Wallen and Berger, 2004). Regarding the recommendation for using
skilled nurses as research assistances, Ferrell and Grant (2001) have a specific cautionary
note about the potential conflict that nurses may have in managing their dual clinicianresearcher roles. This potential conflict should be acknowledged and the nurses helped
with managing it. Indeed, this might be the source of productive questions for future
research.
It does seem that there is one area where more respect might be demonstrated
from each side of the issue to the other side. This is the question of research methods,
most particularly quantitative versus qualitative methodology regarding the evaluation of
the credibility of evidence. It is unlikely that quantitative randomized control trials or
qualitative research separately will be able to tell us all that we wish to know about
palliative care. Krishnasamy, Corner, Bredin, Plant, and Bailey (2001), in describing
their earlier state, "Despite including a>diverse range of instruments to measure the
effects of the intervention, the uniqueness of individuals' experiences of breathlessness
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were often hidden by a requirement to frame the study within a reductionist research
approach." (p 103) Perhaps each side could become more conversant with the other
side's frameworks and methodologies as well as recognize what each side contributes to
the process of evaluating and understanding how we can best pursue the goals of
palliative care.
Regarding the general points of view in the area about appropriate methodologies,
three studies might serve as examples of how these apparently conflicting positions can
benefit from accepting that others might have something of value to offer as well as
actually helping more to move the field forward. Aoun and Kristjanson (2005) make a
strong case for the necessity of methods other than evidence-based medicine and
randomized controlled trials. Yet they do manage to include a few straw men from the
evidence-based side such as the studies being focused on questions that are too simple
and using samples that are too restricted. These charges are not in and of themselves
reasons to use other methods, since evidence-based studies should be able to ask more
complex questions and use either a series of differentially homogenous samples or larger
heterogeneous samples.
Kaasa, Hjermstad, and Loge (2006) reported on their evaluation of the status of
palliative care research in Europe over the last twenty years. Among the attributes of the
literature that they evaluated, they listed types of methodology. They note that the vast
majority of the studies used surveys and descriptive/observational methods and that only
a "small fraction" of studies used randomized designs. Their response to this was to state
that although they judged that palliative care needed to "move forward," become more
evidence-based, and use "larger, randomized, clinical, multi-center studies on treatment,
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treatment procedures, effects and side effects." (p. 733), they also state, "We do not
mean, however, that other methodologies in respect to study design are of little value. On
the contrary, we believe that palliative medicine is ideally suited for multi-disciplinary
research with methodologies that complement each other, provided that the studies are
conducted in a scientifically valid way." (p. 733)
The third study here is a step in the process of addressing this last point. Bailey,
Froggatt, Field, and Krishnasamy (2002) report on the 10-year (1990-1999) contribution
of nursing to qualitative research in palliative care. They noted the important role that
qualitative research plays in generating evidence for nursing practices. They also state
that within medicine qualitative research methodologies are gaining more acceptance,
although there are still questions about how to evaluate such research. Interestingly, the
authors used a rigorous qualitative methodology to evaluate qualitative research. As part
of a follow up to their large study of 138 papers from 50 journals, they used thematic
analyses to evaluate 67 nursing papers and 29 comparison papers from areas such as
death studies, sociology, and medical anthropology journals. In the larger earlier study,
the authors used a procedure to assess content and quality of the papers where reviewers
provided open-ended comments about each paper's strengths and weaknesses. These
constituted the text that was subjected to thematic analyses in this later paper.
The results of this study showed that 30% to 40% of the papers received positive
comments on such dimensions as topic, quality of writing, contribution to understanding,
and practical value. However, on the relationship between data, analysis, and findings as
well as other methodological attributes'along with theoretical and conceptual issues, the
papers received less than 20% positive comments. Importantly, the authors compared the
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positive comment rates for the nursing papers to those of the comparison group. The
comparison group papers received a higher proportion of positive comments than did the
nursing papers: for theoretical and conceptual content the respective proportions were
23.9% compared to 79.3%, and for contribution to understanding the respective
proportions were 29.9% compared to 51.7%. Although these results may in part reflect
the smaller sample for the comparison group (one is more likely to obtain larger effects in
smaller samples), it may be that the comparison group papers were more sophisticated
than then nursing papers. What is important here is that these authors, all nurses, were
willing to evaluate their field and its methods in this way.
It should be emphasized that not only is there no inherent reason not to use both
qualitative and quantitative methods within studies, but that there have been calls for just
this approach. This was already noted above regarding calls for mix methods (Begley,
1996; Ferrell and Grant, 2001; Penrod and Morrison, 2004; Wallen and Berger, 2004;
Aoun and Kristjanson, 2005; Williamson, 2005). Both Begley (1996) and Williamson
(2005) provide overviews, summaries of the methods debates, and details about how to
actually proceed as well as listing additional resources and literature; both are also
directed at nursing research. Williamson (2005) also presents a specific illustration for
guidance that is specific to nursing research. There is even a study using mixed methods
evaluating acupuncture for people with chronic illnesses where the authors that either
method alone would have missed information captured by the other method (Paterson and
Britten, 2003). There seems little rationale for operating within the frame of one category
of methods versus another category. •
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To this point, Giacomini (2001) writes in his short, but excellent article, that
regarding qualitative and quantitative methods, "[c]ontary to popular
misunderstandings, both rely on systematic empirical observation, and both generate
empirical evidence." (p 5) He notes that the two approaches complement each other
rather than compete with each other since each addresses essentially different questions.
"These 2 health research traditions are distinctive in what they look at, how they see it,
and what they can learn." (p 5) He maintains that biomedical or natural causation
questions are best addressed by quantitative methods and that questions about social
meanings or behavior and experience to be understood as symbolically mediated social
phenomena are best addressed by qualitative methods since these later methods are better
suited for understanding why people do what they do. Which method one chooses
depends on what question one wants to ask, what it is that one wants to do. These issues
are further presented and evaluated by Mays and Pope (1995), Pope and Mays (1995),
Green and Britten (1998), and Newman, Thompson, and Roberts (2006).
One approach to coordinating different types of research methods, i.e., qualitative
and quantitative methods, is that of methodological triangulation, one of four types of
triangulation delineated by Denzin (1970). The goal of this type of research method
combination is to better capture the phenomenon under investigation. The intent is that
both approaches are used so that each may address the weaknesses in the other, perhaps
producing a more accurate representation and understanding of the research results.
Bradley (1995) offers a useable overview of the use of methodological triangulation in
healthcare research and Murray (1999)* presents an overview while he reports on the
results of methodological triangulation analyses including qualitative secondary data
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from an earlier study of his (Murray, 1995). The specific triangulation methods the
Murray used were based on those used by Connelly, Bott, Hoffart, and Taunton (1997).
The Bradley (1995), Murray (1999), and Connelly et al. (1997) articles, and particularly
the one by Murray, would be a good introduction to this area for any student.
Importantly, Murray points out that methodological triangulation should be used when
there is reason to expect that, given the nature of the research question, no one method
would "provide a satisfactory explanation of the issue being studied," (p 196) and cites
the Bradely 1995 article as well as Denzin and Lincoln (1994) as support for this
position.
As an important final comment, in spite of the potential difficulties in palliative
care research, research participation can allow those receiving palliative care to
experience contributing to others. Ferrell and Grant (2001) write, "Research participation
often provides an opportunity to derive meaning from illness and to feel that one's
suffering will provide benefit to others." (p. 702) Others have noted this as well (Fine,
2003). Also, there has been both qualitative and quantitative research showing that many
hospice patients want to participate in research. Indeed Addington-Hall (2007) reported
on two such studies using hypothetically presented research projects. One study was a
qualitative study in Australia that found that all hospice inpatients wanted to be a part of
research with there most frequent reasons given being altruism, an increased feeling of
personal value, continuing to feel a sense of autonomy, and the importance of research
efforts to improve palliative care (Terry, Olson, Ravenscroft, Wilss, and Boulton-Lewis,
2006). Another study was a quantitative study in the U.S. where close to half of the
hospice patients were willing to be a part of interview, survey, or therapeutic research
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(Williams, Shuster, Clay, and Burgio, 2006). Another study in the U.S. found that
patients who had actually participated in interview research reported their experience as
positive (Emanuel, Fairclough, Wolfe, and Emanuel, 2004).

Chinese Medicine and Acupuncture Treatment
Complimentary and Alternative Medicine and Human Energy Field Theory
The National Center for Complimentary and Alternative Medicine presents a
great deal of information about human energy field theory (NCCAM website, 2004a) as
well as a general overview of what are termed "whole medical systems" that include
traditional Chinese medicine (TCM), Ayurvedic medicine, naturopathy, and homeopathy
(NCCAM website, 2004b).
A major difference between Western medicine and TCM is that Western medicine
takes a structural view of the human system while TCM adopts a functional approach.
The TCM view of human physiology is based on the central concept of energy fields.
The central tenet is that matter and energy cannot really be separated. Matter and energy,
inner and outer, physical and mental are the same phenomena. They appear different
only because we view them from different perspectives. Human energy theory frames
the view of human systems through this position and its focus is on the perspective of
energy field interpretation. Also, TCM has at its center the concept of Qi, life energy that
flows through the body on the meridian grid that all living beings have (Xinnong, 1999;
Freeman & Lawlis, 2001).
Complementary and alternative, medicine (CAM) has five classifications of CAM
therapies: alternative medical systems, mind-body interventions, biologically based
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therapies, manipulative and body-based methods, and energy therapies (Hawks and
Moyad, 2003; Hospice Palliative Nurse Association, 2003). Although acupuncture is
generally classified within the alternative medical systems group, it is nonetheless based
on a basic concept of life energy and problems related to the flow of that energy through
the body.
Indeed, acupuncture has been singled out as an area of special interest at the
National Institute of Health Consensus Panel (NCCMA, 2004c), and NCCAM (2004a)
places acupuncture under the heading of "energy medicine involving putative energy
fields." Noting that acupuncture is the "most prominent therapy to promote Qi [life
energy] flow among meridians," NCCAM reports that acupuncture has been extensively
studied and that it has been demonstrated as effective in ameliorating some conditions
including some forms of pain (Berman & Straus, 2004). Bringing together TCM and
energy field theories in the application of acupuncture, Kloppenburg (1998) reviewed the
anatomy of acupuncture points in the human energy field in the body and the acupuncture
points' therapeutic consequences.

Principles and Theories of TCM
Chinese medicine has long and complex history that has been dated as far back as
3,000 years. The knowledge of Chinese medicine has been organized and compiled in
texts that go back to the first century BC. The various texts have been instrumental in the
integration an understanding of all natural phenomena, not just health. There is a
religious foundation in traditional Chinese medicine, which comes from Taoism and
Confucianism (Herring & Roberts, 2002). Eastern Asian medicine has a very different

paradigm of thinking than Western Medicine. It places an emphasis on the holistic
patterns, relationships, cycles and processes. In Chinese medicine the healthy individual
is "in harmony" and displays a balance among the mental, physical, and spiritual aspects.
The goal of Chinese medicine is to change the disharmony in the mind, emotion, body,
or behavior to a state of balance, state of harmony, and well-being. The Western
paradigm places an emphasis on linear thinking, causality and reductionist explanations.
This may be part of why traditional Chinese medicine has not been easily accepted in
this country.
Fundamental to Chinese medicine is the concept of Qi. However, as with Tao,
there is no single English word that captures it meaning. All of the universe and
everything in the universe is defined by and composed of Qi. The unobstructed flow of
qi is essential to physical, emotional, and mental harmony. Qi is the life force, the vital
energy of every cell in the body. "One can think of qi as matter on the verge of becoming
energy or energy on the point of materializing." (Bennett, 1978, cited by Freeman &
Lawlis, 2001).
Another important concept is that of meridians. Meridians are of fundamental
importance to acupuncture. Meridians are an invisible network, an energy grid,
responsible for the circulation of the Qi, blood, and bodily fluids. They are distributed
both on the right and left sides of the body, anterior and posterior, as well as located
interiorly and exteriorly. They are linked to one another in a specific order. A cyclical
flow of Qi is maintained by the meridians of the hand and foot, yin and yang, and the
interior and exterior. There are also two main channels that are located in the center of
the body in the anterior and posterior aspects. The twelve meridians share the following
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features according to Xinnong (1999): (1) Its own fixed acupuncture points on fixed
portion of the body surface; (2) Each pertains to a specific organ; (3) The meridians have
an exterior and interior relation of mutual connection; (4) Each meridian has its own
pathological manifestations if the Qi does not have a smooth flow.

Auricular Acupuncture.
Both body and auricular acupuncture originated in ancient China, but, while body
acupuncture has not changed much over the years, auricular acupuncture changed as a
function of work done in Europe. These changes in auricular acupuncture where initiated
by Dr. Paul Nogier in France (Oleson, 1998). While body acupuncture assumes that
energy lines (meridians) along the body have no obvious anatomical relationship to body
organs represented by particular meridians, auricular acupuncture assumes a structured
relationship between the anatomical positions of points and an inverted body image of a
fetus on the external ear (Oleson, 1998). "A large number of sites have been identified on
the ear which become spontaneously tender or otherwise react to the presence of disease
or injury elsewhere in the body. Stimulation of these ear points in the turn exerts certain
therapeutic effects on those parts of the body with which they are associated....
[auricular acupuncture] is relatively simple and economical, and there are few side
effects." (O'Connor and Bensky, 1981, p. 472).
Oleson (1998) offered a clarification of the concept of the relationship between
points on the ears and body parts and organs labeling these relationships "somatotopic
inversion." (p. 6) Regarding somatotopic inversion, Oleson (1998) writes, "The head
areas are represented toward the bottom of the ear, the feet toward the top, and the body
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in between. As with the somatotopic map in the brain, the auricular homunculus devotes
a proportionally larger area to the head and hand than to the body. The size of a
somatotopic area is related to the functional importance rather than its size." (p. 6) A
caution here is noted by O'Connor and Bensky (1981). They emphasize that the
locations of points can differ from person to person because of ear shape variation among
individuals.
This section has presented information regarding auricular acupuncture. It should
be noted that one of the developments in this area is the use of auricular acupressure. The
only difference between auricular acupuncture and acupressure is that acupressure uses
external pressure methods instead of acupuncture needles to stimulate the designated
points.

Existing research evaluating effects of acupuncture
There is evidence for the positive effect of acupuncture procedures (Manning,
2000; Berman, 2001). However, the empirical research literature does not find clear,
consistent support for these effects (Berman, 2001). As with much of the research done
within CAM, there are problems of lack of use of control groups, lack of randomized
assignment of subjects to conditions, and sample sizes that might not yield sufficient
statistical power thus increasing the probability of Type II error (Linde, 2000; Harlan,
2001; Berman, 2001).
Berman (2001) presented a very good overview of research on the effects of
acupuncture, including a set of meta-artalyses publications. Meta-analysis is the
procedure where a search of literature generates a list of qualified studies and then the
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results of these studies are themselves subjected to an analysis that uses their effect size
results to combine the studies and evaluate their implications for the research area being
examined. Most acupuncture research as been on the alleviation of pain.
For chronic pain, three have been three systematic reviews. Patel, Gutzwiller,
Paccaud, and Marazzi (1989) did a meta-analysis of 14 studies, ter Reit, Kleijnen, and
Knipschild (1990) conducted a meta-analysis of 51 studies, and Ezzo, Berman, Hadhazy,
Jadad, Lao, and Singh (2000) also conducted a meta-analysis of 51 studies The first metaanalysis on chronic pain (Patel et al., 1989) found few significant effects among the 14
studies included. Pooling results via meta-analysis did yield results favoring
acupuncture, but this was only for the non-blinded effects. Similar results were found by
the ter Reit et al. group (1990).
In their meta-analysis for effects of acupuncture on chronic pain, Ezzo et al.
(2000) identified four categories of control groups (waiting list, inert placebos, sham
acupuncture, and standard care). Of the 51 studies included in this systematic review 21
favored acupuncture. Other treatments were favored in four studies. The remaining 26
studies had no significant findings and most of these were designs using sham
acupuncture as the control group. Berman (2001) maintained that the risk of Type II
error or false-negative conclusion is high. Although low quality studies were
significantly more likely to yield positive results for acupuncture, there was still limited
support for acupuncture being more effective than waiting lists or inert, non-acupuncture
placebos. Importantly, the evidence for acupuncture being more effective than sham
acupuncture or standard medical care was insufficient. Similarly, a meta-analysis of 12
studies on back pain found that acupuncture was better than various control interventions

but that there was insufficient evidence to demonstrate that acupuncture was superior to
placebo (Ernst & White, 1998). An earlier meta-analysis by Ernst (1997) on 13 studies
found seven positive for acupuncture and six with non-significant results. However, an
examination of these 13 studies reveals design flaws including lack of randomization and
failure to use placebos as a control condition.
There have been two larger studies reporting positive results since these earlier
reviews. Molsberger, Bowing, Jensen, and Lorek (1994; Molsberger & Bowing, 1997)
conducted a clinical trial in Germany with 97 patients. They used real versus shamcontrol conditions and found significant pain relief at a three-month follow up
assessment. Berman and Ezzo (2000) used an acupuncture versus standard care design in
73 patients and found both pain relief and improved functioning for standard outcome
measures at a three month follow up. It may be that many of the earlier studies had
samples too small to provide necessary statistical power, thus generating a higher
likelihood of Type II error.
Berman and colleagues (Berman, Ezzo, Hadhazy, & Swyers 1999) published a
systematic review of acupuncture treatment of fibromyalgia pain. The review included
seven studies with three using randomized control designs and four using cohort designs.
Two of the randomized control designs demonstrated that real acupuncture was more
effective than sham acupuncture for ameliorating pain (Deluze, Bosia, Zirbs, Chantraine,
& Vischer, 1992; Cassisi, Roncaglione, Ceccherelli, Donolato, Gagliardi, & Todesco,
1995).
Although some of the studies of acupuncture treatment of pain reported above
used randomized control designs, a review article by Pan and colleagues examined
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complementary and alternative medicine in the management of 3 symptoms, one of
which was pain (Pan, Morrison, Ness, Fugh-Berman, and Leipzia, 2000) and noted,
"Acupuncture as a treatment for pain in seriously ill cancer patients has been evaluated
only in uncontrolled studies" (p. 379). Hence, in generalizing results of acupuncture
treatment of pain, care should be taken to note the nature of the populations studied and
the type of designs used. Pan et al. (2000) do cite two case series studies demonstrating
alleviation of pain in severely ill cancer patients. One such study reported acupuncture
pain control management for at least 1 month in 72% of patients with severe abdominal
pain resulting from locally invasive or metastatic cancer following daily treatment for one
to two weeks (Xu, S., Lui, A., & Li, Y., 1995). Those patients with such severe pain
were a subset of 92 patients with pain ranging from mild to moderate to severe.
The second case series study involved cancer pain clinic patients with a sample
size of 183 with 142 of these having pain related either directly to cancer or as a sideeffect of treatment (Filshie, J. & Redman, D., 1985). With one to four weekly manual
acupuncture sessions of 5-15 minute duration, 70 patients (48%) reported pain relief
and/or greater mobility for more than three days.
Interestingly, Pan et al. (2000) also reported in their survey what they labeled a
single-blind random controlled trial study examining acupuncture treatment (actual
acupuncture sites versus sham acupuncture sites) for painful peripheral neuropathy in 239
HIV-positive patients from multiple centers (Shlay, Chaloner, Max, Flaws, Reichelderfer,
Wentworth, Hillman, Brizz, & Cohn, 1998). First, this study was not included in the Pan
et al. (2000) review as one done with severely ill cancer patients because here the patients
were HIV-positive patients with peripheral neuropathy. Second, although this is a

controlled study and described by the authors as a modified double-blind study, Pan et al,
were justified in labeling the study as single-blind one because, regarding the
acupuncture conditions, the acupuncturist knew the condition assignment of the patients.
Apparently Shlay et al. called their study double-blind because neither the researchers nor
the patients knew the experimental conditions. However, they appear to have also
labeled the study as "modified" double-blind because the acupuncturist knew the
conditions. In any case, the study was thus open to experimenter effects from the
acupuncturist. Nonetheless, the results showed no difference between actual versus sham
acupuncture treatment in alleviation of pain in the patients.
Some studies have examined the use of acupuncture with breathlessness. Jobst,
Chen, McPherson, Arrowsmith, Brown, Efthimiou, Fletcher, Maciocia, Mole, Shifrin,
and Lane (1986) reported a controlled study comparing actual versus placebo
acupuncture in 24 patients with COPD and disabling breathlessness. They stated that the
actual acupuncture group reported greater improvement in symptoms and walked a
greater distance in six minutes. Filshie, Perm, Ashley, and Davis (1996) published a
study regarding the effects of acupuncture on 20 patients, median age 60, with cancerrelated breathlessness. Using VAS analogue scales, the patients reported significant
improvements in dyspnea, relaxation, and anxiety and these changes lasted up to at least
six hours. However, this study was uncontrolled and not done blind. Hence, the results
may have been a function of either experimenter expectations and/or a patient placebo
effect. Still, this study was cited in the Pan et al. 2000 a review article as supporting the
use of complementary and alternative medicine in managing dyspnea in near the end of
life patients.
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A well-designed study by Vickers, Feinstein, Deng, and Cassileth (2005)
evaluated acupuncture treatment for dyspnea in advanced lung and breast cancer patients
at Memorial Sloan-Kettering Cancer Center. They used a randomized placebo-controlled
design for a pilot study beginning with 47 patients and 45 patients completing the study.
They implanted acupuncture "studs" in either true or placebo acupuncture points. The
patients self-applied pressure to these studs twice daily. Patients rated their dyspnea
sensation on a numerical scale with a 0 to 10 point range right before and after
acupuncture treatment daily for a week. No results were statistically significant, although
the placebo acupuncture patients did report a small absolute improvement that was a little
greater than that reported by the true acupuncture patients. The author concluded, "The
acupuncture technique used in this trial is unlikely to have effects on dyspnea importantly
larger than placebo for patients with advanced cancer." (p 1)
Davis, Lewith, Broomfield, and Prescott (2001) conducted a pilot project
examining methodological issues when evaluating acupuncture as a treatment for
disabling breathlessness. Theirs was a randomized, controlled trial with three treatments:
real acupuncture, dummy acupuncture, and mock trans-electrical nerve stimulation. The
results showed a small, but statistically non-significant effect for acupuncture. As a pilot
project, this study had only 12 subjects, and its statistical power was too low. The
researchers had as one of their goals the calculation of an adequate sample size for
necessary power. They report that their analyses indicated that 25 patients would be
needed for power of .80 with alpha of .05.
These same researchers then ran a larger study with 24 patients completing both
arms of a single-blind, placebo-controlled crossover study. Still, the researchers found no
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difference between an actual acupuncture procedure and a mock one (Lewith, Prescott,
and Davis, 2004). Although this study had twice the number of subjects as that of Davis
et al. (2001), again statistical power was probably insufficient.
There have been studies examining the effects of acupressure on dyspnea. For
example, Maa, Gauthier, & Turner (1997) evaluated the use of acupressure in decreasing
dyspnea in COPD patients and this study was positively evaluated in the Pan et al. (2000)
survey of research on complementary and alternative medicine in managing pain,
dyspnea, and nausea and vomiting near the end of life. Maa's and co-authors' study had
31 severe COPD patients daily self-administer at home acupressure for 6 weeks
alternative with sham acupressure for 6 weeks in a single-blind, randomized crossover
study. When patients were using acupressure as opposed to using sham acupressure, they
reported significantly less dyspnea as assessed via VAS. A problem with the study may
be that there was little compliance control available since the patients were selfadministering at home. Still, the results were positive. Nonetheless, a limitation of the
study should be noted that with a single-blind design it is possible that experimenter
effects were operating.
Another, more recent, study by Maa evaluated the use of acupressure as well as
acupuncture in addressing breathing difficulties evaluated relief among patients with
chronic obstructive asthma (Maa, Sun, Hsu, Hung, Chen, Yu, Wang, & Lin, 2003). This
was a prospective, randomized study with three conditions: eight weeks of daily selfadministered acupressure and standard care (17 patients), 20 acupuncture treatments and
standard care (11 patients), and standafd care alone (13 patients). Both acupressure and
acupuncture conditions showed improvement on the St George's Respiratory
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Questionnaire. The acupressure condition demonstrated improvement in irritability
measured by the Bronchitis Emphysema Symptom Checklist.
A still more recent study by Wu, Lin, Wu, Lin (2007) evaluated acupressure with
COPD patients in Taiwan employing a randomized, block experimental design, randomly
assigning 44 patients to either a true acupressure condition using points for relaxation and
dyspnea or a sham acupressure condition using other unrelated points. The two groups
were also matched on a variety of characteristics including sex, age, pulmonary function,
steroid use, and smoking. Using the Dyspnea Visual Analogue Scale, the Geriatric
Depression Scale, as well as oxygen saturation, the study found that the true acupressure
group statistically improved more than the sham group on all assessments.
An interesting study evaluated the effects of acupressure for patients with
prolonged mechanical ventilation support (Tsay, Wang, Lin, and Chung, 2005). This
study in Taiwan compared acupressure and massage with massage and handholding for
52 randomly assigned patients with COPD. Hence, there was no blinding to conditions.
Still, acupressure produced statistically significantly better results for dyspnea, anxiety,
and object physiological indicators for both heart rate and respiratory rate.
Interestingly, as a side note, acupuncture has been demonstrated to significantly
reduce exercise-induced asthma. Fung, Chow, and So (1986) studied breathing problems
not in cancer patients, nor in end of life patients, not those with COPD. Rather, they
induced asthma symptoms through motor-driven treadmill exercise in children, ages 9 to
13.5, who had mild to moderately severe perennial bronchial asthma. Asthma symptoms
were assessed using forced expiratory flow in the first second, forced vital capacity, and
peak expiratory flow rate. The study used a single-blind, cross-over design where
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children were given real and sham acupuncture in random order. The results that
exercise-induce asthma symptoms in asthmatic children were significantly attenuated by
real acupuncture as compared to placebo (sham) acupuncture.
A case study (Fillmore, 1999) used acupuncture on a 45-year old male with
reactive airway disease comparing the effects of acupuncture versus medication
(albuterol aerosol). The outcome was assessed objectively using a simple peak flow
meter measuring peak flow before and after each treatment. The acupuncture provided
greater increase in peak flow than did the medication. Limitations of this study included
neither the physician nor patient being blinded to the conditions. Although the measure
used was an objective one, it is still possible that the patient made greater effort following
acupuncture. The author does report that the patient appeared to make a best effort for
each peak flow assessment.
As discussed in earlier sections, anxiety and distress are important dimensions of
the symptom of dyspnea. There is some research that supports acupuncture procedures as
interventions that can reduce anxiety, including Tsay et al. (2005) reported above.
Another blinded study treated anxiety in the mothers of children being prepared for
surgery. Subjects were randomized to two groups: auricular acupuncture at the
relaxation points (n = 34) versus sham acupuncture at the shoulder, wrist, and extraneous
auricular points (n = 33) (Wang, Maranets, Weinberg, & Caldwell-Andrews, 2004). This
was a repeated measures design where anxiety was measured by the State-Trait Anxiety
Inventory at the three points of time: baseline, 30 minutes after the intervention, and on
completion of the child's anesthesia induction. Analyses revealed that the group by time
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interaction was significant for the change in mother's anxiety with the actual acupuncture
group reporting less anxiety.
A study that used auricular acupressure for treatment of anxiety also found
support for such intervention (Kober, Scheck, Schubert, Strasser, Gustorff, Bertalanffy,
Wang, Kain, & Hoerauf, 2003). Subjects in the study were patients who needed
ambulance transport secondary to medical conditions. This was a blinded randomized
control study. Subjects were randomized to two conditions: auricular acupressure at the
relaxation point (n = 17) versus auricular acupressure at a sham point (n = 19). State
anxiety and pain were assessed using visual analog scales before and after transport. The
actual auricular acupressure group demonstrated significantly less anxiety and pain than
did the sham auricular acupressure group.
Studies of acupuncture and acupressure need to be done using samples and
procedures that generate sufficient statistical power. Repeated measures designs with
more than two time points should be used since this both allows for assessment of change
over time and benefits from the increased power generated by multiple time points. Such
studies should also be randomized control trials when ethical and practical with as much
blinding to condition as possible.

Summary Syntheses
Dyspnea is a common and debilitating symptom that is not well understood or
controlled even though many patients describe the experience as agonizing and worse
than pain. Carrieri-Kohlman, Janson-Bjerklie, and Jacobs (1984) maintain that the
documents from the 1980 policy statement by American Nurses' Association and the

1982 Fifth National Conference on Nursing Diagnosis "provide a mandate for nurses to
study the measurement and management of symptoms and responses to illness, dyspnea
being an example." Although there has been research on dyspnea over the last 25 years,
the emphasis of this research has been on chronic diseases and there has been very little
research on dyspnea in end-of-life patients. The National Institute of Health State-of-theScience Conference Statement, 2004, has among its recommended future directions for
improving end-of-life care: "Develop and test new interventions, including
complementary and alternative medicines, to improve symptom management in diverse
patient groups, (p. 10)"
This proposed research will evaluate an auricular acupressure intervention for
amelioration of dyspnea in end-of-life patients with lung cancer. This research will
place the dyspnea construct within the theoretical framework of the Revised Symptom
Management Conceptual Model (RSMC Model) that has three basic dimensions of (1)
symptom experience, (2) symptom management strategies, and (3) outcomes. The
RSMC Model also has three sub-dimensions of the symptom experience consisting on (1)
perception of symptoms, (2) evaluation of symptoms, and (3) response to symptoms.
These three sub-dimensions will be captured by the multi-dimensional assessment
instrument, the Cancer Dyspnea Scale, which was developed on lung cancer patients.
Finally, another important contribution of this research will be the use of a true
experimental design with random assignment of subjects to experimental conditions in
the testing of a complementary alternative intervention.
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Chapter 3. Methods
Research Design
This study used both quantitative and qualitative methodologies. Hence, in
addition to the quantitative methods described below, this study also employed
qualitative questions and analysis. Following the quantitative analyses, the qualitative
results are presented. In the Discussion section, the quantitative analyses are reviewed
within the context of the qualitative results. This approach extended the researcher's
understanding of the phenomenon under investigation.
For the quantitative methodology, this feasibility study employed a true
experimental design where group membership was determined through random
assignment. Although the sample was essentially one of convenience, an experimental
design is not a function of the source of a sample. A true experiment is defined by the
subjects being randomly assigned to condition and by the condition or the independent
variable being under the control of the researcher. The basic research design for this
study was a 3 (group: standard care [SC], standard care plus acupressure placebo [SC +
AP] with use of seed adhesive not on lung or anxiety points, standard care plus
experimental auricular acupressure using seed adhesive on lung and anxiety points [SC +
AE]) by 8 (time: 2 assessments for each of 4 days — day 1 baseline, day 2, day 3, day4)
mixed design analysis of variance (ANOVA) with time as the repeated measure (see
Table 2). The auricular acupressure treatment was administered on the morning of Day 2
following the Day 1 baseline assessments. All early and late assessments took place at
the same time each day.
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These three conditions were designed to help differentiate between different
sources of effects. For example, SC versus SC + AP and SC + AE would enable the
determination of any effect due to simple change in procedure, additional attention to the
patient, and general placebo effects. Also, SC + AP versus SC + AE allowed for the
differentiation between effects due to placebo auricular procedures versus those due to
actual auricular therapy. Additionally, a baseline assessment allowed for evaluation of
any differences between the subjects in the three conditions before any treatment begins.

Table 2. 3 (Condition/Group) by 8 (Time) ANOVA with Time as the repeated measure

Da>'1
base ine
Early Late

TIME
Day 2 post-tx

Day 3 post-tx

Day 4 post-tx

Condition*
Early Late Early Late Early Late
ST#
SC
SC + AP
SC + AE
SC = standard care
SC + AP = SC & seed adhesive not on lung or anxiety points (placebo condition)
SC + AE = SC with seed adhesive auricular acupressure on lung and anxiety
(experimental condition)
#ST = Start Treatment of Auricular acupressure or Placebo Auricular acupressure
The major advantage of the basic research design is that it is a true experimental
design that allows for direct manipulation of the primary independent variable. In turn,
this allows for greater confidence in interpretation of results and for making causal
inferences. An additional advantage of a mixed design ANOVA is that with repeated
measures statistical power is increased in that each time a subject is assessed, the power
increases as if an additional subject had been enrolled in the study. The major
disadvantage of this type of design in this study is that each research participant had to be
individually run including repeated follow up assessments rather than subjects being run

75

in groups. A limitation of this design because of the source of this sample is that of
generalizability.
The quantitative independent variable in this study was an experimentally
manipulated one, and consisted of treatment condition (SC group versus SC with
inappropriate seed point adhesive placebo group versus SC plus acupuncture with
appropriate seed adhesive experimental group). The quantitative dependent variables
were self-reported dyspnea (total score as well as three subscales), oxygen saturation, and
use of respiratory treatments.
The two non-SC conditions (SC with seed adhesive placebo group and the SC
plus acupressure with seed adhesive experimental group) were blinded for both the
subjects and the research assistants administering the dyspnea and pulse-oximeter
assessments. Subjects in both conditions had adhesive on their ears.
Additionally, although there was random assignment to condition, there were still
two issues regarding individual differences among subjects. First, even random
assignment does not guarantee lack of differences between the subjects in different
conditions. This is particularly the case with relatively small samples. Second, even if
there were no differences between subjects in different conditions, individual differences
within conditions still contribute to the error terms in statistical analyses. Hence,
statistically controlling for such individual differences can reduce the error terms and,
hence, increase the effect size. Of course, repeated analyses does control for such
individual differences within each condition over time since the same subjects are used
over time. Still, analysis of covariance (ANCOVA) was used in order to ensure control
of differences between conditions because of the relatively small sample in this study.

For the qualitative data, five questions were asked of the subjects. Three
questions were asked on Day 1 baseline. On Day 4, these three questions were asked
again, but specifically regarding the subject's experienced at that time only, along with
two additional questions.
Finally, subjects were told that at the end of their research participation they
would have the opportunity to make a decision about any continued treatment. They
were told that they would be able to continue receiving acupressure if they were in the
experimental group or to begin receiving acupressure if they were in either of the two
other groups.

Sample
The 11 research participants consisted of lung cancer inpatients and homecare
patients at a Southern California hospice. Inclusion criteria consisted of a primary
diagnosis of end stage lung cancer, dyspnea, no lesions in the ears, no allergies to
adhesive materials, at least 45 years old, English speaking, ability to comprehend and
understand consent, and ability to communicate with the researcher. Research
participants were assigned randomly to one of three groups. The first group received
current standard of care. The second group received current standard of care plus sham
Auricular acupressure. The third group received current standard of care plus Auricular
acupressure.
The target sample consisted of 15 subjects in each of the three groups for a total
of 45 research participants. Since this research was being conducted on end-of-life stage
hospice patients, it was expected that some patients might die during the study. Hence,

the plan was that subjects would continue to be recruited until the sample size of 45 was
achieved. This target sample size was chosen as a function of formal statistical power
analyses for quantitative data with power set to at least .80, the conventional cut off level
for sufficient power (Cohen, 1988,1992). The power analyses were conducted using the
SOLO Power Analysis software (Hintze, 1992). For both research and clinical purposes,
the decision was to be able to detect down to at least a medium effect size (f= .25, Cohen
1988,1992) if the full sample were recruited for this feasibility study. For detecting such
medium effects, power analysis demonstrated that originally planned total sample size of
45, there would be more than sufficient power for both the main effect of time (power =
.90) and for the interaction of group by time (power = .81). It is the group by time
interaction that would be used to determine the presence of group effects. That is, the
focus here was on whether the change over time depends on group membership.
Although there would have been insufficient power to detect such an effect size for the
main effect of group (power = .28), the group main effects were neither the focus of this
research nor necessary to demonstrate the efficacy of acupressure in these patients.
For this feasibility study, the target sample of 45 participants was not achieved.
The sample size at the time of data analyses was 11 with two subjects in the control
condition, five in the placebo condition, and four in the experimental condition. Issues
and difficulties regarding participant recruitment are covered in the Discussion Section.
Data collection procedures
There were three general methods of quantitative data collection. First, selfreport was used for both demographic Information and for rating of dyspnea. Second, a
medical assessment of oxygen saturation was conducted. Third, patient charts were used
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for determining use of respiratory treatment as well as a source of other data, e.g.,
diagnosis of small cell versus non-small cell lung cancer. Self-report of demographic
data is a frequently used procedure for assessing such data. The self-report scales for
dyspnea are commonly used in treatment facilities and appear to provide both reliable
and valid information. Patient charts are another frequently used source for research
data. As mentioned above, for qualitative data collection five questions were asked of the
subjects: Three questions on Day 1 repeated on Day 4 but asked regarding current
experience and also on Day 4 two additional questions.

Measures
A short demographic questionnaire was used that asked for self-report of sex, age,
marital status, number of children, and support which is the number of family or close
friends within a 50-mile radius. Although much of this information could have been
obtained from medical records, the taking of such information can also help establish a
research rapport with the patient and research participant.
The CDS (Tanaka et al, 2000) was used to measure dyspnea. This 12-item scale
assesses three dimensions of dyspnea: sense of effort [Dyspnea Effort], sense of anxiety
[Dyspnea Anxiety], and sense of discomfort [Dyspnea Discomfort] using a 5-point Likert
scale for responding to each item from 'not at all' to 'very much'. Also, a total score can
be used. Bruera and Ripamonti (1998) recommended that a scale to measure dyspnea for
investigating etiology and establishing therapeutic strategies should have six
characteristics: (1) be multidimensional, (2) be self-rating since dyspnea is subjective,
(3) be easy and simple enough to be completed by patients with dyspnea, (4) be evaluated
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not by physical effort evoking dyspnea, but by perceived dyspnea itself so that even
bedridden patients can complete it, (5) have its reliability and validity in cancer patients
confirmed, and (6) be sensitive to clinical changes due to treatment or progression of the
disease over time. Tanaka and colleagues stated that they had followed these
requirements in their development of the CDS. Additionally, the Oncology Nursing
Society (2008) formally listed this scale on their web site.
The CDS is best suited for use in this study because its average time required for
completion was 140 seconds. Also if terminally ill patients cannot read the items and/or
use a pencil to respond to them, the items can be read aloud and the patient can respond
with a number from the five-point scale. Construct validity was confirmed through the
use of repeated factor analysis, once in the developmental phase of the research and once
in the validation phase. Both factor analyses yielded the expected three factors.
Convergent validity with both the Visual Analogue Scale and a modified Borg scale was
good (average r = .57 and .52 respectively with both having p < .001). Reliability as
assessed by internal consistency was also good (average Cronbach's alpha = .86). Also
test-retest reliability was good (r = .66, p< .005). It is important to keep in mind that one
might expect dyspnea itself to change over time in a patient. Hence, this level of
obtained test-retest reliability is quite good. Pulse-oximeters are well established,
reliable, and valid medical instruments (Tanaka et al., 2002a, 2002b).
Oxygen saturation was assessed with the Welch-Allyn Sure-Temp Pulse
Oximeter. The pulse-oximeter in this study is manufactured by Welch-Allyn Sure-Temp
Technology and is already available at "the research site. The use of patient charts is also
a well-established procedure.
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For the qualitative data, the three questions on Day 1 were as follows: (1)
Describe what the experience of breathlessness has been for you; (2) Describe how the
experience of breathlessness has affected your quality of life; and (3) Describe any
suffering that you associate with breathlessness. On Day 4, the 5 questions were as
follows: (1) Describe what the experience of breathlessness has been for you at this time;
(2) Describe how the experience of breathlessness has affected your quality of life at this
time; (3) Describe any suffering that you associate with breathlessness at this time; (4)
Describe your experiences of receiving auricular acupressure; and (5) Would you
recommend acupressure to other people with breathlessness? If so, what would you tell
them? If not, why not?

Experimental Procedure
Each new admission to the inpatient hospice center or homecare that had a
primary diagnosis of lung cancer was approached and asked whether the researcher could
give them an overview of the research participation opportunity. If permission was
given, then the subject was provided with such an overview while clearly emphasizing
that the research participation was completely voluntary and that declining participation
or withdrawing from participation once enrolled in the study would have no effect on the
course of the subject's treatment while at the inpatient hospice center or in homecare.
Once the overview was provided and if the potential subject wished to participate, he or
she was given a copy of the Experimental Human Subjects Bill of Rights and asked to
sign a consent form.
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Before allowing the subject to sign the consent form, the researcher asked
whether the subject understood the research, knew what would happen if he or she
consented, understood that he or she could decline or withdraw at any time, and
understood the nature of any risks of participation. After the subject signed the consent
form, he or she was asked to complete the brief demographic form. For each subject, the
same individual researcher followed the patient through to the end of the study.
On Day 1, once in the morning (about 9 AM ±1.5 hour) and once in the evening
(about 6 PM ±1.5 hour), the subject was administered the Cancer Dyspnea Scale and had
oxygen saturation assessed. Both of these assessments were conducted one-on-one. The
Cancer Dyspnea Scale and the oximeter were used twice a day (morning and evening) for
the next three days (Day 2, Day 3, Day 4). The first three qualitative questions were
asked during the early Day 1 assessment period and the subject responses were tape
recorded.
On the morning of Day 2 and before the early Day 2 assessments, the treatment
intervention began. Application of acupressure seed adhesives were carried out by a
licensed acupuncturist. The experimental acupressure condition (SC + AE) consisted of
placing small seeds (botanical name: vaccaria segetalis; English name: vaccaria seeds
obtained from the company Heilo) with an adhesive material that allowed the seed to be
held in place over the appropriate acupressure point on both ears. The placebo
acupressure condition (SC + AP) also included the use of seed adhesive but not placed on
lung or anxiety points. Before the adhesive with seeds was put in place, the auricular
points were mildly stimulated for 3 seconds with a surface, non-invasive probe, making a
slight indentation on the points, then cleansed with an alcohol applicator stick. Subjects
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were asked whether they had any known allergies for adhesives or tape. Additionally, the
site of the adhesive used was monitored for any allergic reaction. Skin integrity was
monitored during both the application and removal of the adhesive to prevent and
ameliorate skin tear. Fatigue was monitored during the subjects' participation in the fourday protocol. The subject was both directly asked about experience of fatigue and
observed for any evidence of increasing fatigue over the course of the protocol. The seed
adhesives were placed on the ears of the subject the morning of Day 2. Then, within two
hours before each morning and evening assessment, research personnel visited the
subject, asked how he or she were doing, and reminded the subject that assessments
would happen at a specified time. For those subjects in the two-acupressure conditions,
pressure was applied to the seeds.
Day 3 and Day 4 involved the morning and evening pre-visits and, for the
acupressure groups pressure being applied to the seeds followed two hours later by the
assessments. On Day 4, the 5 qualitative questions were asked and the subject responses
were tape recorded. On this last day, the subjects were also engaged in conversation
where they were asked whether they had any questions regarding the study. Subjects
were told that if they had not received the auricular acupressure treatment, they would be
offered the treatment when the study was completed. The subjects were thanked for their
participation, told that the researcher greatly appreciated their help, and that this research
may help others.
The site of this research, the San Diego Hospice Inpatient Care Center, is also a
clinical site for the Pacific College of Oriental Medicine. The acupuncturist was licensed
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in California. As covered in the Human Subjects Research section below, all research
personnel were trained in the ethics and procedures of human subjects research.
Table 3. Auricular Acupressure Points Used (Oleson, 1998)*
Point/Representation
Placebo-Sham Points:
1) Ankle
2) Prolapse
3) Shoulder
4) Occiput
5) Internal ear
Experimental Points:
1) ShenMen

Rationale for Selection

Chosen for ease of access, similar physical location as
experimental points, but very little likelihood of impacting
patients' respiration.

One of most commonly used auricular points; calms the
spirit, promoting sense of relaxation, helps with coughing.
2) Kidney
Role in respiration. In TMC, the 'Kidney' (TCM organ)
assists the 'Lung' (TCM organ) in grasping the clear 'Air
Qi' that the Lungs send downward to the absorbed by the
Kidney. If inhalation is difficult, it indicates deficiency in
the 'Kidney.'
3) Lung Lower
Role in respiration. In TCM, the 'Lung' Governs Qi,
manages respiration, regulates the water pathways,
Governs diffusions of Qi and body fluids. When there is a
pathology in the body and phlegm is accumulating it can
sometimes it can sometimes be stored in the "Lung.'
4) Chest
This point as two purposes: (1) The Lung and Kidney's
relationship in TCM goes beyond simple respiration. The
use of this point focuses the action of these two organ
systems directly on breathing. (2) The intention of this
point is to keep the Qui moving in the chest. Hence,
breathlessness is not created by the congestion of Qi in the
chest.
5) Relaxation
Anxiety seems to be a significant component of dyspnea.
AKA St Jerome point, This point along with the Shenmen point above (#1) can
work synergistically to promote a sense of relaxation. This
Jerome point,
sexual compulsion
| point also helps with insomnia. Also ease of placement.
* Jeffrey Smith, LAc, the Licensed Acupuncturist who conducted the acupressure
procedures in this study, helped prepare this information.
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The acupuncturist performed the customary pre-assessment procedures for auricular
acupressure for the condition of breathlessness. This was done the morning of the second
day of the protocol. The placebo or sham acupressure points were chosen for ease of
access, similar physical location as experimental points, but very little likelihood of
impacting patients' respiration. The experimental acupressure points were chosen for
relationships to dyspnea and respiratory distress based upon the Chinese Diagnosis and
disease concept of "breathlessness." (See Table 3 for details. Note that Table 4 describes
possible points that were not used.) This concept is based on rapid difficult continuous

Table 4. Auricular Acupressure Points Not Used (Oleson, 1998; Bensky, xxxx)*
Point/Representation
1) Stop wheezing

Rationale for Non-Selection
Very close to border of antitragus and other points.
Concern about loss of seed through poor adhesion and also
seed could migrate to another point.
2) Adrenal
While easy to activate with a needle, it still had the same
issues as above, but on the traqus.
3) Allergy point
Just hard to get to.
4) Master Cerebral
Could be issue with hair growth.
5) Wheezing
Too close to ShenMen and not as well rounded for the
treatment
Emphysema
Too hare to get for good seed placement
* Jeffrey Smith, LAc, the Licensed Acupuncturist who conducted the acupressure
procedures in this study, helped prepare this information.
breathing with the mouth open and an inability to lie down because of breathing
difficulties. With dyspnea, one of the main problems for the patient is anxiety due to
drowning feelings. Hence, points were chosen so as to focus on anxiety. If anxiety is
controlled then maybe the breathing will become more even and more efficient. So the
points were chosen using three criteria:* breathlessness treatment, anxiety reducing, ease
and retention of seed placement. All placements also followed three axis lines in the ear:
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ShenMen, Kidney and Lower Lung. For detail graphic illustration of these points, see
Appendix F.
As mentioned earlier, the SC versus the SC + AP versus SC + AE conditions used
SC with no adhesive, SC with seed adhesive not on lung or anxiety points, and Auricular
acupressure seed adhesive on lung and anxiety points, respectively. The placement of the
seeds on or not on lung or anxiety points was not easily discernable without very close
inspection by a knowledgeable acupuncturist of the ears. Hence, the subjects and those
who conduct the dependent variable assessments were blind to the SC + AP versus SC +
AE conditions.
While blind to subject assigned condition, the researcher asked the qualitative
questions at the two designated times and administered the CDS and the pulse-oximeter
testing. These quantitative assessments were carried at the eight time points of the
protocol.

Data Analysis
Although as a feasibility study this research enrolled only 11 subjects, generally
the data were analyzed as if the target sample of 45 had been obtained. The analyses
were carried out as part of determining feasibility in that both the researcher tested his
ability in this area and the analyses yielded estimated effect sizes that can be used in
power analyses for planning continued and future research in this area.
The distributional properties of the dependent variables were evaluated to
determine whether they met the assumptions for parametric statistics other than the
assumption of independence. The presence of independence was supported by random

assignment and by running subjects one at a time in this study. Other than independence,
there are two other assumptions: normality and homogeneity of variance (Keppel, 1991).
The initial plan was that in the case where there were violations of these assumptions,
data transformations would be used, e.g., logarithmic transformations for highly rightskewed data. Additionally, for repeated measures designs such as this one, there is the
assumption of sphericity, which can be thought of as the dependent variable having a
similar correlation between any two time points. The original plan was that if this
assumption were violated in the data set, Geisser-Greenhouse corrections for the level of
violation would be used (Keppel, 1991). A final assumption would apply when analyses
of covariance (ANCOVA) were run. That assumption is that the relationship between
covariates and the dependent variable is a linear one. However, since the sample size that
was generated consisted of only 11 participants, such evaluation of these last two
assumptions was not warranted.
Even though random assignment was used, it was always possible for research
participant characteristics to differ between conditions. That is the subjects in the three
conditions could still have been different on important variables at baseline. This was
especially the case with the relatively small target sample size of 45. Since there was the
even smaller sample size of 11 generated in this study, evaluations of such differences
across groups would not be meaningful. Still, for the sake of the protocol, some tests
were run on baseline differences between groups using ANOVA for continuous variables
such as age and chi-squares for categorical variables such as sex. In the case of such
differences in variables central to the study being present, the original plan called for the
basic design to be modified as an ANCOVA where variables that differ between the two
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groups at baseline would have been used as covariates in order to take such differences
into account. Although there were no such statistically significant differences that could
be used here, two such analyses were run as demonstrations of the procedure.
The primary quantitative data analysis that was used in this study was ANOVA
for the 3 (group) by 8 (time) mixed ANOVA design. Additionally, besides the
demonstration ANCOVA used for taking into account a baseline difference between the
groups, a demonstration ANCOVA was also used to test for the effects of controlling
sources of individual differences, thus reducing the error term and increasing statistical
power. Such potential variables included sex, age, ethnicity, marital status, number of
relatives and close friends within a 50-mile radius, number of complementary treatments
used, and medications,. For demonstration purposes some of these possible differences
among groups at baseline were tested using one-way ANOVA for continuous variables
and chi-square for categorical variables. Part of the original plan include considering
some variables such as sex as an additional factor in a 2 (sex) by 3 (group) by 8 (time)
mixed design ANOVA. Because of the final sample size, this was not done.
The relationships among the dependent variables were evaluated. Pearson
product moment correlations were used for these evaluations.
Alpha was set at .05 for evaluating statistical significance. In the original plan, an
alpha of .05 was to be used even though there were a number of tests being run in this
study. The greater concern for error here was for a Type II error (saying that an effect is
not present when it is) than for a Type I error (saying that an effect is present when it is
not). It should be kept in mind that replication would be the best way to control for error.
Although the original plan was that the significance of the group by time interaction term
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for each of the primary dependent variables (dyspnea ratings and oxygen saturation)
would be used to evaluate whether each of the three hypotheses was supported, in this
pilot feasibility analyses, these tests were used to generate estimates of effect size for
each hypothesis.
For the qualitative data, the subjects' tape-recorded responses were transcribed.
The qualitative method employed in this study was Simple Thematic Analysis [Braun and
Clarke, 2008]. The process here was similar to that used by Jackson, Melvin, and Downe
(2007). The procedure was conducted by two people, the author and by a consultant
trained in qualitative research and nursing. The interactive procedure was conducted
through debate and consensus. The initially identified themes were then reevaluated with
an examination for discontinuing data. Thus the transcriptions were evaluated for the
presence of themes, there was an agreement on the final themes, and the results were
used to inform the understanding of the quantitative results.

Chapter 4 Results
Sample
The data analyzed here came from a sample of 11 subjects enrolled and randomly
assigned among three conditions: two in Control, five in Placebo, and four in
Experimental. Subjects all had a primary diagnosis of lung cancer and were drawn from
the San Diego Hospice and Palliative Care Center with four (36.4%) coming from the
Inpatient Care Center (ICC) and seven (63.6%) from Home Care (HC). These 11 were
enrolled from a total of 74 approached from July 2007 through March 2008; 11 were in
the ICC and 63 were in HC. Of those approached, two in the ICC and 10 in HC died
before they could be enrolled in the study. One subject in HC was discharged from San
Diego Hospice and Palliative Care Services because he was doing better and began
looking for curative interventions. The most common reasons provided for not enrolling
were time involvement, appointments for doctors and treatments, and fatigue. For
characteristics of those eligible subjects who were approached but did not enroll in the
study can be found in Appendix K.
Characteristics of the sample included 54.5% female, 72.7% Caucasian, 63.6%
married, and 45.5% with a high school degree. The average age was 68.7 (14.21) with a
range from 49 to 89. Support, the mean number of friends and family living within 50
miles of either the San Diego Hospice and Palliative Care Center or the place of Home
Care on whom the individual could count, was 3.6 (3.59) with a range from 1 to 13. A
little over a third (36.4%) of the subjects had only one person on whom they could count.
The average number of eight different types of complementary medical treatments that
the individual had had was 1.5 (1.51) with a range from 0 to 4. Those who had had at
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least one type of complementary treatment comprised 54.5% of the sample. Also, the
time between eight of the subjects' enrolling in the study and death averaged 64.6 days
with a standard deviation of 47.39 and a range from 6 to 141 days. Three subjects had
not died as of May 9, 2008. See Appendix L for details.
Table 5 presents the sample characteristics with more detail and compares the
attributes of the subjects across the three conditions. Because of the small sample it was
Table 5. Subject Characteristics Across 3 Experimental Conditions
Condition

Variables
Age mean (sd)
SexN(%)
Female
Male
Ethnicity N (%)
Caucasian
Hispanic
Native
American
Marital N (%)
Single
Married
Divorced
Widowed
Education Degree
None
High School
Bachelor
Doctorate
(M.D.)
Support # mean
(sd)
# complementary
tx mean (sd)
Location N(%)
Inpatient Care
Home Care
p<.05

All Subjects
68.7(14.21)

Control
66.0(18.38)

Placebo
68.2 (16.45)

Experimental
70.8 (13.72)

X2
or Ftest
0.07

6 (54.5)
5 (45.5)

2(100.0)
0 (0.0)

3 (60.0)
2 (40.0)

1 (25.0)
3 (75.0)

3.13

8 (72.7)
2(18.2)
1 (9.1)

1 (50.0)
1 (50.0)
0 (0.0)

3 (60.0)
1 (20.0)
1 (20.0)

4(100.0)
0 (0.0)
0 (0.0)
3.71

1 (9.1)
7(63.6)
1 (9.1)
2 (18.2)

1 (50.0)
1 (50.0)
0 (0.0)
0 (0.0)

0 (0.0)
4 (80.0)
0 (0.0)
1 (20.0)

0 (0.0)
2 (50.0)
1 (25.0)
1 (25.0)

7.11

3 (27.3)
5 (45.5)
2(18.2)
1 (9.1)

1 (50.0)
1 (50.0)
0 (0.0)
0 (0.0)

2 (40.0)
2 (40.0)
0 (0.0)
1 (20.0)

0 (0.0)
2 (50.0)
2 (50.0)
0 (0.0)

6.53

3.6 (3.59)

1.0(0.00)

5.0 (4.74)

3.2(2.22)

0.91

1.5(1.51)

3.5 (0.71)

1.4(1.34)

0.5(1.00)

4.50*

1 (20.0)
4 (80.0)

2 (50.0)
2 (50.0)

1.06

*

4 (36.4)
7 (63.6)

1 (50.0)
1 (50.0)
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not expected that the conditions would be statistically significantly different on sample
characteristics. Still, the statistics were run as part of the feasibility study, using chisquare for nominal variables and one-way ANOVA for continuous (interval or ratio)
variables. In general the differences across the three conditions were not significant. The
one exception was for the number of the eight types of complementary medical treatment.
Here the difference across the three conditions was significant (F(2,10) = 4.50, p < .05),
with Control subjects reporting an average of 3.5 (0.71) types of treatments, Placebo
subjects reporting 1.4 (1.34), and Experimental subjects reporting 0.5 (1.00). Even with a
small sample size, it is possible to obtain significant results if the estimated effect size is
large. For the ANOVA analyses in this study, partial eta square (r|p ) was used to
represent effect sizes. This effect size estimate is available as part of the ANOVA
programs within SPSS. For r\p2, effect sizes are as follows: small ~ .01, medium ~ .06,
large ~ .20 (Cohen, 1988). For the significant result for number of complementary
treatments across the three conditions, the T|P2 = .53, a very large effect.

Hypotheses Testing
A 3 (condition) by 8 (time) mixed design ANOVA with time as the repeated
measure was used for testing the two hypotheses predicting change in dyspnea and
oxygen saturation as a function of assigned experimental condition (Control, Placebo,
Experimental).
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Hypothesis 1: Dyspnea Change
Four statistical analyses were conducted to test this hypothesis about the change
in dyspnea being a function of the experimental condition. These analyses were run for
four different dependent variables: Dyspnea Total, Dyspnea Effort, Dyspnea Anxiety,
and Dyspnea Discomfort. The means and standard deviations for these dependent
variables over eight time points within each of the three experimental conditions are
presented in Tables 6 through 9. The effect that was of interest for each of these analyses
was that of the condition by time interaction. Condition by time interactions are reported
below for the general overall effect and for the type of interaction: linear where the
change is generally in the same direction over time or quadratic where the change shifts
directions at least once over time. The type or form of interaction tests have more
statistical power since they test for a specific shape of a change rather than testing for
whether there is any type of change present. The results of these analyses are presented
below and the plots of the results of the changes over time in dyspnea for the three
conditions are presented in Figures 2 through 5. Figures 6 and 7 are presented for
demonstration purposes to show how possible covariates would be used in an ANCOVA.
Dyspnea Total. For Dyspnea Total, there appears to be a general change in
alleviation of dyspnea over time for all subjects, as can be seen in Table 6 and Figure 2.
This is reflected in the significant ANOVA main effect for time (F(7,56) = 2.33, p < .04)
with a large effect size (np2 = .23). The form of this time effect appears to be a simple
linear one (F(2,8) = 9.22, p < .02) with a very large effect size (t|p2 = .54). It should be
noted that main effects are best not interpreted if there is a disordinal interaction effect
present, and the effect interest here is that of the condition by time interaction.

93
Table 6. Experimental Conditions: Cancer Dyspnea Scale Total [Mean (SD)].
Time
Condition
Control
Placebo
Experimental

Time 1
9.0
(12.73)
8.4
(6.84)
11.5
(5.74)

Time 2
10.5
(14.85)
7.0
(7.11)
11.0
(6.88)

Time 3
13.0
(18.38)
7.4
(7.34)
9.5
(5.92)

Time
5
4.0
(5.66)
6.4
(8.14)
6.8
(3.95)

Time 4
11.0
(15.56)
11.8
(12.93)
9.0
(5.48)

Time
6
4.5
(6.35)
4.4
(4.56)
2.75
(3.10)

Time
7
6.0
(8.49)
7.6
(7.57)
8.2
(5.91)

Time
8
3.5
(5.00)
9.2
(6.76)
5.0
(4.24)

Table 7. Experimental Conditions: Cancer Dyspnea Scale Effort [Mean (SD)].
Time
Condition
Control
Placebo
Experimental

Time
1
4.5
(6.36)
3.6
(1.82)
6.5
(3.32)

Time
2
3.5
(5.00)
2.2
(1.92)
5.2
(2.87)

Time
3
4.0
(5.66)
3.0
(2.34)
4.8
(3.20)

Time
4
3.0
(4.24)
4.4
(5.60)
4.2
(2.06)

Time 5
1.5
(2.12)
2.8(3.27)
1.8
(1.50)

Time
6
2.5
(3.54)
2.2
(1.64)
0.50
(0.58)

Time
7
2.0
(2.83)
3.4
(3.13)
3.0
(2.45)

Time
8
1.5
(2.12)
3.2
(2.95)
2.0
(1.41)

Table 8. Experimental Conditions: Cancer Dyspnea Scale Anxiety [Mean (SD)].

Condition
Control
Placebo
Experimental

Time
Time 1 Time 2 Time 3 Time 4 Time 5 Time 6 Time 7 Time 8
2.5
5.5
4.5
0.5
5.0
0.5
0.0
0.5
(3.54) (7.07) (7.78) (6.36) (0.71) (0.71) (0.00) (0.71)
4.4
0.4
1.4
1.0
0.8
0.2
1.0
1.4
(1.67) (2.34) (1.30) (6.19) (0.89) (0.45) (1.41) (1.67)
0.2
0.8
1.2
0.5
0.8
0.0
0.0
0.0
(0.96) (1.50) (1.00) (0.96) (0.50) (0.00) (0.00) (0.00)

Table 9. Experimental Conditions: Cancer Dyspnea Scale Discomfort [Mean (SD)].
Time
Condition
Time 1 Time 2 Time 3 Time 4 Time 5 Time 6 Time 7 Time 8
3.5
3.5
2.0
2.0
2.0
1.5
1.5
Control
4.0
(2.83) (2.83) (5.00) (5.00) (2.83) (2.12) (5.66) (2.12)
3.2
Placebo
3.4
3.8
3.0
2.0
3.2
4.6
3.6
(4.67) (4.09) (4.51) (3.08) (4.38) (3.08) (3.63) (3.13)
Experimental
4.2
4.5
4.2
4.0
4.8
3.0
2.2
5.3
(2.87) (3.00) (2.06) (3.16) (3.40) (2.87)
(3.56)
(3.86
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Figure 2. Plot of Condition by Time for Dyspnea Total.
experimental condition
control
placebo
experimental

Time

Regarding this interaction effect, the plot in Figure 2 suggests that the Experimental
condition has a general overall trend of improvement through time point 6 while the other
two conditions bounce around a bit, thus reflecting an interaction. However, the ANOVA is
not significant for the overall test of condition by time interaction (F(14,56) = 0.62, p = .84),
although it does have a large size effect (np2 = .23). A better result is reflected by the test for
a linear condition by time interaction with an F-value at least greater than 1, a p-value that is
much better than the overall interaction test (F(2,8) = 2.34, p = .16), and a fairly large effect
size (rjp2 = .37).
Dyspnea Effort. For the dependent variable Dyspnea Effort, the results are a little
clearer (see Figure 3). Here, neither the overall main effect for time (F(7,56) = 2.15, p =
.053) nor condition by time effect (F(14,56) = 0.86, p = .62) were significant. However, the
effects were of reasonable sizes for both the time main effect and the condition by interaction
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effect (large with r|p2 = .21 and medium with np2 = .17 respectively). Importantly, the tests
for the form of the changes were significant with large effects for both the main effect of

Figure 3. Plot of Condition by Time for Dyspnea Effort.
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time(F(l,8) = 11.63, p < .01; large np2 = .59) and the condition by time interaction (F(2,8) =
4.69, p < .05, rip2 = .54). It appears that the Experimental condition changes more over time,
more steeply, will the other two conditions are flatter over time as well as becoming worse
and better at different time points. Because of concerns regarding the use of such parametric
statistics as ANOVA with a small sample size, these data for Dyspnea Effort were re-run via
the nonparametric statistic Friedman two-way ANOVA by ranks (Siegel and Castellan,
1988). The nature of the Friedman is such that the three conditions could not be
simultaneously run. Hence, the Friedman was run once for each of the three conditions. The
only condition that resulted in a statistically significant change over time was auricular

acupressure experimental condition (control condition: *£tf=n - 7.0, p = .43; placebo: % dM
3.3, p = .86; experimental: x 2 ^ = 21.4, p < .01). These nonparametric results support those
generated by the parametric test. A final step here was an example exploration of possible
confounding effects using the dependent variable Dyspnea Effort. These results are
presented below following the results for Dyspnea Anxiety and Dyspnea Discomfort.
Dyspnea Anxiety. The dependent variable Dyspnea Anxiety has dramatic plots (see
Figure 4) that look like they would yield a significant condition by time effect. However,
although both the overall main effect for time and the overall condition by time interaction
are large effects (t|p = .26 and np = .22, respectively), the main effect for time is significant
(F(7,56) = 2.82, p < .02) while the condition by time interaction is not (F(14,56) = 1.10, p =
.38). The same pattern was found for the test of the linear form of the effects with a
Figure 4. Plot of Condition by Time for Dyspnea Anxiety.
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significant time main effect (F(l,8) = 5.64, p < .05, np2 = .41) and a non-significant condition
by time interaction (F(2,8) = 1.81, p = .23, np2 = .31).
Dyspnea Discomfort. The dependent variable Dyspnea Discomfort yielded neither
significant effects nor any easily discernable patterns (see Figure 5). For the time main
effect, neither the overall test (F(7,56) = 1.15, p = .35) nor the test for linear form (F(l,8) =
0.16) were significant and the effects were medium for the overall test (r|p2 = .13) and small
for the test for linear form (r|p2 = .02). As well, for the condition by time interaction, neither
the overall test (F(14,56) = 0.59, p = .86) nor the test for linear form (F(2,8) = 0.20) were
significant and the effects were medium for the overall test (np2 = .13) and small to medium
for the test for linear form (np = .05).

Figure 5. Plot of Condition by Time for Dyspnea Discomfort.
experimental condition
- - - control
placebo
experimental
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Demonstrating Use ofCovariates. To present a demonstration regarding the issue of
possible confounding variables, the dependent variable Dyspnea Effort is revisited here. For
examples of possible confounding variables, age and the number of family and friends living
within 50 miles of the subject's location on whom the subject could count were chosen. The
problem with using other possible confounding variables can be seen in Table 5. Note that
sex is completely confounded for the Control condition with only females in this intervention
and hence 0.00% males. Also, the variables ethnicity, marital status, and education degree
have some cells with 0.00%, indicating some complete confounding. If confounding is
complete, then the separate effects for the experimental independent variable and the
complete confounding variable are impossible to parse. With a larger sample, it would be
expected that these 0.00% cells would have some entries and, thus, no variable would be
completely confounded with condition interventions.
The first example used age as the possibly confounding variable, where the potential
confounding effects were evaluated through the use of age as a covariate. Figure 6 presents
the plots for Dyspnea Effort across the three conditions. If Figure 6 is compared to Figure 3,
where it is obvious that age as a covariate had little effect. This lack of effect was also
reflected in the statistical results. The overall age by time interaction was not significant
(F(7,49) = 2.68, p = . 14) although it was nearly a large effect (np2 = . 19). Neither was the test
of the linear form of the age by time interaction significant (F(l,7) = 1.37, p = .28) and this
effect size was medium to large (r|p2 = .26). On the other hand, the overall condition by time
interaction was still large (rip2 = .22), although, as it was without age as a covariate, not
significant (F(14,49) = 0.98, p = .49); and the test of the linear form of the condition by time
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Figure 6. Plot of Condition by Time for Dyspnea Effort with Age as Covariate.
experimental condition
- - • control
placebo
experimental

Time

interaction was still significant (F(2,7) = 5.15, p < .05) and the effect size was still large (riP
= .59), as was the case when this analysis was run without age as a covariate.
In the example of testing for possible confounding variables using as the potential
covariate support which is the number of family or close friends living within 50 miles and
on whom the subject can depend (see Figure 7 for plots). In this case, for the overall support
by time interaction, the covariate did have a significant large effect (F(7,49) = 6.79, p < .001,
x\v = .49). For the test of the form of the interaction, support did have a significant large
effect that was not linear, but rather was for a high order shape that is not easily interpreted
(F(l,7) = 8.26, p < .03, rip2 = .54). Importantly, even with such large effects, and significant
in the case of the overall interaction, the condition by time interaction effect was still large
(r|p2 = .32), although still, as it was initially, not significant (F(14,49) = 1.61, p = .11). Also
importantly, the test of the linear form of the condition by time interaction was still large and
about the same size as in the initial analysis (np2 = .52) and, although not significant as it was

Figure 7. Plot of Condition by Time for Dyspnea Effort with Support as Covariate.
experimental condition
- - - control
placebo
experimental

Time

initially the significance level is still notable (F(2,7) = 3.86, p = .074). If Figure 7 is
compared with the original Figure 3, the effects of controlling for support can be identified,
although the general patterns of the plots remain quite similar reflecting the near significant
condition by time interaction.

Hypothesis 2: Oxygen Saturation Change
Two statistical analyses were conducted to test this hypothesis about the change in
oxygen saturation being a function of the experimental condition. The first analysis uses as
the dependent variable simple percent oxygen saturation. However, as Winer, Brown, and
Michels (1991) point out, conducting ANOVAs with a dependent variable using percent or
proportion metrics is a problem. The problem is that given the nature of upper and lower
limits of such metrics, having values close to the upper or lower limits makes it difficult to
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detect the presence of interactions. A remedy for this problem is to use an arcsin data
transformation on the percentages or proportions. Given that interaction effects are the
effects of interest in this study, a second analysis was run on oxygen saturation using an
arcsin data transformation. Tables 10 and 11 present the oxygen saturation means and
standard deviations for the eight time points across the three conditions. Table 10 presents
the raw percentage values and Table 11 presents the arcsin transformed variables.
Oxygen Saturation Percent Values. See Figure 8 for plotting of the condition by time
interaction effect. The ANOVA for the dependent variable using percent values yielded no
significant effects for either the overall time main effect (F(7,56) = 0.19, p = .99) or the
overall condition by time interaction (F(14,56) = 0.66, p = .81). The effect size for the
overall time main effect was small (t|p2 = .02), while that for the condition by time interaction
was medium (riP2 = .14). The testing of the linear form of the main effect for time yielded
non-significant results (F(l,8) = 0.13, p = .73) for a small effect (r|p2 = .02). Testing for the
linear form of the condition by time interaction also yielded non-significant results (F(2,8) =
1.33, p = .32), but it did have a large effect size ((rjp2 = .25).

Table 10. Experimental Conditions: Oxygen Saturation, Percent [Mean (SD)].

Condition
Control
Placebo
Experimental

Time 1
98.5
(2.12)
95.8
(2.49)
96.5
(1.73)

Time 2
99.0
(1.41)
95.2
(0.84)
96.7
(0.96)

Time 3
98.5
(2.12)
96.8
(2.28)
96.5
(0.58)

Time
Time 4 Time 5
99.0
98.0
(2.83)
(1.41)
96.8
97.4
(2.28)
(1.52)
96.2
97.0
(1.71
(1.41)

Time 6
98.0
(2.83)
97.2
(1.30)
97.0
(0.82)

Time 7
97.5
(2.12)
97.0
(1.41)
97.5
(1.92)

Time 8
97.5
(0.71)
96.2
(2.78)
97.2
(0.96)
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Table 11. Experimental Conditions: Oxygen Saturation, Arcsin Transformed [Mean (SD)].

Condition
Control

Time 1
1.4
(0.17)
1.3
(0.15)
1.3
(0.07)

Placebo
Experimental

Time 2
1.5
(0.14)
1.3
(0.03)
1.3
(0.04)

Time 3
1.4
(0-17)
1.3
(0.10)
1.3
(0.02)

Time
Time 4 Time 5
1.4
1.5
(0.20)
(0.14)
1.3
1.3
(0.07)
(0.09)
1.3
1.3
(0.06)
(0.06)

Time 6
1.4
(0.20)
1.3
(0.06)
1.3
(0.03)

Time 7
1.4
(0.10)
1.3
(0.06)
1.4
(0.09)

Time 8
1.3
(0.03)
1.3
(0.10)
1.3
(0.04)

Figure 8. Plot of Condition by Time for Oxygen Saturation as Percent.
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Oxygen Saturation Arcsin Transformed Values. See Figure 9 for plotting of the condition by
time interaction effect. The results here were essentially the same as for the oxygen
saturation percent values dependent variable.
The ANOVA for the dependent variable using arsin transformed values did not have
significant effects for the overall time main effect (F(7,56) = 0.32, p = .94) nor for the overall
condition by time interaction (F(14,56) = 0.86, p = .61). The effect size for the overall time
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main effect was small (np2 = .04), while that for the condition by time interaction was
medium (np2 = .18). The analysis regarding the linear form of the main effect for time also
yielded non-significant results (F(l,8) = 0.24, p = .64) for a small effect (np2 = .03). As well,
the testing for the linear form of the condition by time interaction yielded non-significant
results (F(2,8) = 1.95, p = .21), although it did have a large effect size (np2 = .33). It is
interesting that although the results of both of the oxygen saturation analyses were similar,
the arcsin transformation did result in larger F-values, smaller p-values, and large effect
sizes.
Figure 9. Plot of Condition by Time for Oxygen Saturation as Arcsin Transformation.
experimental condition
— control
placebo
experimental

Time

Correlations Between Dyspnea Assessments and Oxygen Saturation
The correlations between the four measures of dyspnea over the eight time points and
the two variables used to assess oxygen saturation were evaluated. See Tables 12 and 13.
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Although there is reported in the literature some disconnect between a patient's report of
dyspnea and physical measures of functioning, the correlation here suggested that there
might be some relationship between the four dyspnea measures and the two oxygen
saturation variables. This relationship was not consistent across time or measures. However,
some of the correlations were quite large. Effect sizes for correlations are as follows: small
= .10, medium = .30, and large = .50. Some correlations here exceeded .80. This may have
been due to the small sample and, hence unreliable estimations of effect size. As an example
of testing for this, the correlation of Dyspnea Anxiety and arcsin transformed oxygen

Table 12. Correlations of Cancer Dyspnea Scale with Percent Oxygen Saturation.
CDS Scale
Total
Effort
Anxiety
Discomfort

Time 1
.21
.39
.25
-.09

Time 2
.44
.49
.72a
-.10

Time 3
.01
-.11
.37
-.23

Time
Time 4 Time 5
.62a
-.20
.52
-.12
a
.29
.61
-.30
.40

Time 6
.53
.54
.82"
.31

Time 7
.37
.25
-.15
.51

Time 8
.36
.41
.30
.25

p-values a = .05, b = .01 c = .001
Table 13. Correlations of Cancer Dyspnea Scale with Arcsin Transformed Oxygen
Saturation.
CDS Scale
Total
Effort
Anxiety
Discomfort

Time 1
.16
.33
.29
-.13

Time 2
.50
.48
.83"
-.05

p-values a = .05, b = .01 c = .001

Time 3
.23
.05
.62a
-.09

Time
Time 4 Time 5
-.14
.64a
.49
-.07
a
.31
.65
-.23
.43

Time 6
.56
.62a
.86°
.30

Time 7
.41
.29
-.16
.54

Time 8
.46
.50
.39
.32

Table 14. Spearman Rho Coefficients of Cancer Dyspnea Scale with Percent Oxygen
Saturation.*
Time
CDS Scale Time 1 Time 2 Time 3 Time 4 Time 5 Time 6 Time 7 Time 8
Total
.30
.41
-.19
.62a
-.37
.42
.32
.49
Effort
.57
-.21
.48
.39
.45
.39
.46
-.01
Anxiety
.62a
.63a
.34
.70b
-.23
.37
.11
-.06
Discomfort
.22
.57
-.10
-.26
.41
-.41
.48
-.09
p-values a = .05, b = . 01c = .001
*Note: Because of the nature of Spearman rho coefficients, they are the same for both
oxygen saturation variables. Hence, only a single table needs to be presented.

saturation (See Table 13, r = .83, p < .01) was evaluated further via the use of a scatter plot
(see Figure 10). A visual examination of the scatter plot identified one outlying subject with
a Dyspnea Anxiety score of 10 and an arcsin transformed oxygen saturation level of 1.57
(corresponding to 100 percent oxygen saturation). When this subject was removed from the
analysis, the correlation dropped to .33 (p = .36). If there are relationships between dyspnea
scores and oxygen saturation, the effects may be more medium than large.
Again, because of the small sample size, a nonparametric statistic was also used to
check the parametric results. Here, Spearman rho coefficients (Table 14) were used to
compare with the results of the Pearson product moment correlations (Tables 12 and 13).
The general pattern of results was remarkably the same. Only the relationships within Time
3 appeared to be much at variance.

Figure 10. Scatter Plot of Relationship Between Time 2 Dyspnea Anxiety andArcsin
Transformed Oxygen Saturation.
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Evaluation of Parametric Assumptions
As stated in the Methods Section, the assumption of independence is likely to have
been met here since random assignment was used and by subjects were run one at a time.
The assumption of homogeneity of variance could not be tested within the 3 (condition) by 8
(time) mixed design ANOVA due to the small sample size. The SPSS general linear model
program use to run the ANOVAs was unable to compute Box's Test of Equality of
Covariance Matrices because of sample size. Also, as stated in the Methods Section, due to
the small sample size, evaluating the assumption of sphericity and ANCOVA linearity
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assumption of the relationship between covariates and dependent variables across conditions
was not warranted.
Regarding the assumption of normality, again the small sample size limits the
usefulness of evaluation this assumption. However, for illustrative purposes, the evaluations
of the normality assumption for two dependent variables are presented here. The Dyspnea
Effort score at Time 1 had z-scores of less than 1 for both the test of skewness (z = 0.20) and
kurtosis (z = -0.82) strongly supporting the assumption of normality. Yet, an examination of
the histogram for this variable strongly suggests that the distribution was not actually normal
(see Figure 11). The second dependent variable used as an example here was that of arcsin
transformed oxygen saturation at time 1. Again, neither of the z-scores for skewness (z =
1.58) and kurtosis (z = 1.22) were significant and thus provided support for the assumption of
normality. And, again, however, a visual examination of the histogram for this variable
suggests that the distribution was not actually normal (see Figure 12).
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Figure 11. Histogram Evaluating Normality Assumption for Dyspnea Effort Time 1
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Figure 12. Histogram Evaluating Normality Assumption for Arcsin Transformed Oxygen
Saturation Time 1
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Qualitative Analysis of Themes
Qualitative data were collected, transcribed, and analyzed for themes. Subjects all
had a primary diagnosis of end-stage lung cancer. They received palliative care in a hospice
setting at the time of data collection. Subjects were interviewed twice, pre-treatment and
post-treatment. All subjects were willing to give answers to qualitative questions but at times
struggled to communicate due to medical problems, medication effects, and fatigue. Some
subjects declined to answer the first three questions of the post interview questions because
they had no additional information to share. Simple thematic analysis was performed with
the goal of identifying cogent themes that were pertinent to most subjects. There was little if
any change in themes from pre-treatment to post-treatment. The following is a discussion of
the six themes that emerged along with one global theme most frequently present outside of
the formal taping sessions.

Breathlessness
Subjects were asked to describe their experience of breathlessness. All subjects had
at least mild or intermittent bouts of breathlessness and were able to describe these
experiences vividly. Some descriptions included smothering, drowning, or being buried
alive. Subjects noted "It was horrible, sheer fright, that is it", and "Terrible, because you feel
like your gonna die." One description characterized it as "Breathlessness is not panting. It is
just short breaths without the speed."
Breathlessness was noted to be associated with fatigue and was seen as a part of
everyday life: "I am worn out. I still keep trying to walk." and "It's kinda wrapped around
everything else, I am worn out." Some subjects injected humor into their discussion: "It's an
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interesting experience. I wouldn't wish it on anybody," "It is like being one of those puffer
fish," and "I am enjoying the breath I'm getting." Finally, subjects felt that it was a symptom
that evidenced a great mortality: It's a consequence of something that's life-threatening. It's a
reminder of how close the end is."

Suffering
Most subjects denied that they experienced suffering even with repeated questions
related to the concept of suffering. Subjects were prompted with possible aspects of
suffering that included physical, spiritual, and psychological suffering. One subject stated "I
can't relate to that at all." Another gave the vague response "I can't live my life normal."
Several subjects gave responses that indicated discomfort at being cared for by others
to the questions about suffering. Some examples of these responses were: "It is watching
what my wife has to go through j ust to take care of me... waiting on me hand and feet and
this hurts me deeply." And "Suffering is irritating. Irritating is having people being bothered,
paying too much attention to me."
Finally, several subjects reported anger and sadness at the loss of ability to work and
the need to accept help from others. One noted also that the future was a "wait and see
game" of unknown further changes.
These responses may indicate that suffering was a difficult concept for subjects to
understand within the context of dyspnea; possibly they associated suffering with extreme
pain only. Alternately, subjects who self-selected for this study may have experienced less
suffering. Most subjects seemed to be accentuating the positives in their lives and
minimizing the negatives. This may have inhibited their discussion of suffering.
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Quality of Life

Quality of life questions elicited the biggest response from subjects. These responses
fell into two general subcategories: loss of abilities and changes in relationships.
Loss of abilities encompassed the areas of loss of power and energy, loss of ability to
work, and loss of ability to care for themselves. Subjects spoke about the process of adapting
to these losses while accepting some loss in the pursuit of maintaining their independence.
Losses included inability to work outside of home, accomplish activities of daily living, or
travel.
Subjects shared their experiences of loss of ability: "I can't do anything. If I could do
something I know I'd feel better, but I can't do it today." and "(activities) they are very
curtailed. The center of your life seems to be on breathing rather than on enjoying the things
in life," and "It's very much slowed me down, my ability to do normal activities has changed
incredibly."
They also shared ideas about how they adapted: "I know how to equip myself and I
go." and "I'm not doing a lot of things I used to, but you can adapt." They accepted some
losses: "It prevents me from traveling so my family has to travel without me. So it's harder
for them and not as much fun for me," and "I can't visit like I used to, talk on the phone or
any of that (for long periods)."
Changes in relationships were profound. Subjects reported the discomfort of having
their wives/partners waiting on them, of having other caring for them, the loss of socializing,
role-reversal, and loss of sex life. "I do have a babysitter.. .my daughter, she is my caretaker
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now," "Independence, it's everything, everything," "All of my independence has been taken
away," and "It seems like day by day, its using up your energy and your intelligence."
One subject spoke of changes in her relationship with her husband and said, "We
have no sex life. That's sad. God, I could cry. It's because I have no desire, that's the main
thing, I'm done with that."
Other subjects reported positive changes in their relationships due to illness: "It has
brought us closer together in a way that is almost impossible to imagine, a really deep way,"
and "I am more (emotionally) mature than I was when I came into the ICC (in-patient
center)."

Experience of Acupressure Therapy
All subjects found the experience to be pleasant, not noticeable, or minimally
uncomfortable at times. None experienced significant discomfort or stopped treatment early.
Subjects were happy with their decision to participate, even without noticeable benefits.
Two subjects noticed a significant result, one in the reduction of breathlessness and another
in the reduction of pain and use of pain medication.

The subject who reported a decrease in

breathlessness was in the placebo acupressure group. Still, his qualitative reports of
breathing more easily are also reflected in his CDS ratings for dyspnea effort across the eight
time points. His eight dyspnea effort scores for the eight time points were 3, 3, 5, 5, 0,0, 3,
4, 1. For the subject who reported less breathlessness, this was also noted by interviewer and
family members. However, the subject did not attribute this change to the acupressure. The
subject who reported using less pain medication said, "It's beneficial. I think that it might
have me not needing my Dilaudid." It should be noted this subject was in the placebo
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condition and that, although the subject attributes the lower pain and less use of medications
to the acupressure, she stopped taking the medication on the baseline day. Hence, per
experimental protocol, she did not receive placebo intervention before she stopped taking
pain medication.
Some subjects described the experience as pleasant. "Interesting and curious. It felt
very pleasant," "It's been fun, I enjoyed it," "It works out fine," "Very easy," and "I found
the whole thing interesting and I was very skeptical". Others noticed nothing during the
treatment: "It was sort of not an experience," and "It was nothing." Many subjects noted
their satisfaction in deciding to participate even if they did not notice a benefit: "I'm glad that
I participated," and "I was hopeful last time but didn't derive much benefit."
The subject who described the experience as fun and enjoyable was in the
experimental acupressure condition and on his CDS dyspnea ratings went from 10 to 3 on
effort and 15 to 8 for the total score. He is also the subject who stated that he would
recommend the treatment to others: as reported below, "Of course I would, I would
recommend it 100%." The subject who reported that the experience as being "Interesting
and curious. It felt very pleasant" was in the placebo acupressure condition and rated dyspnea
effort and total as quite high across all eight time points. The subject who reported "It was
sort of not an experience," was in the placebo acupressure group and gave very low ratings (0
and 1 's) on the CDS for all eight time points across the four days. Given his low ratings
from the first time point, he could not have shown improvement on the scales.
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Awareness of Mortality
Subjects spoke indirectly about the process of death and about fears of discomfort
during the dying process. They had an awareness that time was limited. Many mentioned
similar thoughts, of time being short, making the day count, and making the best of your time
and energy. A few subjects' comments included: "I'm half afraid of something happening,"
"I don't know what will happen at the next stage," "Things mean a lot more and I notice
things," and "I was too far gone for immediate help."

Recommendation of Acupressure for Others with Lung Cancer
Subjects generally were positive in recommending it to others in similar situations.
Some noted that it was not clearly proven to work. Others noted that it would do no harm
and there was little risk associated with trying it. Others noted that cancer put them in a
precarious position and that they would try almost anything.
The positive comments included, "Of course I would, I would recommend it 100%"
and "Absolutely, I would recommend it highly." More cautious comments included, "I
haven't seen any advantage and I haven't seen any disadvantage," and "I don't know, I really
don't know." Harm was a big component in recommending acupressure for others with lung
cancer, as evidenced by the comments such as "It didn't do me any harm " and "It didn't hurt
me any." Cancer-related comments included, "When you are in my position, you really try
anything as long as it doesn't interfere with your traditional treatment."
Finally, there was a sense of hopefulness in one subject who said, "I would
recommend anybody try it. It is something new and different, and that is where the promise
is, in something new and different I think, so yes, I would recommend it." Another subject
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said "I hope if it don't help me, it will help others with their breathing and their quality of
life." Other subjects also spoke of the possibility that the treatment might help someone else
more that it helped them.

Global Theme: Helping Others and Meaning
Subjects spoke outside of actual taping about their desire to help others with similar
health challenges and to leave something positive behind. They were looking beyond
themselves with a positive view of life, wanting to be involved with something bigger than
themselves. Many had hopeful attitudes about their own illness, and positive attitudes about
growing and maintaining relationships. They chose freely to participate in the study even
though they were experiencing fatigue and breathlessness at times during the study, and were
at the end of life. These comments and behaviors point to a desire for connection with others
and a wish to contribute to the well being of others and continuing to have meaning in their
own lives.
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Chapter 5 Discussion
Purpose of the Study and Preliminary Overview of Results
The primary purpose of this research was to conduct a pilot feasibility study for
evaluation of the effects of auricular acupressure on dyspnea in hospice patients with a
primary lung cancer diagnosis. The general conclusion regarding feasibility is that this type
of study can be done, although it is quite difficult, as has been previously reported (Storey,
2004). Of the 74 patients approached, 11 (14.9%) were enrolled as subjects. Twelve
additional patients did accept the invitation to be in the study, but before they could be
enrolled, their condition quickly deteriorated and they began the active dying process. This
emphasized the general fragility of this population. Had these 12 additional patients lived to
participate in th& study, the enrollment rate would have been 31.1%. Storey (2004) reported
that, in the hospice where he was conducting the research, there was a steadily decreasing
average length of stay that, "By the time patients were admitted they were usually too ill to
participate." (p. 393)
Importantly and similar to what is found in the literature (Ferrell and Grant, 2001;
Fine, 2003; Emanuel, et al., 2004), the subjects in this study generally stated that they liked
and valued participating in this study. It has also been reported in the literature that from half
(Williams et al., 2006) to all (Terry, et al., 2006) hospice patients said that they would like to
be in some research. As is discussed below in the sub-section on implications for future
research, it might be helpful in the initial recruitment stage to tell potential subjects that most
patients find attractive the idea of participating in research and those who have actually been
in such research state that they liked the experience.
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As part of the feasibility assessment, the planed quantitative and qualitative analyses
were carried out. The statistical analyses were used to determine whether effects were
present and to estimate effect sizes that might be used in planning future research. There was
a statistically significant effect for the auricular acupressure with the general effect sizes
being from medium to large. Even the non-significant results generally had the expected
pattern of changes over time as a function of experimental condition. The qualitative results
yielded six themes and one global theme.

Testing of Hypotheses and Estimating Effect Sizes
The experimental effects of primary interest in this study were those of treatment
condition by time interactions with the expectation that the interaction effects would be linear
in form. Linear in form means that the changes over time would have the general shape of
change in one direction. In general, estimation of these effect sizes yielded medium to large
effects with the larger effects being for linear shapes. For the dependent variable of Dyspnea
Effort, this interaction was statistically significant and linear with the effects of actual
auricular acupressure being greater than those of either the control or the placebo acupressure
conditions. It is surprising that the Dyspnea Effort was significant given the small sample
size, but it was carried by the very large effect size. Dyspnea Anxiety and Dyspnea Total
both had large condition by time interaction effects as well, although they were not
significant. Dyspnea Discomfort had much smaller effect sizes and no overall linear pattern.
ANCOVA was used to test for the effects of possible covariates when the dependent
variable was Dyspnea Effort. Dyspnea Effort was used in these examples because it had the
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only statistically significant condition by time interaction. Age and support were used as
example covariates.
Age was not related to the dependent variable and the ANCOVA results reflected this
in that the condition by time interaction was still significant and large. Given the absence of
any substantial relationship between age and the dependent variable, this was expected. For
the second example, the level of support was used because it was related to Dyspnea Effort.
Here the ANCOVA still yielded a large condition by time interaction effect, but the effect
was not significant, neither for the overall interaction nor the test of the linear form (although
the p-value for linear form was .074).
This same pattern of change was also found for the dependent variable oxygen
saturation. Here for both the raw percent and arcsin transformed variables, the condition by
time interaction effects were large ones, although neither was statistically significant. That
the same pattern of change over time was present for oxygen saturation as for dyspnea was
also reflected in the presence of some correlations between oxygen saturation and selfreported dyspnea. This is interesting because often the experience of dyspnea is not directly
related to physical assessments. Even with oxygen therapy as a treatment for dyspnea, there
is some lack of clarity as to its effectiveness.
Some research has been shown oxygen therapy to be helpful in ameliorating dyspnea
(Bruera, Stoutz, Velasco-Leiva, Schoeller, and Hanson, 1993). Other research has shown
that oxygen is not more helpful than administration of air, although both do help (Booth,
Kelly, Cox, Adams, and Guz, 1996). Sadly, a recent review of literature on oxygen and
airflow effects for treatment of dyspnea found that there were no earlier systematic reviews
of this literature and that most published studies, both case studies and case control studies,

had small samples without matched or cohort controls (Gallagher and Roberts, 2004). These
authors concluded that there is little solid high-grade scientific evidence for oxygen or
airflow improving dyspnea.
Statistical assumptions were evaluated and were technically met. However, for
example, the distributions did not look normal. Still, lack of their both not looking normal
and not being found different from normality may itself be due to the small sample size.
Larger sample sizes may indeed yield data distributions that both look reasonable and meet
assumptions. The perils of small a sample size was also apparent in the example of scatter
plots that was run (see Figure 10). Arcsin transformed oxygen saturation was highly
correlated with Dyspnea Anxiety at Time 2. However, this relationship was carried by a
single subject. When that subject was removed from the analysis, the correlation became
much smaller.

Qualitative Results
For the simple thematic analysis of qualitative data, six themes emerged along with
one global theme. The presence of six themes was surely partly due to the questions that
were asked. The six themes were breathlessness, suffering, quality of life, experience of
acupressure therapy, awareness of mortality, and recommendation of acupressure to others
with lung cancer. Strikingly, the content across these six themes was similar to that listed by
Ferrell and Coyle (2001). These included the four dimensions of quality of life: physical,
psychological, social, and spiritual, although there was not much regarding the latter (see
below). Some specific content areas listed'by these authors were also found here: social
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relationships, sexual intimacy, visiting family and friends, being a burden to others, concern
about the suffering of others because of oneself, and working and employment.
The global theme that emerged was that the subjects enjoyed and/or valued their
participation in the study. They spoke of the experience as being one of still being useful,
potentially helping others, and providing a sense of continued purpose. It may be that the
process of gathering the qualitative data was itself part of why every subject communicated
that they enjoyed and/or valued being a part of this research. The qualitative process allowed
a specific opportunity for the subjects and researcher to engage in a conversation. It is also
of note that there were some relationships between what an individual said during the
qualitative assessments and what he or she reported on the CDS.
It is also interesting that only one subject mentioned much about spirituality, and her
comment was that she did not feel that she was being punished by God. This general lack of
response may have been a function of how the question was asked or that the qualitative
questions specifically addressed the experience of dyspnea. Even the quality of life question
was focused on dyspnea. There is research that supports the important role of spirituality in
the well-being of patients with lung cancer (Meraviglia, 2004).
Regarding changes over time, many subjects reported no such major changes. This is
reflected in many subjects also not responding much to the first three qualitative questions at
the end of the study what were asked at the beginning. Notably there were some
relationships between the qualitative and quantitative analyses. For example, the one subject
who spoke of her experiences of general anxiety was also the subject who scored the highest
on Dyspnea Anxiety.

Study Limitations
Although as a feasibility study, it was expected that the sample size would not be
large, the sample size of 11 that was gathered did pose problems not only of issues of
statistical power, but for the confidence that one could have in the reliability of the estimates
of effect size. For example, this can be clearly seen in the scatter plot of Figure 10 were a
single subject can be understood as having a disproportionate affect on the estimation of the
effect size of the relationship between Dyspnea Anxiety and the arcsin transformed oxygen
saturation.
Beside sample size there is the issue of sample recruitment not reflecting
characteristics and attributes of the population being sampled. For example, there is little
ethnic or racial diversity. This means that any generalizations one might wish to make, even
based on such a small sample, would necessarily be limited. Of course, even if the sample
were large and representative of those at San Diego Hospice and Palliative Care, the
population at the San Diego Hospice and Palliative Care may not be the same as other
hospice and palliative care centers elsewhere in the country.
The researcher read the CDS out loud for nine of the 11 subjects. It is unknown what
effects this may have had on the responses of the subjects. In future research, having the
instrument read to the subjects versus the subjects being able to read the instrument
themselves would need to be evaluated. Since in this study it was the subject who
determined whether to have the researcher read the CDS, those who were having more
difficulty may have made such a request. Regarding the issue of reading effects, see the
discussion in the future research implications above.
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Although the CDS is a multi-dimensional, it is still a single instrument. Results using
other assessments may be different. This is one reason to use more than a single instrument,
even with the increase in subject research burden.
An important limitation and a possible explanation for the effects that were found in
this study is that not all personnel were blind to the experimental conditions. Although the
primary researcher and the subjects in the two acupressure conditions were blind to their
treatment, the acupuncturist was not. This could have produced a form of experimenter
expectation effect. However, the presence of such an effect here is not supported by the
pattern of results across the dependent variables. Why would such an effect affect Dyspnea
Effort, Dyspnea Anxiety, and oxygen saturation while not affecting Dyspnea Discomfort?
Nonetheless, the general issue of blindness in such research needs careful consideration.

Nursing Profession Implications
Dyspnea, a leading symptom among lung cancer patients as well as among end-of-life
patients, can create a feeling of suffocation. Further, Ferrell and Coyle (2001) report,
"Studies tell us that most people fear a protracted, painful death; unfortunately, this is what
many experience. Palliative nursing care seeks to change this" (p. 26). Ferrell and Coyle
(2001) also note, "Nurses spend more time with patients and families facing advanced illness
than do any other health care professionals and are intimately involved in all aspects of endof-life care" (p. 29). Hence, it is important that nurses understand dyspnea, its treatment, and
treatment alternatives.
It is important to keep in mind thata person can have high oxygen saturation and still
be experiencing extreme dyspnea. It is the patient's experience, not the observation of others
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that is central. Additionally, dyspnea does appear to be multi-dimensional. In this study,
using a multi-dimensional assessment of dyspnea, dyspnea related effort and anxiety
appeared to change over time due to auricular acupressure while discomfort did not. Also,
total dyspnea did not significantly change over time as a function of condition, although
some of its sub-scales did. This general point is reinforced by the previously cited research
by Carrieri-Kohlman et al. (1996) who used a visual analog scale that subjects employed to
rate components of dyspnea. The four components of dyspnea were effort in breathing,
shortness of breath, distress associated with dyspnea, and dyspnea associated anxiety. They
found that the subjects could and did differentiate among these four components. These four
components are quite similar to the three sub-scales of the CDS: effort, anxiety, discomfort.
If such procedures as auricular acupressure are shown to be helpful with symptoms
like dyspnea, it may be possible to incorporate them into the hospice and palliative care
settings. For example, Johnstone, Polston, Niemtzow, and Martin (2002) report on the
integration of acupuncture into the oncology clinic of the Naval Medical Center in San
Diego, California.
Other implications for nursing would include the education of nurses, nursing staff
faculty, and hospice staff regarding CAM and regarding research generally. Specifically, it
might be reasonable to provide information on how to complement Western Medicine with
the use of CAM in symptom management. Additionally, it might be beneficial to both end of
life patients and to the field to educate nurses regarding the potential experience of end of life
patients when they participate in research. Specifically, as reflected in this study, end of life
patient participants expressed that this experience added purpose to their lives through
potentially helping others. This might lead to nurses being appropriately less protective of

such patients when being approached by researchers seeking end of life patient participation
in research.

Future Research Implications
This feasibility study certainly demonstrated that researchers should expect such
research to take long periods of time to complete if designed as this study was. One way of
shortening the time required would be to have more than one experimenter and more than
one source of potential subjects. A possible positive implication of this study is that the
effects involved may be quite large. If so, then the required sample sizes would be smaller
than if the effects generally medium or even small. However, see the limitations of the study
section above regarding concerns about the estimation of effect sizes in this study.
Related to issues of time for recruitment and low recruitment rates, reducing subject
research burden might help. One way of reducing some potential subject burden might be to
use ratings by nursing staff and/or caregivers. Moody and McMillian (2003) found,
"Patients' and caregivers' ratings of the patient's dyspnea intensity revealed no significant
differences in ratings thus verifying that caregivers can assess dyspnea severity accurately"
(p. 1). However, if such an approach is used, there should be careful consideration of the
general issue that dyspnea is a symptom experienced by the patient. In the Moody and
McMillan (2003) study, the measurement of dyspnea was done using the Memorial Symptom
Assessment Scale (MS AS). Perhaps the results of this study are specific to this instrument.
Perhaps involvement of hospice patients, their caregivers, and hospice nurses would
be helpful in the development of research protocols that would lead to better recruitment of
subjects and a better experience for all involved, including the identification of other ways to

lessen as much as possible subject research burden. Moody, Webb, Cheung, and Lowell
(2004) report on the use of a focus group of caregivers of hospice patients with severe
dyspnea to gather information that might help in research and treatment.
Although it may add to subject research burden, thought should be given using
another dyspnea instrument in addition to the CDS. Because of its general utility, its use in a
great deal of successful previous research, its psychometric properties, and its low subject
research burden, the visual analogue scale might be considered. It was a set of such scales
that was used by Carrieri-Kohlman et al. (1996) cited above. It might be interesting and of
value to use four such scales, one for each the scores that can be derived from the CDS:
effort, anxiety, discomfort, and total.
An important design addition to future research would be not only larger samples, but
more diverse samples. Although the sample in this study was too small and had too little
diversity regarding ethnicity and race to evaluate the effects of such variables, still it would
be important in future research to assess the effects of such variables as age, sex, ethnicity,
race, education, etc., since such characteristics may be related to response to auricular
acupressure as well as to the experience of dyspnea. This would be the case for both
quantitative and qualitative methodologies. For example, Hardie, Janson, Gold, CarrieriKohlman, and Boushey (2000) found that African-Americans as compared to white patients
with asthma were different in their perception of breathlessness and in the words that they
used to describe their breathlessness during induced airflow obstruction.
Generally, it appears that the best type of research approach would seem to involve
both quantitative and qualitative methodologies. Not only for the arguments made in the
earlier section on issue of hospice and palliative care research, but because use of at least
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some qualitative methodology may be helpful in ensuring that the subjects value more being
in research and are more willing to continue in a project. It is also an opportunity for the
subjects and researchers to have conversations and exchanges that are not limited to
structured instruments. Additionally, even if there were no benefits to the researcher and the
study, use of such methodology could be considered part of what the researcher does for the
subjects and their end-of-life experience.
In the current study, most subjects requested that the researcher read the CDS to
them. Having the instrument read to a subject versus the subject reading the instrument may
have effects on subject responses. This is particularly the case since those subjects who are
having more difficulty may be more likely make such a request. For future research to
evaluate possible effects here, researchers might take all those subjects who can read the
instrument themselves and randomly assign them to one of two conditions: being read to
versus reading themselves.
Regarding qualitative open-ended questions, it is interesting to note that the dyspnea
measures showed an increase in dyspnea assessments at time 7. This was the morning of the
last day of the study. The subjects were aware that the study was then ending. It may be that
this increase in dyspnea experience reflected a more general distress response to the end of
the study, the loss of twice daily visits from the acupuncturist and the researcher, and the loss
of any perceived benefit of the acupressure. Future research might include a question about
the subjects' response to the study ending, their interest in the study continuing, their interest
in continuing acupressure, and any distress that they are experiencing at study's ending.
In the current study, the researcher,was blind to the placebo versus experimental
auricular acupressure, but the acupuncturist was not. This could have allowed for some

experimental expectation effect (see limitations of study section below). This is a common
problem for such complementary treatment studies as those involving acupuncture or
acupressure. Still, in future research, since auricular acupressure points are specific to
individuals and are thus individually placed, it may be possible to have an acupuncturist
place the seeds, but have the patient, a caregiver, a nurse, or a research assistant do the
stimulation of the seeded areas. This might be one way to reduce the opportunities for an
experimenter expectancy effect.
Finally, this study did find medium to large effect sizes for the impact of one form of
CAM on one important symptom, dyspnea. It might be reasonable for future research to
exam different CAM approaches and/or the effects of CAM on other important symptoms.
More generally, it might be of interest to evaluate the impact on general quality of life when
a patient participates in CAM approaches to the management of symptoms.

Conclusions
The primary conclusion here is that such a study is feasible. It may take longer than
initially expected, but it can be done. The experience with this study highlighted the
importance of paying attention to and attempting to improve subject recruitment.
Another conclusion would be that the results of this study suggest that there may be
medium to large effects of auricular acupressure on the experience of dyspnea. The likeliest
outcome is that the effects are probably medium, since any confidence placed in these results
should be made with caution because of the small sample size.
The CDS performed well and the importance of the multi-dimensionality of the CDS
was highlighted by the differential pattern of results across the CDS sub-scales. Still other

instruments should also be used in future research so that the results will be more
generalizable. Also, other instruments may define additional components of dyspnea.
Using both qualitative and quantitative methodology was important. In fact, the use
of both qualitative and quantitative methods might be the best way to advance the field.
Within quantitative methods, the use of both randomized control trials and quasiexperimental designs may be helpful given the difficulties of developing reasonable control
or sham conditions. Even in the face of important concerns and challenges, both ethical and
practical, palliative care research must continue to be carried out. Such research should
include compliments to Western medicine such as auricular acupressure. As stated earlier,
given the goals of palliative care, not conducting research would itself be unethical. Ferrell
(2004) writes, "There is no option to avoid research within the field of palliative care, as like
all disease areas, there is a critical need to conduct research to advance the field. Improved
care will not happen without inquiry." (p. 408)
In the end, there are two basic points. One, there is a continued need for symptom
control at end of the life (National Institutes of Health, 2005). Two, the role of nursing is
central to end of life care.
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APPENDIX A
REVISED SYMPTOM MANAGEMENT CONCEPTUAL MODEL (RSMC MODEL)
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APPENDIX B
BACKGROUND INFORMATION FORM

BACKGROUND INFORMATION
Instructions:
Please check or provide the most accurate response in each question.
Please answer every question.
The information that you give will be held in the strictest confidence and your
questionnaires will be identified only by a code.
1. What is your sex?
1. Female
2. _ Male
2. What is your age?
3. What is your marital status?
1. single
2.
married
3.
living as married
4.
separated
5.
divorced
6.
widowed
4. What is your ethnic/racial background?
This has two parts. Please answer both.
A.
1. Not Hispanic or Latino
2.
Hispanic or Latino
B.
l . _ White
2.
Native Hawaiian or Other Pacific Islander
3.
Black or African American
4.
Asian
5.
American Indian or Alaska Native
5. What is the highest educational degree you obtained?
1. none
2. high school diploma
3.
associate degree
4.
bachelor
5.
masters
6.
doctorate
7. other If other, please specify
6. What is your approximate current yearly salary?
7. How many family members and friends do you have that you can count on and that
live within 50 miles of the inpatient care center?
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APPENDIX C
THE CANCER DYSPNEA SCALE
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The Cancer Dyspnea Scale (Tanaka, et al. 2000)
We would like to ask you about your breathlessness or difficulty in breathing. Please answer
each question by circling only the numbers that best describe the breathing difficulty that you
felt during the past few days* Base your response on your first impressions.
Use the scale of
1= Not at all
2 = A little
3 = Somewhat
4 = Considerably
5 = Very much
12
1.2
12
1 2
1 2

3
3
3
3
3

4
4
4
4
4

12 3 4
1 2 3 4
1 2
1 2
12
1 2
12

3
3
3
3
3

4
4
4
4
4

5 1. Can you inhale easily?
5 2 . Can you exhale easily?
5 3. Can you breathe easily?
5 4. Do you feel short of breath?
5 5. Do you feel breathing difficulty accompanied by palpitations and
sweating?
5 6. Do you feel as if you are panting?
5 7. Do you feel such breathing difficulty that you don't know what to do
about it?
5 8. Do you feel your breath is shallow?
5 9. Do you feel your breathing may stop?
5 10. Do you feel your airway has become narrower?
5 1 1 . Do you feel as if you are drowning?
5 12. Do you feel as if something is sticking in your airway?

*For this research, on the first administration these instructions will read, "that you felt in the
last 12 hours," and on subsequent administration will read, "that you felt since the last time
you completed this scale."
Computation of three factors [subtractions adjust for 0 as state of absence of dyspnea]:
Factor 1 [sense of effort] =
(items 4 + 6 + 8 + 1 0 + 1 2 ) - 5
Factor 2 [sense of anxiety] =
(items 5 + 7 + 9 + l l ) - 4
Factor 3 [sense of discomfort] =
15 - (items 1 + 2 + 3)
For total scores add the three factors together.
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APPENDIX D
HUMAN SUBJECTS RESEARCH

Human Subjects Research
An Overview of Subject Selection and Characteristics.
The composition of the sample being studied was established by the requirements of
subject selection per the purpose, aims, and hypotheses of the study. Subjects were recruited
over the course of 2007 to 2008. These volunteer subjects were end stage lung cancer
patients hospitalized in a free-standing inpatient care center that was within a hospice.
Inclusion criteria consisted of lung cancer diagnosis, English speaking, and ability to
communicate with the researcher. There were no sex or ethnicity criteria for enrollment,
although there was an age inclusion criteria of 45 or older. It is also important to note that
none of these subjects were selected because of any present mental illness, and there were no
subpopulations chosen because of pregnancy, prisoner status, institutionalization, or for any
specific characteristic other than their being lung cancer patients enrolled in a hospice
program.
Inclusion of Women. Given the nature of the populations within hospice settings, there were
women as well as men enrolled in the study. Therefore, we believe that this investigation
adequately gathered information relevant to females and males.
Inclusion of Minorities. Minorities were present in the current study population. These
groups could have include Latino, Native American, African American, Asian (South East,
Chinese, Korean, Japanese), and Ethiopian, but only Latino and Native American enrolled.
Inclusion of Children. Due to the nature of the research question, there were no children in
the study's sample.
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Sources of Research Material.
The materials gathered were generated from patient charts, questionnaires, a pulseoximeter, and up to five open-ended questions for qualitative data that were tape recorded
and then transcribed. There were two questionnaires: a demographic survey asking for basic
descriptive information and the Cancer Dyspnea Scale (CDS). All materials were limited to
specific research purposes that were outlined in the proposal.

Potential Risks.
There were no significant risks known to be associated with the protocol. As described in
the proposal, the subjects responded to a brief demographic questionnaire, one
psychometrically sound instrument used to assess dyspnea (the CDS), and up to five openended questions that were tape recorded and transcribed. Subjects were free not to
participate and free to refuse any questions or testing they would like. No medications or
similar materials were administered to subjects, and no blood draws or invasive procedures
were included in this protocol. The treatment intervention consisted of a non-invasive
auricular acupressure procedure that involved the use of small seeds with an adhesive
backing that were applied to the ear at designated breath and anxiety related points. A
placebo condition consisted of non-invasive use of small seeds with an adhesive backing that
were applied to the ear at points other than those designated for breath and anxiety. There
were no needles used and the skin was not broken. However, there was some risk regarding
any allergic reaction to the adhesive used fpr the auricular acupuncture, although no were
present Additionally, given the age and medical conditions of these research participants, it

was possible that skin tears could take place, although, this did not happen. Finally,
participating in this protocol could have produced fatigue in the subjects over and above that
which would be found in this population generally. However, there was no more fatigue
present than they would normally have.
There was a minimal risk for psychological harm through responding to the CDS. Again
however, this scale had been used in previous research with similar populations without
reports of such harm and no such harm was reported here.
The pulse-oximeter was simply placed on the finger of the patient. This procedure was
also non-invasive involving no broken skin.

Procedures for Protecting Subjects and Minimizing Risks.
In this study, the protection of human subjects was an important consideration. The
following briefly describes the steps taken:
Informed Consent. Consent was obtained from each subject using IRB approved consent
forms. The consent form was presented to the subject along with a written description of the
study and a copy of the Medical Research Patient's Bill of Rights. The consent process, the
use of demographic questionnaire, the CDS, the pulse-oximeter, and the protocols for
managing the data were evaluated by two IRBs. One IRB was from USD and the other was
from San Diego Hospice and Palliative Care. An additional consideration for this informed
consent in this research was the enrollment of hospice patients. The National Hospice and
Palliative Care Organization (NHPCO) (Casarett, Ferrell, Kirschling, Leveton, Merriman,
Ramey, & Silverman 2001) procedures regarding the ethics of hospice participation in
research were used.
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Procedures to Protect Confidentiality. Careful procedures were instituted to protect
confidentiality. These included having all research material identified only by code numbers,
keeping any information that connects codes with specific names in a locked file cabinet with
access limited only to the research personnel working on this protocol, and keeping access to
the computer storage of information only to those individuals directly involved in this study.
Special considerations were taken regarding maintaining security of computerized
data. These include using complex passwords for access; avoiding any easily guessed
password for any of the datasets; working with computer experts; data were stored and
analyzed on a computer system isolated from the internet; and with steps taken to build a
wall against Trojan-horse-like programs. All data will be kept for 4 years before being
destroyed.
Pledges of Confidentiality were signed by the acupuncturist, statistical consultant,
transcriber, and qualitative data analyst expert. Copies of these signed Pledges of
Confidentiality can be found in Appendix H.
Risk Reduction. Subjects were asked whether they have any known allergies for adhesives or
tape. Additionally, the site of the adhesive use was monitored for any allergic reaction. Skin
integrity was monitored during both the application and removal of the adhesive to prevent
and ameliorate skin tear. Regarding fatigue, this too was monitored during the subjects'
participation in the four-day protocol. The subject were both directly asked about experience
of fatigue and observed for any evidence of increasing fatigue over the course of the
protocol.
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All Personnel Were Well Trained and Were Monitored Regarding Maintenance of
Confidentiality and Other Human Subjects Protection Issues.
The person administering auricular acupuncture was an acupuncturist (LAc) licensed
by the state of California. This individual was trained at and a graduate of the Pacific
College of Oriental Medicine.
All research staff was trained regarding confidentiality procedures. All consent forms
were in accordance with HIPAA regulations and were reviewed by two IRBs. All project
staff working on the study complied with HIPAA regulations by taking online training,
including: 1) Research Aspects of HIPAA Tutorial, 2) Basic principles of Human Research
Subjects Protection, and 3) Basic HIPAA 1021: Workforce Training. All individuals
working on the study also complied with HIPAA regulations by signing a Healthcare
Confidentiality Agreement [see Pledges of Confidentiality in Appendix H). Part of this
training and ongoing supervision involved reminders regarding the need to never put
identifying information inappropriately into the computer or onto any of the research
instruments. Once the demographic questionnaire and the CDS had been completed, no
identifying information was kept in the same database as the completed forms. Identifying
data were kept in a locked file cabinet with access limited to the doctoral student and the
specific research assistants for whom such information was essential. Furthermore, a series
of safety measures were developed and limited access to information stored in passwordprotected computers.
Use of Control Groups with Option for Treatment Procedure. Although a control group and
a placebo group were used in this study, the control group was a standard care condition and
the placebo group was a standard care condition and were also administered the same non-
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invasive auricular acupressure seed adhesives but not on breath or anxiety points. Subjects
who were randomly assigned to these conditions were given the option of receiving the
auricular acupressure seed adhesive procedure immediately following completing their
participation in the study.

Potential Benefits of the Proposed Research and the Safety Ratio.
This research helped evaluate the effectiveness of auricular acupressure in reducing
dyspnea in end of life hospice patients with lung cancer. This is a common symptom and one
that is not generally well managed. Also, the results supported the relevance of the UCSF
School of Nursing Symptom Management Faculty Group's Model for Symptom
Management to the symptom of dyspnea.
Benefits to the individual subject included the possibility of having some relief from
the experience of dyspnea. Benefits also included the possibility of having a sense of
purpose, the ability to contribute to helping other individuals who are or will be facing the
same problem. Such a sense of being useful and of value has been anecdotally reported by
end of life patients even for participating in rounds and teaching of medical students. Indeed
this experience of meaning and purpose has been reported in research literature (see Chapter
1, section Hospice and Palliative Care) and it was also reported by all but one subject in this
research study.
When one considered the low level of risk involved in this research that used only
non-invasive procedures, the careful steps to optimize confidentiality, and the potential
benefits of the research including that to the participating subjects, the ratio of risks to
potential benefits appeared to be extremely low.
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APPENDIX E
HUMAN SUBJECTS TRAINING DOCUMENTS

Human Participant Protection' "Education for Research Teams

Page

Completion Certificate

This is to certify that

Roger Strong
has completed the Human Participants Protection Education for Research Teams online course,
sponsored by the National Institutes of Health (NIH), on 06/18/2005.
This course included the following:
• key. historical events and current issues that impact guidelines andlegislation on human participant
protection in research.
• ethical principles and guidelines that should assist in resolving the ethical issues inherent in the
conduct of research with human participants.
• the use of key ethical principles and federal regulations to protecthuman participants at various stage
in the research process.
• a description of guidelines for the protection of special populations in research.
• a definition of informed consent and components necessary for a validconsent.
• a description of the role of the IRB in the research process.
• the roles, responsibilities, and interactions of federal agencies, institutions, and researchers in
conducting research with human participants.

National Institutes c
http://www

Home | Contact Us | Policies | Accessibility | Site Help | Site Map
A Service of the National Cancer Institute
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Human Participant Protections-Education for Research Teams

)

Completion Certificate
This is to certify that
Jeffrey Smith
has completed the Human Participants Protection Education for Research Teams online course,
sponsored by die National Institutes of Health (NIH), on 08/16/2007.
This course included the following:
• key historical events and current issues that impact guidelines and legislation on human participant
protection in research.
• ethical principles and guidelines mat should assist in resolving the ethical issues inherent in the
conduct of research with human participants.
• ore use of key ethical principles and federal regulations to protect human participants at various stages
in the research process.
• a description of guidelines for the protection of special populations in research.
• a definition Of informed consent and components necessary for a valid consent
• a description of the role ofthelRB in the research process.
« die roles, responsibilities, and interactions of federal agencies, institutions, and researchers in
conducting research with human participants.

National Institutes of H
http://www.nir.

Home | Contact Us [ Policies [ Accessibility [ Site Help [ Site Map
A Service of the National Cancer Institute
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Completion Report

CITI Course in The Protection of Human Research Subjects
Human Research Curriculum Completion Report
Printed on Thursday, February 1, 2007
Learner: Tom Smith (username: thurber6)
Institution: San Diego, CA-664
Contact
9326 Twin Trails Dr. #205
Information:
San Diego, CA 92129 USA
Department: Psychiatry Research
Phone: 858-642-3883
Email: dtomr@aol.com
2006 VA PRIDE Curriculum:
Stage 2. Refresher 1 Course Passed on 02/01/07 (Ref # 873056)
Date
Required Modules
complete)
101 Refresher Course - History and Ethics
02/01/07
101 Refresher Course - Regulations and Process
02/01/07
101 Refresher Course - Informed Consent
02/01/07
101 Refresher Course - Social and Behavioral Research
02/01/07
101 Refresher Course - Records Based Research
02/01/07
101 Refresher Course - Genetics Research
02/01/07
101 Refresher Course - An Overview of Research with Vulnerable
02/01/07
Subjects
101 Refresher Course - FDA Regulated Research and Conference on 02/01/07
Harmonization
101 Refresher Course - Conducting human subjects Reserch at the
02/01/07
VA
GCP Update Course: Module 1, Good Clinical Practices for VA Staff
02/01/07
GCP Update Course: Module 2, Accountability
02/01/07
GCP Update Course: Module 3, Informed Consent
02/01/07
GCP Update Course: Module 4, Safety Reporting
02/01/07
GCP Update Course: Module 5, Documentation
02/01/07
GCP Update Course: Module 6, Privacy and Confidentiality
02/01/07
GCP Update Course: Module 7, Application of GCP Concepts
02/01/07
For this Completion Report to be valid, the learner listed above must be
affiliated with a CITI participating institution. Falsified information and
unauthorized use of the CITI course site is unethical, and may be considered
scientific misconduct by your institution.
Paul Braunschweiger Ph.D.
Professor, University of Miami
Director Office of Research Education
CITI Course Coordinator
Qatnrn

Certificate: VA Research Data Security And Privacy

Employee Education System

Certificate of Completion
This is to certify that

Thomas Smith
has completed the course entitled

VA Research Data Security And Privacy
The Employee Education System has presented this
Continuing Education Activity for 1 contact hour(s)
The Employee Education System maintains responsibilityfor the program.
This On-Line Course was completed on Tue May 15 11:23:32 PDT 2007

Joy W. Hunter
Dean, VA Learning University
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APPENDIX F
AURICULAR ACUPRESSURE POINTS

Accupressure point

Placet

Shown on the left side

Shown O!

Shen Men

Ankle

Kidney

Chest

Lung

Point Jerome

Ear Acupuncture Points
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APPENDIX G
INFORMED CONSENT

(
SAN Dieqo Hospk* IRB
CENTER ton PAUIATIVE Studies

HUMAN Sutfccra tomtom
AppnovEd by-.
^=»0
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CPS STUDY #: 03-01 (
SPONSOR STUDY #

CENTER FOR PALLIATIVE STUDIES
PATIENT INFORMATION AND CONSENT FORM
PROTOCOL TITLE:

Dyspnea: Effect of Auricular Acupressure in End Stage Lur
Cancer Patients

CPS SUTUDY NUMBER:

CPS Study: 03-010-ED

SPONSOR PROTCOL NO.:

Not Applicable

SPONSOR:

Not Applicable

INVESTIGATOR:

Roger Strong, APRN, BC-PCM
San Diego Hospice & Palliative Care
4311 Third Avenue
San Diego, CA 92103

This consent form may contain words you do not know. Please ask the study nurse
the study staff to explain any words or procedures that are not clear to you.
INTRODUCTION
We are asking you to take part in a research study. The nurse in charge of the study has ft
that you meet what is required to take part in this study. Please read this consent form befi
you agree to take part in this study.
This consent form contains facts to help you decide if it is in your best interest to take part i
study. Study staff members will help with any questions that are not answered for you in th
consent form.
The Principal Investigator is a student in the Doctoral Program in the School of Nursing at t
University of San Diego. San Diego Hospice in combination with University of San Diego r
approved this study.
PURPOSE OF THE STUDY
The purpose of this research study is to evaluate the use of pressure on parts of the exterr
ear in helping control the experience of shortness of breath in lung cancer patients.
DESCRIPTION OF THE RESEARCH STUDY
This study will involve about 45 patients at one center in the United States.
Your participation will last S days.
Version Date: 03/18/2007
Approval Date: 07/11/2007
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Patient's Initials:
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Screening:
•
•
•
•
•

Researchers will explain the study to you and obtain informed consent.
You will be asked to be part of the formal study for 5 days.
If you agree, you will complete one brief background information form at the beginni
(takes about 3 minutes).
If you participate, you will agree that the researchers can look at your medical recon
record your receiving oxygen, respiratory treatments, or medications for pain or to h
you breath.
If you participate, you will be assigned to 1 of 3 usual care groups.

Randomization:
If, based upon the results of the screening tests, you continue to qualify for the study; you \
randomly assigned by chance (like a flip of a coin) into one of three treatment groups:
•
•
•

Standard care (SC).
Standard care plus auricular acupressure with points for lung and anxiety (SC + AE
Standard care plus auricular acupressure with placebo points (SC + AP).

You will have a 33-1/3% chance of receiving standard care, standard care plus auricular
acupressure with points for lung and anxiety, or standard care plus auricular acupressure \
placebo points.
The statistician will randomly assign you into one of three groups. Neither you nor your sh
nurse will know which of the treatments you are receiving. The acupuncturist, student inte
and statistician only will be aware of who is receiving the auricular acupressure (SC +AE),
auricular acupressure (SC +AP).
Audiotape Recording:
At two times you will be asked for verbal responses to some short questions. We will audi
record what you tell us. You may ask us not to record certain things, and we'll turn off the
recorder for that part. Anything you tell the researcher or assistant will be kept confidentia
the extent permitted by law. We are required by state law to report any abuse and the ide
of the alleged offender if you should tell us that information. Everything you tell us on tape
be typed without using your name. The actual tape recording of your voice will not be hes
anyone other than the investigator, research assistant, and the person typing the informat
from the tape. Following the completion of the study the tape will be erased. All of the typ
information will only use a number to identify you. Even this typed information will be desti
after 5 years. During the study the tape, and any coded information will be kept in a locke
accessible only to the researcher or assistant. You are protected by federal regulations w
require a subpoena from a court for the release of information from research studies.

Version Date: 03/18/2007
Approval Date: 07/11/2007
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If you agree to be in this study the following will occur:
Day 1
•

•
•
•
•

Once in the morning (between 7:30 and 10:30 AM) and once in the evening (betwe
4:30 and 7:30 PM), you will be administered the Cancer Dyspnea Scale, will have
oxygen level in your body assessed, and be asked a series of questions. It may be
necessary to wake you up.
Oxygen level in your body will be assessed with a small finger device that will place
over the tip of your finger This device reads your oxygen level without going throu
the skin.
Both of these will be conducted one-on-one.
All three groups will receive standard care on this day that has been ordered by th<
physician.
Each visit will take from 5 to 10 minutes.

Day 2
•

•
•
•
•
•
•

•
•
•

On the morning of Day 2 and before the early Day 2 assessments, the treatment
intervention will begin. Application of acupressure seed adhesives will be carried *
a student intern under the supervision of a licensed acupuncturist. It may be nece
to wake you up.
You will be asked whether you have any known allergies for adhesives or tape.
The experimental acupressure condition consists of placing small seeds with an
adhesive material that allows the seed to be held in place over the appropriate
acupressure point on both ears.
Before the adhesive with seeds is put in place, the auricular points are mildly stim
for 3 seconds with a surface, non-invasive probe, making a slight indentation on ti
points, then cleansed with an alcohol applicator stick.
Additionally, the site of the adhesive use will be monitored for any allergic reactior
condition will be monitored during both the application and removal of the adhesiv
prevent and treat skin tear.
Fatigue will be monitored during your participation in the four-day protocol. You v
both directly asked about experience of fatigue and observed for any evidence of
increasing fatigue over the course of the protocol.
Then, within two hours before each morning and evening assessment, research
personnel will visit you, ask a series of questions, and remind you that assessmei
happen at a specified time. If you are in one of the two-acupressure conditions,
pressure will be applied to the seeds.
Once in the morning (between 7:30 and 10:30 AM) and once in the evening (betv
4:30 and 7:30 PM), you will be administered the Cancer Dyspnea Scale and will I
oxygen levels in your body assessed.
Oxygen level in your body will be assessed with a small finger device that will be
over the tip of your finger. This device reads your oxygen level without going thrc
the skin.
Each visit will take from 5 to 10 minutes.

Version Date: 03/18/2007
Approval Date: 07/11/2007
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Day 3 and 4
Then, about two hours before each morning and evening, research personnel will visit
you, ask you a series of questions, and remind you that assessments will happen at a
specified time. If you are in one of the two-acupressure conditions, pressure will be
applied to the seeds. It may be necessary to wake you up.
Fatigue will be monitored during your participation in the four-day protocol. You will be
both directly asked about experience of fatigue and observed for any evidence of
increasing fatigue over the course of the protocol.
Additionally, the site of the adhesive use will be monitored for any allergic reaction. Skii
integrity will be monitored during both the application and removal of the adhesive to
prevent and ameliorate skin tear.
Once in the morning (between 7:30 and 10:30 AM) and once in the evening (between
4:30 and 7:30 PM), you will be administered the Cancer Dyspnea Scale and will have
oxygen levels in your body assessed.
Oxygen level in your body will be assessed with a small finger device that will placed
over the tip of your finger.. This device reads your oxygen level without going through
the skin.
Each visit will take from 5 to 10 minutes.
Day 5
•

You will be approached and told that you have finished your participation in the study.
You will be asked a series of questions, a short debriefing will take place and the
researcher will express his or her appreciation for your participation.

RISKS / DISCOMFORTS
As with all studies there are some added risks (or discomforts) to you. There may be other ris!
or discomforts we do not now know about besides those listed here.
•
•
•
•

If you have adhesive (tape) placed on your ear, it is like a small band-aid, you may hav
an allergic reaction to the adhesive or your skin may tear like when you take off a band
aid
Some mild discomfort when mild pressure is applied to the seeds
Participation in this study may lead to some fatigue
Some people may feel anxious when being part of a study, when they know that
research personnel are looking at some of their medical records or when they are fillini
out forms asking about their background information or how they are doing

Some people may find that this added amount of time and energy required during their
participation in a study to be a burden. However, it is also true, that some people find t
extra time and attention provided to them through additional appointments and attentic
from the research team to be a real benefit to them.

Version Date: 03/18/2007
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NEW FINDINGS
Your research nurse will tell you in a timely manner of any new facts he or she learns that mig
cause you to change your mind about taking part in the study. We may be able to give you th
final study results. We will tell you how to learn more about the results at the end of the study
POSSIBLE BENEFITS
You may get no direct benefit from being a part of this study. We hope you may be helped b\
•
•
•

Being able to breathe more easily
Feeling less anxious
Feel good about helping with research that aims to help those in similar situations to
yours

Also, information that we learn from this study may help future patients. It is possible, howev
that you may not be helped during or after this study.
PAYMENT FOR PARTICIPATION
We will not be giving you any payment for taking part in this research study. This is not a wa
or release of any of your legal rights.
ALTERNATIVE TREATMENTS
If you decide not to take part in this study, there are other treatments that you may discuss w
the study doctor or your Primary Care Physician. These other treatments are already avaiiab
to you here at the inpatient care center and you are eligible to receive whether you are in the
study or not. These would consist of receiving oxygen, respiratory treatments, and medicati<
for pain or difficulty in breathing.
CONFIDENTIALITY AND RELEASE OF MEDICAL RECORDS
What we talk about in this study will be kept private to the extent allowed by law. We will kei
the records under a code number rather than by name to protect your privacy. We will keep
records in locked files. Only study staff will be allowed to look at them. Your name and othe
facts that might point to you will not appear when we present this study or publish its results.
Certain persons or institutions may sometimes look at your study records and those of other
like you who take part in the study. They include:
•
•
•
•

Your study nurse and study staff
Your Primary Care Physician
San Diego Hospice & Palliative Care
San Diego Hospice Institutional Review Board (IRB)

The tape recorded and transcribed short questions will be identified by a code number, not j
name. The tape and transcription will be stored in a locked file cabinet. The results of this
research may be presented at meetings or in published articles. However, your name will b
kept private. You have already signed a separate authorization form. This form explained wl
will have access to your protected health information.
Version Date: 03/18/2007
Approval Date: 07/11/2007
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A court of law could order study records shown to other people, but this is unlikely.
COMPENSATION FOR RESEARCH RELATED INJURY
Mishaps can occur in any study. We may or may not expect them. They may be no one's fa
San Diego Hospice will provide any medical and supportive care for any harm that happens t
you from being in the study. San Diego Hospice has not set aside funds to pay you for
other costs if you are injured. You may call the San Diego Hospice, Center for Palliative
Studies at 1-619-278-6296 to learn more about this or to report problems you have with bein<
the study.
LEGAL RIGHTS
The above section does not restrict your right to seek legal assistance.
RISK MANAGEMENT
Report any unusual symptoms or side effects at once to your study nurse. If you have any
question regarding:
•
•
•
•

Your adhesives and seeds attached to your ear
Your reaction to adhesives and seeds attached to your ear
Any possible study related injury
Your participation in the study

Contact your study nurse, Roger Strong, at his work number [619-688-1600 x6280], voice n
number [619-688-1600 x6913], or cell number [619-922-4058].
CONTACT FOR QUESTIONS
If you have general questions or questions about your rights as a research subject you may
contact:
Eugene Grimshaw
Coordinator, Research Programs
San Diego Hospice
San Diego, CA 92103
Telephone: 1-619-278-6296
If you would like to speak to someone not associated with the study about your rights as a
participant, or any other matter related to the study contact:
Vice PresidemVCIO/Compliance Officer
San Diego Hospice
San Diego, CA 92103
Telephone: 1-619-278-6309

Version Date: 03/18/2007
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VOLUNTARY NATURE OF PARTICIPATION
You are free to join the study or not. You are also free to join the study and later decide to I©
for any reason. Please tell your study nurse if you wish to leave. This will allow the nurse to
you of any medical risk to your decision to leave.
WITHDRAWAL
Your study nurse has the right to stop the study at any time. He or she can stop the study wi
or without your consent for any of the following reasons:
•
•
•

If you have an adverse effect from the study treatment
If you need a treatment not allowed in this study
If you do not take keep the treatment adhesive on your ear.

Please note that the San Diego Hospice Institutional Review Board (IRB) has signified by the
Committee's stamp that it has approved this consent form. The IRB will review the consent
form each year. The form expires on the date that is on the stamp.
An IRB is a group of doctors and nurses and laypersons that review a research plan with the
aim of protecting each study's subjects from harm.

THIS SPACE INTENTIONALLY LEFT BLANK
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SUBJECT CONSENT
I know that if I qualify and would like to take part in this research study, the study nurse ma
enroll me in the study. I know that my taking part in this research study is my choice. I kn(
that I may decide not to take part or to withdraw from the study at any time. I know that I c
this without penalty or loss of benefits or treatment to which I am entitled. I also know that
study nurse or the study Sponsor may stop the study without my consent.
I have had a chance to ask the study nurse and study staff member's questions about this
study. They have answered those questions to my satisfaction.
I state by my signature below that I have read the information above
I know the conditions and procedures of the study
I know what the possible risks and benefits are from taking part in this research sti
I know that I do not give up my legal rights by signing this form
I know that I will receive a signed and dated copy of this consent form as well as a
signed and dated copy of "The Patient's Bill of Rights"

Printed Subject's Name
Subject's Signature

Date/Time

Printed Name of Legally Authorized Representative
(If applicable)
Signature of Legally Authorized Representative
(If applicable)

Date/Time

Printed Name of Person Obtaining Consent
Signature of Person Obtaining Consent

Date/Time
IRB APPROVAUEXPIF

Version Date: 03/18/2007
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CPS STUDY #: 03-01
SPONSOR STUDY #

Medical Research Patient's Bill of Rights
California law and our policy requires that any person asked to take part as a subject in
research involving a medical experiment, or any person asked to consent to such participal
on behalf of another, is entitled to receive the following list of rights written in a language in
which the person is fluent. This list includes the right to:
1.

Be informed of the nature and purpose of the research.

2.

Be given an explanation of the procedures to be followed in the medical experiment
any drug or device to be used.

3.

Be given a description of any attendant discomforts and risks reasonably to be exp
from the experiment.

4.

Be given an explanation of any benefits to the subject reasonably to be expected fr
the experiment, if applicable.

5.

Be given a disclosure of any appropriate alternatives procedures, drugs or devices
might be advantageous to the subject, and their relative risks and benefits.

6.

Be informed of the avenues of medical treatment, if any, available to the subject af
experiment if complications should arise.

7.

Be given an opportunity to ask any questions concerning the experiment or the
procedures involved.

8.

Be instructed that consent to participate in the medical experiment may be withdra
any time and the subject may discontinue participation in the experiment without
prejudice.

9.

Be given a copy of the signed and dated written consent form.

10.

Be given the opportunity to decide to consent or not to consent to a medical exper
without the intervention of any element of force, fraud, deceit, duress, coercion or
influence on your decision.

Signature of Subject

Date/Time

Signature of Witness

Date/Time

Version Date: 03/18/2007
Approval Date: 07/11/2007
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CENTER FOR PALLIATIVE STUDIES
AUTHORIZATION TO USE YOUR PRIVATE HEALTH INFORMATION
PROTOCOL TITLE:

Dyspnea: Effect of Auricular Acupressure in End Stage Lung Cane

CPS STUDY NUMBER:

03-010-ED

SPONSOR PROTCOL NO.:

Not applicable

SPONSOR:

Not Applicable

INVESTIGATOR:

Roger Strong, APRN, BC-PCM
San Diego Hospice & Palliative Care
4311 Third Avenue
San Diego, CA 92103

What is private health information? Private health information is any information that can be
to you. We need your authorization (permission) to use your private health information in this res<
The private health information that we will use and share for this study includes:
* Your past and present health information,
* Information that can be used to contact you,
s Results of your medical tests
•
Who else will see my information? This information may be shared with:
s
*
•

Your study nurse and study staff,
Your primary care physician,
Institutional committees that review research to help protect people who join research studi

Once we have shared your information, we cannot be sure that it will stay private. If you share y
information with people outside the research team, it will no longer be private. Your name will not
any report that is written.
How long will the institution use and share my information? Your information will be used i
until the research is completed. If you are participating in a clinical drug study, your records will be
maintained at the institution for no more than two (2) years after FDA approval/decline of the stuch
your study is not a clinical drug study, any records will be retained for up to but no more than four
You may not participate in this study unless you sign this approval.
What if I change my mind about sharing my research information? If you decide not to sr
informatfon anymore:

Vprcinn Oatp:

D a / i a 1 rtf O

Dr&K/M** T » * : M ^ I « » I

• The research team may continue to use the private information that they have already colli
• You will no longer be a part of the research study,
• You will still get the same medical care that you've always had at San Diego Hospice & Pall
s You must write to the study doctor and tell him or her that you no longer want to share yo
information. Write to the study nurse at:
Principal Investigator.
Complete mailing address:
Street Address
City/State/Zip
v

Roger Strong, APRN, BC-PCM
San Diego Hospice & Palliative Care
4311 Third Avenue
San Diego, CA 92103

If you do not withdraw your consent, this form will expire 25 years after the date of study <

Do I have the right to see and copy my research information? No, you may not see your r
information unless it is also being used for your health care.
If you agree to share your information you should sign this form below. You will be given a copy c

I agree to share my information as described in this form:

Printed Subject's Name
Date/Time

Subject's Signature

Printed Name of Legally Authorized Representative
(If applicable)
Signature of Legally Authorized Representative
(If applicable)

Date/Time

Printed Name of Person Obtaining Consent

Signature of Person Obtaining Consent

Version Date:
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APPENDIX H
UNIVERSITY OF SAN DIEGO IRB APPROVAL

Roger Strong
From:

Sent:
To:
Cc:
Subject:

Thomas Herrinton [herrinton@sandiego.edu]
Thursday, May 11, 2006 10:44 AM
Roger Strong; Jane Georges
Bernadette Maidonado; Sally Hardin
IRB approval of your human subjects research proposal

Ely
2006-O5-O68pas-tr
h.doc

Dear Mr. Strong and Dr. Georges,
Your request for IRB authorization of your human subjects research
proposal entitled "Dyspnea: Effect of Auricular Acupressure in End
Stage Lung Cancer Patients" has been approved. Please see the
attached Project Action Summary form for your project number and action date.
Sincerely,
Dr. Thomas R. Herrinton
IRB Administrator
Associate Provost
University of San Diego
*** eSafe scanned this email for malicious content ***
*** IMPORTANT: Do not open attachments from unrecognized senders

***
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14 November 2005

C E N T E R FOR
PALLIATIVE STUDIES
AT S A N DIEGO HOSPICE
• PALLIATIVE CARE
CHARLES VON GUNTEN, MO, PHD
MEDICAL DIRECTOR

Roger Strong, APRN, BC-PCM
San Diego Hospice & Palliative Care
4311 Third Avenue
San Diego, CA 92103

LHOASTRAUS£,PHD
CHAIR, IRS
BARBARA BAILEY, U S RN
SENIOR FACULTY
MAY BULL. RN
SENIOR FACULTY

RE: CPS Study 03-010-gD; "Dyspnea: Effects of Auricular
Acupressure in End Stage Lung Cancer Patients."

GAILRENER,MS,RN,FNP
ASSOC DIRECTOR, EDUCATION
ANN STURLEY. BSN. DLPH
ASSOC DIRECTOR, RESEARCH
JUOIMCCARTER.BA
PROJECT MANAGER
JENNIFER HMECKI, MS
COORDINATOR
TARAHICKSON
COORDINATOR
A M E E DAVIS, DA
COOROMATOR
K e a r CARTER
COOROMATOR
EUGENE GRIMSHAW.BS
COORDINATOR
DAWOHAWLEY
ASSISTANT
DIANE MUHSOH.MPH
GRANTS A DEVELOPMENT
ROBYN HUFFMAN
FINANCE

FELLOWS
K M BOWER. MD
MARIA OANILYCHEV, MO
RANDY FEDORCHUK.MD
ROBERT F R E D , MO
STEVE GRABOWSW, MO
SUZANNA MAKOWSKI. MO
WILUAM MITCHELL, MO
ANOYPROEOLUS.MO
TODOSAUER.MO
ISAAC VELMA. MO
HOLLY YANG, MO

FACULTY

Dear Mr. Strong:
The Chair of the San Diego Hospice IRB has reviewed the changes as
requested in our letter dated, July 21,2005:
Your protocol dated 28-June-200S is approved.
Your consent form dated 28-June-2005 is approved. Please find
enclosed an original, stamped, and approved consent. Please use this
copy to generate copies for consenting subjects.
Approval for this study expires on 13-July-2006
As a reminder, any modifications to the protocol or consent forms must be
approved by the IRB prior to their implementation. Any forms, except
Case Report Forms, to be used during the study, or any advertisements
must be approved by the IRB prior to their implementation. If you are
unsure as to what needs review contact this office directly at 619-2786296.

ROSLYN ALUNA. MSWIMQMLCSW
JERRY BOLTZ, BA, RN FNP
NOREEN CARRMOTON, MA LMFT
LYNETTC CEDERQUOT, MD
DEBORAH DUNNE, MSN, MBA
FRANK FERRIS, MD
-SILVIA GARCIA, MD
EU.YHANN.OO
3HEHYL HARDING, MA, RO.OHCFA
LAUREL HERB8T. MO
CHARLES LEWIS. MO
CONNIE LESUE. MSWUCSW
BEN MARCANTONK). M ED. MS
OJLBERTNACaMD
SHARON OMARY. MSN
STEVEN OPPENHSM, MO
JULIE PRAOCH.MD
RENEESMILOE,MD

All Serious or Unexpected Adverse Events must be reported in a timely
manner. If you are unsure as to what constitutes a Serious or
Unexpected Adverse Event please contact this office directly at 619-2786296.
You will be required to complete a quarterly report indicating the status of
your research. This office utilizes the following as its quarterly reporting
requirement (January/February/March - 1 * Quarter), (April/May/June 2nd Quarter), (July/August/September-3"1 Quarter),
(October/November/December - 4th Quarter).

JEFFSTONEBEnO.DO
ROGER STRONG, MSN FNP
JAY THOMAS. MO FM)
PROFESSOR 0ORI8 HOWELL. MO
DIRECTOR EMERTTA
TRUE RYNDES, AMP MPH
FOUNDING DIRECTOR

Along with quarterly reporting, federal regulations state, "An IRB shall
conduct continuing review of research covered by these regulations at
intervals appropriate to the degree ofrisk,but not less than once per
year. TJitle 21 Part 56, Section 56.109(f)]

A T5ACHJ.-.0

•:a RESEARCH n.-*:<jr.-:\

."==?3"
4311 TWrd Avenue, San Diego, CA 92103-1407

619-688-1600

www.sdhospice.org

14 November 2005
Page 2
When your study has completed you will be required to complete a Study Summary.
The San Diego Hospice is in compliance with Good Clinical Practices, the Common Rule [Title
45 CFR Part 46], the Declaration of Helsinki, the Belmont Report and the regulations set fort by
the Food and Drug Administration and all amendments thereto, contained in Title 21 of the
Code of Federal Regulations, Parts 50,56 and 312.
Please contact this office for any matters that you are unsure of by calling direct at 619-2786296.
Sincerely,

Linda G. Strause, Ph.D.
IRB Chair
Enclosure LGS/eag
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July 14, 2006

Roger Strong, APRN, BC-PCM
San Diego Hospice & Palliative Care
4311 Third Avenue
San Diego, CA 92103
RE:

CPS Study 03-010-CM: Dyspnea: Effect of Auricular Acupressure in End Stage
Dyspnea

Dear Mr. Strong:
Your application for Continuing Review was addressed at the San Diego Hospice IRB meeting
held on July 13, 2006.
The protocol dated June 28, 2005 is approved. Your consent form dated June 28, 2005 is also
approved. Your HIPAA Consent remains in effect unless amended. As a reminder, if your
consent form has been modified at this review or at any time during the study duration you are
required to re-consent all subject currently enrolled or in follow-up.
Approval for this site expires on July 12, 2007.
As a reminder, any modifications to the protocol or consent forms must be approved by the IRB
prior to their implementation. All forms to be used during the study, or any advertisements must
be approved by the IRB prior to their implementation. Contact this office at 619-278-6296 should
you have any questions.
All Serious or Unexpected Adverse Events must be reported in a timely manner. If you are
unsure as to what constitutes a Serious or Unexpected Adverse Event please contact this office
directly at 619-278-6296.
All protocol deviations or exceptions should be reported to the IRB in a timely manner:
Deviation is defined as: An incident involving noncompliance with the protocol, but one
that typically does not have a significant effect on the subject's rights, safety, welfare,
and/or integrity of the resultant data. Deviations may result from the action of the
participant, Investigator, or staff.
Exception is defined as: Accidental or unintentional changes to the IRB approved
protocol procedures without prior sponsor or IRB approval. Violations generally affect
the subject's rights, safety, welfare, and/or the integrity of the resultant data.

4311 Third Avenue • San Diego, CA 92103-1407
619-688-1600 • 866-688-1600 (tollfree)• www.sdhospice.org

July 24, 2006
Continuing Review Approval
Page 2
Per federal regulations, "An IRB shall conduct continuing review of research covered by the:
regulations at intervals appropriate to the degree ofrisk,but not less than once per year." [T
21 Part 56, Section 56.109(f)]
When you have completed your study, you will be required to complete a Final Report
Summary.
The San Diego Hospice is in compliance with the regulations Food and Drug Administration
all amendments thereto, contained in Title 21 of the Code of Federal Regulations, Parts 50,
and 312. The IRB is also compliant with ICH guidelines.
Please contact this office for any matters that you are unsure of by calling direct at 619-2786296.
Thank you.
Sincerely,

Linda G. Strause, Ph.D.
IRB Chair
Enclosure
LGS/eag
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APPLICATION FOR AMENDMENT REVIEW

San Diego Hospice
& Palliative Care

Investigator Name: Roger Strang APRN, BC-PCM
PI Phone:

619-922-4058

PI Email Address:
Sponsor Name:
Protocol Title

IRB #: 03-010-ED
PI Fax:

619-688-6599

rstrong@sdhospice.Ofg
NA

Sponsor ID #:

Dyspnea: Effect of Auricular Acupressure in End Stage Lung Cancer
Patients

REVISION OR ADDITIONS:
1. Revision or Addition Description [check all that apply]
Ex] Revision to currently approved protocol: Amendment # :
Original Version Date: 06-28-05
New Version Date: 3-18-07
Revision to currently approved consent:
Current Version Date: 06-28-05
New Version Date: 3-18-07
2. Check ail that apply:
13

This revision involves minor changes only. [Administrative or having no direct impact
or intervention pertaining to research subject]

13

This revision does not increase risks to participants enrolled in the study.

D

This revision does increase risks to participants enrolled in the study. [Include
explanation in revision description.]

3. Protocol: Submit a strikeout copy or a summary of changes to the protocol electronically.
3A. Consent From: Submit a strikeout version electronically.
4. If requesting Expedited Review, complete the IRB Request for Expedited Revie
Application.

Certification and Assurances:
I certify that this form is complete and is correct.
I accept ultimate responsibility for the conduct of this study, the ethical performance
the project, and the protection of the rights and welfare of the human subjects who;
directly or indirectly involved in this project.
I will comply with all SHDIRB policies and procedures as well as with all applicable
federal, state and local laws regarding this project.
I acknowledge that if this activity changes or extends beyond the expiration date, th<

certificate is voided.
In the event of any legal action the applicant will hold SDH IRB harmless.

Signature of Principal Investigator:

Date s>V3oy

APPROVAL STATUS

ElApp
f Approved

• Conditionally Approved

•

Not Approved

IRB Signature:

Q Rejected

jjljC^'
Steve Oppeflneirri, MD
Chair, San Diego Hospice & Palliative Care IRB

Date
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REQUEST FOR EXPEDITED REVIEW

San Diego Hospice
& Palliative Care
Investigator Name:
PI Phone:

Sponsor Name:
Protocol Title

PI Fax:

619-922-4058

PI Email Address:

IRB#:

Roger Strong APRN, BC-PCM

03-010-ED

619-688-6599

rstrong@sdhospice.org

NA

Sponsor 10 #:

| Dyspnea: Effect of Auricular Acupressure in End Stage Lung Cancer Patients

JUSTIFICATION FOR EXPEDITED REVIEW: (Also choose one of the criteria below)
Title 21 CFR Part 56 Sec 56,110 /Title 45 CFR Part 46 Sag 46.110 - Expedited review procedures for certain
kinds of research involving no more than minimal risk, Please give a brief description for your request and for mine
changes in approved research.

The risks to the subjects in this research are minimal. The only
change in the protocol and the consent form consists of adding detail
regarding the first qualitative question and noting that the response
to the four qualitative questions will be audio taped. Subjects will
be informed about the audio taping, that they may choose to not have
taped part or all of their responses, that the audiotapes and
transcripts of the tapes will be securely stored, and that the
audiotapes will be destroyed after the completion of the study.

If in your judgment your research project fails In one of the categories below, please check the appropriate box:
• CATEGORY 1: Clinical studies of drugs and devices only when condition (a) or (b) Is met (a) Research on drugs
for which an Investigational new drug application (21 CFR Part 312) is not required, (b) Research on medical devices
for which (i) an Investigational device exemption application (21 CFR Part 812) is not require; or (II) the medical
devices Is cleared/approved for marketing and the medical device Is being used in accordance with its
cleared/approved labeling.
• CATEGORY 2: Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows: (a)
from healthy, non-pregnant adults who weigh at least 110 pounds. For these subjects, the amounts drawn may not
Page 1 of 3

exceed 550 ml In an 8 week period and collection may not occur more frequently than 2 times per week;
other adults and children, considering the age, weight, and health of the subjects, the collection procedui
amount of blood to be collected, and the frequency with which It will be collected. For these subjects, the
drawn may not exceed the lesser of 50 ml or 2 ml per kg in an 8 week period and collection may not occ
frequently than 2 times per week.
• CATEGORY 3: Prospective collection of biological specimens for research purposes by non-Invasive
Examples: (a) Hair and nail clippings in a non-disfiguring manner; (b) Deciduous teeth at time of exfoliati
routine patient care Indicates a need for extraction; (c) Permanent teeth if routine patient care indicates s
extraction; (d) Excreta and external secretions (including sweat); and (e) uncannulated saliva collected e
unstimulated fashion or stimulated by chewing gumbase or wax or by applying a dilute citric solution to tr
Placenta removal at delivery; (g) Amniotic fluid obtained at the time of rupture of the membrane prior to c
labor; (h) Supra- and subgingival dental plaque and calculus, provided trie collection procedure is not mi
than routine prophylactic scaling of the teeth and the process is accomplished in accordance with accept
prophylactic techniques; (i) Mucosal and skin cells collected by buccal scraping or swab, skin swab, or rr
washings; (j) Sputum collected after saline mist nebulization.
• CATEGORY 4: Collection of data through noninvasive procedures (not including general anesthesia
routinely employed in clinical practice, excluding procedures Involving x-rays or microwaves. Where mei
are employed, they must be cleared/approved for marketing. (Studies intended to evaluate the safety ar
effectiveness of the medical device are not generally eligible for expedited review, including studies of cl(
medical devices for new indications.) Examples: (a) physical sensors that are applied either to the surfac
or at a distance and do not involve input of significant amounts of energy into the subject or an invasion c
subject's privacy, (b) weighing or testing sensory acuity; (c) magnetic resonance imaging; (d) electrocart
electroencephalography, thermography, detection of naturally occurring radioactivity, electroretinoraphy,
diagnostic infrared imaging, doppler blood flow, and echocardiography; (e) moderate exercise, muscular
testing, body composition assessment, andflexibilitytesting where appropriate given the age, weight anc
the individual.
D CATEGORY 5: Research involving materials (data, documents, records, or specimens) that have be
for any reason or will be collected solely for nonresearch purposes (such as medical treatment or diagno
FJ3 CATEGORY 6: Collection of data from voice, video, digital or Image recordings made for research DL
• CATEGORY 7: Research on group characteristics or behavior (including, but not limited to, research
perception, cognition, motivation, identity, language, communication, cultural beliefs or practices, and soc
or research employing survey, interview, oral history, focus group, program evaluation, human factors ev
quality assurance methodologies.
D CATEGORY 8: Continuing review of research previously approved by a convened IRB as follows: (a)
research is permanently closed to the enrollment of new subjects; (ii) all subjects have completed all rest
interventions; and (ill) the research remains active only for the long term follow-up of subjects; or (b) whei
subjects have been enrolled and no additional risks have been identified or (c) where the remaining rese:
activities are limited to data analysis.
• CATEGORY 9: Continuing review of research not conducted under an investigational new drug applic
investigational drug exemption where categories 2 through 8 do not apply but the IRB has determined an
documented at a convened meeting that the research involves not greater than minimal risk and no addit
have been Identified.
Expedited review Is NOT allowed for research involving persons under the age of 18 years except
collections, which are part of the usual diagnostic or therapeutic regimen of children. A full review is requ
these projects.
Certification and Assurances:
•
•
•
•

I certify that this form is complete and is correct.
I accept ultimate responsibility for the conduct of this study, the ethical performance of the project,
protection of the rights and welfare of the human subjects who are directly or indirectly involved in
I will comply with all SHO IRB policies and procedures as well as with all applicable federal, state a
laws regarding this project.
I acknowledge that if this activity changes or extends beyond the expiration date, the certificate is v

•

In the event of any legal action the applicant will hold SDH IRB harmless.

Signature of Principal mVestlgator

Z

VAL STATUS
•oved

•

Conditionally Approved

•

Not Approved

IRB Signature:
Steve Oppenheim, MD
Chair, San Diego Hospice & Palliative Care IRB

• Rejected
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REQUEST FOR EXPEDITED REVIEW

San Diego Hospice
& Palliative Care

Investigator Name:
PI Phone:

619-922-4058

PI Email Address:
Sponsor Name:
Protocol Title

Roger Strong APRN, BC-PCM

IRB #:
pi Fax:

03-010-ED

619-688-6599

rstrong@sdhospice.org
NA

Sponsor ID #:

i Dyspnea: Effect of Auricular Acupressure in End Stage lung Cancer Patients

JUSTIFICATION FOR EXPEDITED REVIEW: (Also choose one of the criteria below)
Title 21 CFR Part 56 Sec 56.110 /Title 45 CFR Part 46 Sec. 46.110 - Expedited review procedures for c«
kinds of research involving no more than minimal risk, Please give a brief description for your request and f
changes in approved research.

The risks to the subjects in this research are minimal. The onlj
change in the protocol and the consent form consists expanding tr
source of potential research participants to include those in the
hospice homecare program.

If in your judgment your research project falls in one of the categories below, please check the appropriate bo
• CATEGORY 1: Clinical studies of drugs and devices only when condition (a) or (b) is met (a) Research c
for which an investigational new drug application (21 CFR Part 312) is not required, (b) Research on medical
for which (i) an investigational device exemption application (21 CFR Part 812) is not require; or (ii) the medic
devices is cleared/approved for marketing and the medical device is being used in accordance with its
cleared/approved labeling.
D CATEGORY 2: Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows
from healthy, non-pregnant adults who weigh at least 110 pounds. For these subjects, the amounts drawn m.
exceed 550 ml in an 8 week period and collection may not occur more frequently than 2 times per week; or (b
other adults and children, considering the age, weight and health of the subjects, the collection procedure, tin
amount of blood to be collected, and the frequency with which it will be collected. For these subjects, the amc
Page 1 of 3

drawn may not exceed the lesser of 50 ml or 2 ml per kg in an 8 week period and collection may nc
frequently than 2 times per week.
D CATEGORY 3: Prospective collection of biological specimens for research purposes by non-im
Examples: (a) Hair and nail clippings in a non-disfiguring manner; (b) Deciduous teeth at time of ex
routine patient care indicates a need for extraction; (c) Permanent teeth if routine patient care indie
extraction; (d) Excreta and external secretions (including sweat); and (e) uncannulated saliva collec
unstimulated fashion or stimulated by chewing gumbase or wax or by applying a dilute citric solutJoi
Placenta removal at delivery; (g) Amniotic fluid obtained at the time of rupture of the membrane pri<
labor; (h) Supra- and subgingival dental plaque and calculus, provided the collection procedure is n
than routine prophylactic scaling of the teeth and the process is accomplished in accordance with s
prophylactic techniques; (i) Mucosal and skin cells collected by buccal scraping or swab, skin swab
washings; (j) Sputum collected after saline mist nebulization.
• CATEGORY 4: Collection of data through noninvasive procedures (not including general anestl
routinely employed in clinical practice, excluding procedures involving x-rays or microwaves. Wher
are employed, they must be cleared/approved for marketing. (Studies intended to evaluate the saf
effectiveness of the medical device are not generally eligible for expedited review, including studies
medical devices for new indications.) Examples: (a) physical sensors that are applied either to thes
or at a distance and do not involve input of significant amounts of energy into the subject or an inva
subject's privacy, (b) weighing or testing sensory acuity; (c) magnetic resonance imaging; (d) elect
electroencephalography, thermography, detection of naturally occurring radioactivity, electroretinor;
diagnostic infrared imaging, doppler blood flow, and echocardiography; (e) moderate exercise, mus
testing, body composition assessment, and flexibility testing where appropriate given the age, weigl
the individual.
D CATEGORY 5: Research involving materials (data, documents, records, or specimens) that hs
for any reason or will be collected solely for nonresearch purposes (such as medical treatment or d
K l CATEGORY 6: Collection of data from voice, video, digital or image recordings made for reseat
• CATEGORY 7: Research on group characteristics or behavior (including, but not limited to, rese
perception, cognition, motivation, identity, language, communication, cultural beliefs or practices, ar
or research employing survey, interview, oral history, focus group, program evaluation, human facte
quality assurance methodologies.
• CATEGORY 8: Continuing review of research previously approved by a convened IRB as follow
research is permanently closed to the enrollment of new subjects; (ii) all subjects have completed a
interventions; and (iii) the research remains active only for the long term follow-up of subjects; or (b;
subjects have been enrolled and no additional risks have been identified or (c) where the remaining
activities are limited to data analysis.
• CATEGORY 9: Continuing review of research not conducted under an investigational new drug
investigational drug exemption where categories 2 through 8 do not apply but the IRB has determin
documented at a convened meeting that the research involves not greater than minimal risk and no
have been identified.
Expedited review is NOT allowed for research involving persons under the age of 18 years e
collections, which are part of the usual diagnostic or therapeutic regimen of children. A full review is
these projects.
Certification and Assurances:
•
•
•
•
•

i certify that this form is complete and is correct.
I accept ultimate responsibility for the conduct of this study, the ethical performance of the pn
protection of the rights and welfare of the human subjects who are directly or indirectly involv
I will comply with all SHD IRB policies and procedures as well as with all applicable federal, s
laws regarding this project
I acknowledge that if this activity changes or extends beyond the expiration date, the certifica
In the event of any legal action the applicant will hold SDH IRB harmless.

PanR 7 of 3
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Signature of Principal Investigator

Date

APPROVAL STATUS
H'Approved

• Conditionally Approved

•

IRB Signature:
—Undo C, StrotttB, PhD—
Chair, San Diego Hospice IRB

Not Approved

D Rejected
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San Diego Hospice
& Palliative Care
Caring for Our Community
3nce 1977

July 10, 2007

Roger Strong, APRN, BC-PCM
San Diego Hospice & Palliative Care
4311 Third Avenue
San Diego, CA 92103
RE:

CPS Study: 03-010-ED
Study Title: Dyspnea: effect of Auricular Acupressure in End Stage Lung
Patients.

Dear Mr. Strong:
The IRB Chair has had the opportunity to review your request for Expedited review on 0'
1. The protocol dated 06/23/07 is approved.
Approval for this site expires on 07/12/07.
As a reminder, any modifications to the protocol or consent forms must be approved by t
prior to their implementation. All forms to be used during the study or any advertisemen
be approved by the IRB prior to their implementation. Contact this office at 619-278-629)
you have any questions.
All Serious or Unexpected Adverse Events must be reported in a timely manner. Shoulc
unsure as to what constitutes a Serious or Unexpected Adverse Event, please contact tr
directly at 619-278-6296.
All protocol deviations or exceptions should be reported to the IRB in a timely manner:
Deviation is defined as: An incident involving noncompliance with the protocol, bi
that typically does not have a significant effect on the subject's rights, safety, wei
and/or integrity of the resultant data. Deviations may result from the action of the
participant, Investigator, or staff.
Exception is defined as: Accidental or unintentional changes to the IRB approved
protocol procedures without prior sponsor or IRB approval. Violations generally i
the subject's rights, safety, welfare, and/or the integrity of the resultant data.

4311 Third Avenue • San Diego, CA 92103-1407
619-688-1600 • 866-688-1600 (toll free) • www.scihospice .org

208

July 10,2007]
Continuing Review Approval
Page 2
Per federal regulations, "An IRB shall conduct continuing review of research covered by
regulations at intervals appropriate to the degree ofrisk,but not less than once per year
21 Part 56, Section 56.109(f)]
When you have completed your study, you will be required to submit a close-out letter ai
complete a Final Summary Report.
The San Diego Hospice is in compliance with the regulations Food and Drug Administra
all amendments thereto, contained in Title 21 of the Code of Federal Regulations, Parts
and 312. The IRB is also compliant with ICH guidelines.
Please contact this office for any matters that you are unsure of by calling direct at 619-2
6296.
Thank you.
Sincerely,

Steve Oppenheim, MD
IRB Chair
Enclosure
SO/eag
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San D i e g o H o s p i c e
& Palliative Care
Caring for Our Community
3nce 1977

July 11, 2007
Roger Strong, APRN, BC-PCM
San Diego Hospice & Palliative Care
4311 Third Avenue
San Diego, CA 92103
RE:

CPS Study: 03-010-ED
Study Title: Dyspnea: Effect of Auricular Acupressure in End Stage Lung Cane
Patients

Dear Mr. Strong:
Your application for Continuing Review was addressed at the San Diego Hospice IRB n
held on July 11, 2007.
1. The protocol dated 06/23/07 is approved.
2. Your consent form dated 03/18/07 is approved.
3. Your HIPAA Consent meets the requirements as set forth in Privacy Rule and s1
If your consent was modified, you are required to re-consent those subjects currently or
or in follow-up.
Approval for this site expires on July 10, 2008.
As a reminder, any modifications to the protocol or consent forms must be approved by
prior to their implementation. All forms to be used during the study or any advertisemer
be approved by the IRB prior to their implementation. Contact this office at 619-278-62$
you have any questions.
All Serious or Unexpected Adverse Events must be reported in a timely manner. If you
unsure as to what constitutes a Serious or Unexpected Adverse Event please contact tr
directly at 619-278-6296.
All protocol deviations or exceptions should be reported to the IRB in a timely manner:
Deviation is defined as: An incident involving noncompliance with the protocol, b
that typically does not have a significant effect on the subject's rights, safety, we
and/or integrity of the resultant data. Deviations may result from the action of th<
participant, Investigator, or staff.

4311 Third Avenue • San Diego, CA 92103-1407
619-688-1600 • 866-688-1600 (toll free) • www.sdh0spice.0r9
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July 11, 2007
Continuing Review Approval
Page 2
Exception is defined as: Accidental or unintentional changes to the IRB approv
protocol procedures without prior sponsor or IRB approval. Violations generall
the subject's rights, safety, welfare, and/or the integrity of the resultant data.
Per federal regulations, "An IRB shall conduct continuing review of research covered I
regulations at intervals appropriate to the degree of risk, but not less than once per ye
21 Part 56, Section 56.109(f)]
When you have completed your study, you will be required to submit a close-out letter
complete a Final Summary Report.
The San Diego Hospice is in compliance with the regulations Food and Drug Administ
ail amendments thereto, contained in Title 21 of the Code of Federal Regulations, Par
and 312. The IRB is also compliant with ICH guidelines.
Please contact this office for any matters that you are unsure of by calling direct at 61!
6296.
Thank you.
Sincerely,

Steve Oppenheim, MD
IRB Chair
Enclosure
SO/eag

San D i e g o H o s p i c e
& Palliative Care
Caring for Our Community
Snce1977

July 11, 2007
Roger Strong, APRN, BC-PCM
San Diego Hospice & Palliative Care
4311 Third Avenue
San Diego, CA 92103
RE:

CPS Study: 03-010-ED
Study Title: Dyspnea: Effect of Auricular Acupressure in End Stage Lung Cane
Patients

Dear Mr. Strong:
Your application for Continuing Review was addressed at the San Diego Hospice IRB i
held on July 11, 2007.
1. The protocol dated 06/23/07 is approved.
2. Your consent form dated 03/18/07 is approved.
3. Your HIPAA Consent meets the requirements as set forth in Privacy Rule and s
If your consent was modified, you are required to re-consent those subjects currently oi
or in follow-up.
Approval for this site expires on July 10, 2008.
As a reminder, any modifications to the protocol or consent forms must be approved by
prior to their implementation. All forms to be used during the study or any advertisemei
be approved by the IRB prior to their implementation. Contact this office at 619-278-62!
you have any questions.
All Serious or Unexpected Adverse Events must be reported in a timely manner. If you
unsure as to what constitutes a Serious or Unexpected Adverse Event please contact tl
directly at 619-278-6296.
All protocol deviations or exceptions should be reported to the IRB in a timely manner:
Deviation is defined as: An incident involving noncompliance with the protocol, t
that typically does not have a significant effect on the subject's rights, safety, we
and/or integrity of the resultant data. Deviations may result from the action of th
participant, Investigator, or staff.

4311 Third Avenue • San Diego, CA 92103-1407
619-688-1600 • 866-688-1600 (toll free) • www.sdhospice.org

July 11, 2007
Continuing Review Approval
Page 2
Exception is defined as: Accidental or unintentional changes to the IRB approve
protocol procedures without prior sponsor or IRB approval. Violations generally
the subject's rights, safety, welfare, and/or the integrity of the resultant data.
Per federal regulations, "An IRB shall conduct continuing review of research covered b
regulations at intervals appropriate to the degree ofrisk,but not less than once peryei
21 Part 56, Section 56.109(f)]
When you have completed your study, you will be required to submit a close-out letter
complete a Final Summary Report.
The San Diego Hospice is in compliance with the regulations Food and Drug Administi
all amendments thereto, contained in Title 21 of the Code of Federal Regulations, Pari
and 312. The IRB is also compliant with ICH guidelines.
Please contact this office for any matters that you are unsure of by calling direct at 61J
6296.
Thank you.
Sincerely,

Steve Oppenheim, MD
IRB Chair
Enclosure
SO/eag
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APPENDIX J
PLEDEGES OF CONFIDENTIALITY

Acupuncturist's Pledge of Confidentiality
I will be participating in this research project as a licensed Acupuncturist administering
auricular acupressure. Although I will know the names of the participants, I will not
purposefully acquire other identifying information. In any case, I agree to maintain the
confidentiality of the participants. I will maintain confidentiality by not discussing anything
that I learn about the participants with anyone for any reason and by not identifying the
participants to others in any way. I understand that if I do not maintain confidentiality that
the participants' right to privacy will be seriously violated and that this will constitute
unethical behavior that will jeopardize this research project.

Jefferv S. Smith. L.Ac.. MSTOM. National Diplomat of OM
Name of Acupuncturist

Date: <4~ L~Ql

S^gn^tjfre of Acupuncturist
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Transcriber's Pledge of Confidentiality
I will be participating in the transcription of audio taped research interviews to typed 1
will not purposively know the names of the participants being interviewed. However,
inadvertently obtain information that would give me clues to participants' identity. I i
maintain the confidentiality of the participants. I will maintain confidentiality by not
discussing the information that I transcribe with anyone for any reason and by not ide
the participants to others in any way. I understand that if I do not maintain confidenti
that the participants' right to privacy will be seriously violated and that this will const
unethical behavior that will jeopardize this research project.

Jennifer Mitch. RN.BSN
Name of transcriber

signature of'transcriber

Statistical Consultant's Pledge of Confidentiality
I will be participating in this research project as a statistical consultant. I will not know th
names of the participants. I will not purposefully acquire other identifying information. Ii
any case, I agree to maintain the confidentiality of the participants. I will maintain
confidentiality by not discussing anything that I learn about the participants with anyone f
any reason and by not identifying the participants to others in any way. I understand that i
do not maintain confidentiality that the participants' right to privacy will be seriously
violated and that this will constitute unethical behavior that will jeopardize this research
project.

Tom L. Smith. Ph.D.
Name of statistical consultant

Date:<p6>/~(9f—

:ghature of stat^tic^ri-eorisultant

Qualitative Data Analyst Expert's Pledge of Confidentiality
I will assist in the qualitative analysis of transcribed audio taped research interviews,
not purposively know the names of the participants being interviewed. However, I m
inadvertently obtain information that would give me clues to participants' identity. I
maintain the confidentiality of the participants. I will maintain confidentiality by not
discussing the information that I help analyze with anyone for any reason and by not
identifying the participants to others in any way. I understand that if I do not maintai:
confidentiality that the participants' right to privacy will be seriously violated and tha
will constitute unethical behavior that will jeopardize this research project.
Rhoberta J. Haley. Ph.D.. RN
Name of Qualitative Data Analyst Expert
Date:

/'/jf

Signature of Qualitative/Data Analyst Ei
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APPENDIX K
NON-ENROLLED SUBJECT CHARACTERISTICS

Characteristics: Approached Eligible Subjects Who Did Not Participate
Variable
Sex

N = 54
male
female

Mean(SD)orN(%)
24 (44.3)
30 (55.6)
Age
72.8 (9.83)
Location Home Care
51 (94.4)
ICC
3 (5.6)
Died
Reason
13 (24.1)
SNF*
2 (3.7)
Declined no specific reason
17(31.5)
Declined fatigue
14 (25.9)
Declined fatigue/appointments 2 (3.7)
Declined by family/spouse
3 (5.6)
Declined study length
1 (1.9)
Declined anxiety
1 (1.9)
Declined appointments
1(1.9)
* moved to Skilled Nursing Facility
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APPENDIX L
TIME TO DEATH OF SUBJECTS ENROLLED

Enrolled Subjects: Characteristics and Number of Days Between End of Study
Participation and Subjects' Death as of 5-08-09
End Date of
Study
Ss
Number Sex
Age Participation
001
F
75
7/12/07
F
80
7/27/07
002
M
89
8/2/07
003
64
8/1/07
004
M
M
80
9/24/07
005
F
85
9/27/07
006
54
11/2/07
M
007
12/18/07
F
49
008
75
1/14/08
F
009
F
2/19/08
010
53
55
2/23/08
011
M
=
skilled
nursing
facility
*SNF
= homecare
HC
B/C = board & care
ICC = inpatient care center
** Still alive as of 5-08-08

Date of
Death
9/10/07

No. Days
Until Death
60

**
**

**
**

11/21/07
10/29/07
12/8/07

112
35
72

**

**

5/7/08
3/21/08
2/25/08
3/4/08

141
81
6
10

Death Location*
SNF

HC
SNF
B/C
ICC
HC
ICC
HC
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Dear Strong*1.
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I'm Dr. Tanak^,, a physician in Palliative Care Unit, who developed the
Cancer Dyspnea Scale. Dr. Uchitomi sent your mail to me.
It is our pleasure1.that you are planing the study using the CDS.
Acupuncture and accupressure are used to alleviate symptoms also in cancer
patients. But they are not regarded as "medicine". They are delivered not
.in Jssspltal nor even in PCU. There is few reports showing how it works, and
few or no scientific studies on it.
I suppose CAM like acupuncture and accupressure is perhaps more widely
applied to patients in USA than in Japan.
Sincerely,
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Keiko TANAKA M.D., Ph.D.
Division of Palliative Medicine,
Shizuoka Cancer Center Hospital
Naga-izumi, 411-8777, JAPAN
Tel: +81-55-989-5222
Fax:+ 81-55-989-5634
**********************

Rightslink Printable License

NATURE PUBLISHING GROUP LICENSE
TERMS AND CONDITIONS
Apr 14, 200

This is a License Agreement between Roger A Strong ("You") and Nature Publishing Qrouj
("Nature Publishing Group"). The license consists of your order details, the terms and
conditions provided by Nature Publishing Group, and the payment terms and conditions.
License Number

1927770747259

License date

Apr 14, 2008

Licensed content publisher

Nature Publishing Group

Licensed content publication British Journal of Cancer
Licensed content title

Development and validation of the Cancer Dyspnoea Scale: a

Licensed content author

Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y.

multidimensional, brief, self-rating scale.

Volume number

82

Issue number

4

Pages

800-805

Year of publication

2000

Portion used

Text

Requestor type

Student

Type of Use

Thesis / Dissertation

PO Number
Total

0.00 USD

Terms and Conditions

Terms and Conditions for Permissions
Nature Publishing Group hereby grants you a non-exclusive license to reproduce this
material for this purpose, and for no other use, subject to the conditions below:
1. NPG warrants that it has, to the best of its knowledge, the rights to license reuse of
this material. However, you should ensure that the material you are requesting is
original to Nature Publishing Group and does not carry the copyright of another entity
(as credited in the published version). If the credit line on any part of the material you
have requested indicates that it was reprinted or adapted by NPG with permission
from another source, then you should also seek permission from that source to reuse
the material.
2. Permission granted free of charge for material in print is also usually granted for any
electronic version of that work, provided that the material is incidental to the work as
a whole and that the electronic version is essentially equivalent to, or substitutes for,
the print version. Where print permission has been granted for a fee, separate
permission must be obtained for anv additional, electronic re-use (unless, as in the

Rightslink Printable License
case of a full paper, this has already been accounted for during your initial request in
the calculation of a print run). NB: In all cases, web-based use of full-text articles
must be authorized separately through the 'Use on a Web Site1 option when requesting
permission.
3. Permission granted for a first edition does not apply to second and subsequent edition:
and for editions in other languages (except for signatories to the STM Permissions
Guidelines, or where the first edition permission was granted for free).
4. Nature Publishing Group's permission must be acknowledged next to the figure, table
or abstract in print. In electronic form, this acknowledgement must be visible at the
same time as the figure/table/abstract, and must be hyperlinked to the journal's
homepage.
5. The credit line should read:
Reprinted by permission from Macmillan Publishers Ltd: [JOURNAL NAME]
(reference citation), copyright (year of publication)
For AOP papers, the credit line should read:
Reprinted by permission from Macmillan Publishers Ltd: [JOURNAL NAME],
advance online publication, day month year (doi: 10.1038/sj.[JOURNAL
ACRONYMJ.XXXXX)
6. Adaptations of single figures do not require NPG approval. However, the adaptation
should be credited as follows:
Adapted by permission from Macmillan Publishers Ltd: [JOURNAL NAME]
(reference citation), copyright (year of publication)
7. Translations of 401 words up to a whole article require NPG approval. Please visit
http://www.macmiIlanmedicalcommunications.com for more information.
Translations of up to a 400 words do not require NPG approval. The translation
should be credited as follows:
Translated by permission from Macmillan Publishers Ltd: [JOURNAL NAME]
(reference citation), copyright (year of publication).
We are certain that all parties will benefit from this agreement and wish you the best in the
use of this material. Thank you.
vl.l

226

From: Roger Strong
Sent: Tuesday, April 01, 2008 8:34 PM
To: 1oumalsriQht5@oxon.blaclwellpublisinq.com
Subject: Permission to use Figure
Blackwell Publishing
Company
04-01-08
To Whom This May Concern:
I am a doctoral student at the University of San Diego in the School of Nursing. I am in the
process of completing my dissertation. I am requesting permission to use the Revised Symptom
Management Conceptual Figure in my dissertation. This is found in the following reference:
DoddrM.1Janson,S.,Facione>N.>Froelicher,E.S.,Humphreys,J.1Lee,K.,MiaskowskilC, Puntillo, K.,
Rankin, S..& Taylor ,D .(2001). Advancing the science of symptom management. Journal of
Advanced Nursing, 33 (5), 668-676
Thank you,
Roger A. Strong ,RN, PhD(c)
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From: Byers, Sally - Oxford rmailto:sally.byers@wiley,com]
Sent: Friday, April 18, 2008 6:41 AM
To: Roger Strong
Subject: RE: Request for Permission to Use Figure for Doctoral Dissertation

Dear Roger Strong,
Thank you for your email request. Permission is granted for you to use the material below for
your thesis/dissertation, subject to the usual acknowledgements and on the understanding that you
will reapply for permission if you wish to distribute or publish your thesis/dissertation
commercially.
With best wishes,
Sally
Sally Byers
Permissions Assistant
Wiley-Blackwell Publishing
PO Box 805
9600 Garsington Road
Oxford OX4 2DQ
UK
Tel.01865 476149
Fax. 01865 471149
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Subject: RE: Request For Permission to Use Diagram and Table
Hello Roger,
You have our permission to reproduce this illustration and diagram for the limited purpose
mentioned here (dissertation).
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John O'Connor
Managing Editor
Eastland Press
info@eastlandpress.com

From: Roger Strong rmailto:rstrona@SDHospice.ora1
Sent: Sunday, April 06, 2008 10:15 AM
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Subject: Request For Permission to Use Diagram and Table
Eastland Press,INC
Po Box 99749
Seattle,WA08139
TO WHOM IT MAY CONCERN:
My name is Roger Strong, doctoral student, in the School of Nursing, at the University of San
Diego. I am completing my dissertation currently and going to defend it this month. I am
requesting permission to use Diagram 3-54 on page 478 and Table 3-5 on pages 479-490.
This is located in the following book: O'Connor ,J.& Bensky ,D.(1981).Acupuncture: A
comprehensive text .Seattle: Eastland Press Inc. My dissertation is Titled: Dyspnea :Effect of
Auricular Acupressure on Lung Cancer End Stage Patients
Thank you for your help,
Roger A. Strong,PhD(c), RN

